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PREFACE
The investigations which form the main part of this thesis 
were carried out between 1955 and 1958 in the University 
Department of Medicine, Gardiner Institute, Western Infirmary, 
Glasgow. They comprise observations on more than 800 subjects 
all of whom have been studied by me personally.
Some of the conclusions have already been published 
in the following communications.-
’♦The Red Cell Mass in Thyrotoxicosis and i/yxoedema”. Clinical 
Science (1957) 16> 309* (with F.P. Muldowney and E.J. Wayne). 
•♦The Sleeping Pulse Rate in Thyrotoxicosis”• Scottish Medical 
Journal (1958) j>,> 120. (with I.P.C* Murray).
”The Basal Metabolic Rate in Thyrotoxicosis” Lancet (1958) 
i_, 604. (with I.P.O. Murray and E.J. Wayne).
The following papers have been accepted for publication.- 
•♦Statistical Methods Applied to the Diagnosis of Thyrotoxicosis”. 
Quarterly Journal of Medicine (with I.P.C. Murray and E.J. Wayne)0 
’♦Studies of Body Composition in Normal and Pathological States 
Using Isotope Dilution Techniques”. Proceedings of the 2nd 
World Conference on the Peaceful Uses of Atomic Energy. Geneva, 
1958. (with M.M. Bluhm and E.J. Wayne) .
The section which deals with the medical treatment of 
thyrotoxicosis has already been presented in abbreviated 
form to the British Pharmacological Society during their 
annual meeting in Glasgow in 1958*
The majority of the observations made in this thesis has 
been carried out by the author himself. He would like, however, 
to acknowledge the help he has received from his collaborators 
at both the clinical and technical levels. Dr. R. A. Robb, 
Mitchell Lecturer in Statistics, University of Glasgow, has 
given throughout the work invaluable advice on the statistical 
aspectse
Finally the author wishes to acknowledge the continued 
interest of Professor E. J. Wayne who first inspired him to 
take an interest in the field of thyroid disease and who 
provided the clinical and laboratory facilities which have 
made this thesis possible*
Whereas in the past clinicians relied on the empirioal 
application of clinical impressions in the diagnosis and 
treatment of disease, latterly they have tended to place 
increasing emphasis on indices derived from laboratory 
procedures.
This tendency has developed notably in the assessment 
of thyroid gland function since many reliable laboratory aids 
have become available in recent years. The advent of these 
new diagnostic techniques, such as radioactive iodine studies, 
has decreased the value accorded to clinical evidence in the 
diagnosis of thyrotoxicosis. Further, no comparison of the 
diagnostic accuracy of clinical and laboratory procedures is 
to be found in the literature. Part I of this thesis describes 
an investigation designed to provide this comparison and for 
this purpose statistical techniques have been applied to clinical 
evidence in an attempt to increase the precision of clinical 
diagnosis*
The logical sequel to this investigation was an evaluation 
of the therapeutic measures available to the physician in the 
treatment of thyrotoxicosis. Part II of the thesis, which 
is concerned with this subject, again emphasises the correlation 
between clinical methods and laboratory procedures. The first 
section compares the effectiveness of the antithyroid drugs, 
potassium perchlorate, methyl thiouracil and carbimazole, while 
the second section comprises a study of different methods of
estimating dosage of radioactive iodine and an' assessment 
of the results of this form of treatment.
The treatment of a thyrotoxic patient represents a 
dynamic metabolic experiment. Advantage has been taken 
of this fact to apply biochemical and radioisotopic 
techniques to a study of the changes in the total red cell 
mass and total exchangeable electrolytes produced by the 
disease. Part III of the thesis describes these investigations.
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PART I
THE DIAGNOSIS OP THYROTOXICOSIS
2.
Physicians in general approach the diagnostic problem 
of suspected thyrotoxicosis by investigating four aspects of 
thyroid function and the methods by which a diagnosis can 
be reached are conveniently classified in the following way.-
(1) The effects of the thyroid hormone on target cells#
(a) Symptoms and signs (clinical diagnosis)*
(b) Basal metabolic rate.
(c) Cardiac effects (e.g. sleeping pulse rate)*
(d) Serum cholesterol*
(2) The amount of thyroid hormone released*
(a) Serum protein bound iodine*
(b) Serum protein bound radioactive iodine*
(3) The iodine requirements of the thyroid*
(a) The uptake of radioactive iodine by the thyroid*
(b) The clearance of radioactive iodine by the thyroid*
(c) Urinary excretion of radioactive iodine*
(4) Response to anti-thyroid drugs (therapeutic trial).
These different methods measure various aspects of thyroid 
function but althoiigh there is an extensive literature on each 
method there is a paucity of data which would allow a comparison 
of the diagnostic effectiveness of the various procedures*
This is especially true when one attempts to compare the value 
of the clinical diagnosis with the other methods*
In this section of the work I will describe a method of 
clinical diagnosis which I believe increases the diagnostic
value of clinical evidence. I have compared the results 
of the clinical diagnosis with those given by radioactive 
iodine studies, basal metabolic rate estimations, sleeping 
pulse rate, and serum cholesterol levels. I have also used 
the data made available by this investigation to study the 
way in which these various parameters of thyroid function 
reflect the severity of the disease*
SECTION 1
The Background to the Present Study*
The clinical diagnosis.
The clinical picture called thyrotoxicosis was first 
described by the Bath physician, Caleb Parry, in 1786 but his 
account of the disease was not published until after his death 
(Parry, 1825). Robert Graves of Dublin, published three 
cases of the disorder in 1835 and first drew attention to 
the relation of the ocular complications to the diseaseo 
The most complete of the early clinical descriptions of the 
condition is acknowledged to be that of von Basedow (1840) 
and little has been added to this description up to the 
present day. Apart from identifying other clinical features 
of the disease he emphasised the diagnostic importance of the 
triad of exophthalmos, goitre, and palpitation.
Trousseau (i860) who labelled the condition Graves fe Disease, 
regarded the syndrome as a neurosis analogous to hysteria*
The suggestion, however, that the clinical features were due 
to excessive thyroid secretion was not made until 1884 by 
Rehn who performed the first sub-total thyroidectony.
Plummer (1923) concluded that Graves *s Disease or 
exophthalmic goitre was a different clinical entity to 
"adenomatous goitre with hyperthyroidism” basing his opinion 
on the varying therapeutic effect of iodine on the clinical 
features of the disease. Fraser (1926), however, did not subscribe 
to this opinion and concluded that these two conditions were 
different phases of the one disease (Fraser, 1931)* He was
supported in this view by Marine (1927) and Harington (1933,
1935)• Exophthalmic goitre, toxic nodular goitre, and toxic 
adenoma are now generally accepted to be variations of the 
same disease. I have accepted this view throughout the present 
study and have used the term thyrotoxicosis to describe the 
various combinations of symptoms and signs associated with 
excessive thyroid activity.
Radioactive iodine studies.
Following the initial studies of thyroid physiology 
using radioactive iodine by Hertz et al (1938), both he 
(1942) and Hamilton and Soley (1940) pursued these observations 
in disorders of thyroid function. They established the 
inverse relationship of thyroid uptake and urinary excretion 
of radioiodine. Since then various tests of thyroid function 
using radioactive iodine have been described and an extensive 
literature has resulted which has been reviewed by Werner 
et al. (1950) and Macgregor and Wayne (1957) • These tests 
fall into four main groups —  the percentage of the dose 
of radioactive iodine taken up by the gland at a fixed time; 
the clearance rate of radioactive iodine by the gland; the 
amount of radioactivity excreted in the urine; and the measurement 
of protein bound radioactivity. The relative value of the 
different tests still remains a matter of controversy. McConahey 
et al0 (1956) considered that a six-hour uptake was the best
routine radioactive iodine test. On the other hand, Pochin 
(1950) considered that the "neck to thigh11 ratio, which 
correlates closely with thyroidal clearance of radioactive 
iodine, was more likely to he conclusive than measurements 
of urinary, plasma, or external body counting rates# Fraser 
(1953) favoured urinary radioactive iodine measurements to 
discriminate between hyperthyroid and euthyroid subjects#
In a large series Goodwin et al. (1951) compared the relative 
diagnostic value of seven of these tests and concluded that 
the 48-hour protein bound radioactive iodine was the best single 
test. After further experience with this test, Wayne (1954) 
advocated its combination with the 4-hour uptake of radioactive 
iodine in order to improve the diagnostic accuracy. It is 
abundantly clear from the literature that these standard 
radioactive iodine tests have a high degree of diagnostic 
accuracy, that no one test is infallible, and that a clear 
comparison between them is made difficult by the varying 
selection of cases, and the impracticability of carrying out 
all the tests in one series# In the present series the radio­
active iodine criteria chosen were the 4-hour uptake and the 
48-hour protein bound radioactive iodine.
Basal metabolic rate.
Magnus-Levy (1895) first described the characteristic 
elevation of the basal metabolic rate associated with overactivity 
of the thyroid gland# Over many years, estimation of the 
basal metabolic rate has been a standard method of assessing
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thyroid function and its value has been well established.
The subject is well reviewed by Du Bois (1936) and l^ller (1927). 
There are, however, three circumstances which decrease the 
reliability of the test and which are worthy of special consideration.
(a) Normal basal metabolic rates in thyrotoxicosis.
The possibility that a normal basal metabolic rate might 
be found in thyrotoxicosis was considered as early as 1916 
by Du Bois. This association has been found by many workers 
including Means (1937)* Bartel (1950) and Crooks, Murray and 
Wayne (1958) and accounts for the majority of the diagnostic 
errors given by estimation of the basal metabolic rate in the 
present investigation.
(b) Elevated basal metabolic rates in patients without 
thyroid disease.
The basal metabolic rate has been found to be elevated 
in leukaemia (Grafe, 1911), polyeythaemia (Minot and Buckman,
1923)> Hodgkin*s Disease and lymphosarcoma (Du Bois, 1936)#
Elevated basal metabolic rates have also been recorded in 
diseases of endocrine glands other than the thyroid e.g. acromegaly 
(Boothby and Sandiford, 1922), and phaeochromocytoma (Howard 
and Barker, 1937)* These conditions together with other causes 
of ** extra-thyroidal hypermetabolism** do not in practice give 
rise to diagnostic difficulty since they are readily recognised 
and excluded o
(c) Reference standards.
The choice of a reference standard is an important factor
producing disagreement concerning the diagnostic accuracy of 
basal metabolic rate estimations# m  an. admirable review of 
this aspect of the subject Skanse (1949) points out that in 
various series the upper limits of normality have been +10$,
+12$, +13$* +15$> and +20$ of the mean standards laid down 
by Aub and Du Bois (1917)* These standards are the usual ones 
used in clinical work but Robertson and Reid (1952) showed 
that they were inapplicable in this country, and provided 
alternative standards, which are not yet, however, widely 
applied# The advantages of the Robertson and Reid standards 
over those of Aub and Du Bois in the diagnosis of thyrotoxicosis 
have been confirmed by Crooks, Murray and Wayne (195®) and 
for this reason have been adopted in basal metabolic rate 
estimations throughout the present study#
Sleeping pulse rate#
In text-books dealing with thyroid disease numerous 
statements can be found concerning the value of the sleeping 
pulse rate in the diagnosis of hyperthyroidism# Rundle (1951) 
for example, states that thyrotoxic tachycardia is distinguishable 
from functional techycardia by the fact that it does not subside 
during sleep, or after a period of rest# Werner (1955) s^d 
McGavack (1951) agree with this statement# Spence (1953)*on 
the other hand, believes that the pulse rate in hyperthyroidism 
may fall considerably during sleep, but that it still remains 
above the normal level# It should be noted that these writers
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do not record a normal range for sleeping pulse rate which 
would allow it to be used in the diagnosis of hyperthyroidism. 
Many authors, referring to this diagnostic procedure, base 
their opinions on the observations of Boas (1932)* Using 
a cardiotachometer Boas recorded the average minimal sleeping 
pulse rates in nine toxic cases, ten subjects with neurogenic 
sinus tachycardia, and 103 normal subjects. Although there 
was some reduction of the pulse rate during sleep in the toxic 
cases, it remained about 30 beats per minute above the average 
minimal rate for the normal subjects, and over 20 beats per 
minute above that of the patients with sinus tachycardia*
His conclusion that the sleeping pulse rate was of diagnostic 
value in hyperthyroidism can be criticised on the grounds 
of the small number of abnormal subjects studied. Moreover, 
the use of a cardiotachometer converts a simple physical sign 
into a rather complex procedure and in addition the determination 
by any other means of an average minimal sleeping pulse rate 
is one of extreme difficulty. Accordingly, the normal values 
quoted by him cannot be used in routine clinical practice. 
Consequently before the diagnostic value of the sleeping 
pulsj^  rate in thyrotoxicosis could be compared in the present 
study with other diagnostic procedures a normal range had to 
be established and a standard procedure adopted for making 
the measurements*
Serum cholesterol.
Following the description by Epstein and Lande (1922)
of serum cholesterol changes in hyperthyroidism many reports 
have appeared concerning the place of this investigation in 
the diagnosis of this disease^  Mason et al. (195^ Hurxthal 
(1955a) > and McElroy et al. (1938) observed that the serum 
cholesterol tends to be low in hyperthyroidism. On the other 
hand Luden (1918), Gardner and Gainsborough (1928), Levy (1931) 
and Br^ohner-Mortensen and M^ frler (194-0) found that the serum 
cholesterol was usually normal. Further, Peters and Man (1950) 
in a comparison of the diagnostic value of serum precipitable 
iodine and cholesterol stated that the latter was of no aid 
in detecting over-activity of the thyroid. This is opposed 
to the opinion of Hurxthal and Hunt (1955) who considered 
that the serum cholesterol estimations had a definite place 
in the diagnosis. The value of serum cholesterol estimations 
therefore in the diagnosis of thyrotoxicosis remains controversial.
SECTION 2
The Clinical Diagnosis of Thyrotoxicosis Based on a Clinical
Diagnostic Index.
15.
Most physicians would agree that while the diagnosis 
of thyrotoxicosis is often easy, there are many cases which 
give rise to uncertainty. This is especially so when 
the clinical picture is incomplete or when atypical features 
are present and in these circumstances even experienced 
clinicians may differ in their conclusions. Sometimes the 
same observer may alter his opinion on the same case on 
consecutive days. The reason for this state of affairs is 
not immediately obvious but it seems to depend on the nature 
of the mental processes involved in arriving at a diagnosis.
In making his clinical assessment a physician must first 
obtain a reliable history and elicit accurately the appropriate 
physical signs. At this stage observer variation is encountered 
since there is rarely complete agreement even among a group 
of experienced clinicians. Next the physician must decide 
upon the relative importance he should attach to the 
diagnostically significant clinical features of the case.
In so doing he falls back on his own experience or if he is 
more junior on that of his teachers. At this point further 
differences of opinion arise partly because some clinicians 
regard certain features as of greater diagnostic significance 
than do others and partly because anyone tends to be influenced 
by a fortuitous run of positive or negative findings occurring 
towards the end of the clinical examination.
It is because of these difficulties in making a diagnosis 
on clinical grounds alone that so many tests of thyroid function 
have been devised and are so widely used. This in its turn 
has had the unfortunate effect of making some clinicians feel 
that they must always have laboratory confirmation of their 
diagnoses even in the most obvious cases, or what is worse, 
of making them place too much significance on laboratory results 
which run counter to their clinical judgement. As Bauer (1956) 
has said "for these physicians the clinical evaluation lacks 
that one tangible asset, a figure reported in per cent 
elevation, per cent uptake or gamma per cent".
No comparisons have so far been reported between the 
initial diagnosis made by a clinician at his first interview 
with the patient and the results of laboratory tests.
The present study was initially devised to make this comparison 
but by adopting a statistical procedure incorporating some of 
the principles of discriminant analysis (Rao, 1948? Zieve and 
Hill, 1955a) it was found possible to increase the accuracy 
of the initial clinical diagnosis and to study the effects of 
observer error. This was done by allocating a positive or 
negative score to each clinical feature, the values being based 
on an analysis of the relative frequency of symptoms and signs 
in the disease. In this way a total score, or clinical 
diagnostic index, can be obtained in each case. I shall produce
15.
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evidence that there is a wide difference between these scores 
in frankly thyrotoxic patients and in normal persons and 
that in practice they are helpful in distinguishing between 
toxic and non-toxic patients in cases presenting diagnostic 
difficulty. The index also provides a numerical estimate 
of the degree of severity of the disease which can be correlated 
with other indices of thyroid function.
The Development of the Clinical Diagnostic Index in Thyrotoxicosis 
Study of definitely non-toxic and toxic subjects
Material. The group studied consisted of 182 cases 
of which 99 were unquestionably non-toxic and 83 unquestionably 
thyrotoxic. The non-toxic section of this group included 
not only normal subjects, mainly medical and nursing staff, 
but also patients with simple goitres, anxiety states and 
post-menopausal symptoms. This group is termed ’’definite” 
in the tables and discussion.
Method of clinical examination. In each subject the 
presence or absence of the clinical features, shown in Table I, 
was recorded. These signs and symptoms were chosen because 
they had previously been shown by a clinical survey to differ 
in their incidence in thyrotoxic patients and normal subjects 
(Wayne, 1954). A written questionnaire was not used to elicit 
symptoms and the method of history taking is described in 
Appendix I '’Clinical Diagnostic Index —  Recommendations for Use”. 
In order to reduce the effects of observer variation the procedure
17.
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for the physical examination was rigid and the criteria to be 
fulfilled are described under the same heading.
The Clinical Index
The clinical features recorded in the cases which had 
given rise to no clinical diagnostic difficulty were weighted 
by allocating a score to each. The positive or negative 
values of these scores were initially allocated on the basis 
of the relative diagnostic significance of each symptom and 
sign as found by Wayne (1954)> or in a few instances by 
Williams (1950). These scores were then modified so as to 
diminish the effects of observer variation. This was done by 
reducing in value the highest scores because, although attached 
to features of great diagnostic importance, differences between 
observers were found to give rise to considerable variation 
in the total score. The clinical diagnostic indices i.e. the 
total scores, were then calculated. These produced a good 
separation between non-toxic and toxic subjects, but the 
weighting factors for the individual clinical features were 
further modified to produce the widest possible separation 
between the two groups without reintroducing excessive observer 
variation effects. The final weighting factors arrived at are 
shown in Table I. The indices were then recalculated.
When the: clinical diagnostic indices of the 99 non-toxic 
and 8J toxic subjects of the definite group were analysed (Table II, 
and Appendix II), the range of values was found to be from -16 to
FIGUBE 1
The clinical diagnostic index applied to cases in 
the definite group*
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+10 for the former and from +21 to +42 for the latter. Figure 
1 illustrates the distribution of these unequivocally non­
toxic and toxic subjects and the division between them. Thus, 
an index of +10 or under indicated non-toxicity and indices 
of +20 or over indicated toxicityo
Statistical analysis of the results allowed the probabilities 
corresponding to the observed percentages, given in Table II, 
to be calculated.
Clinical diagnostic index Definite non-toxic Definite toxic 
+10 and less 0.9758 0.0002
+20 and over 0.0005 0.9895
It will be seen that for values of the index below +11
and above +19 there is good agreement between the observed 
percentages of Table II and the above probabilities multiplied 
by 100. The agreement is due to the fact that "normal** 
distributions can be satisfactorily fitted to the definite 
non-toxic and toxic groups#
Study of subjects presenting clinical diagnostic difficulty 
Material and methods. This group which is subsequently 
called "doubtful" consisted of 118 cases each of which had 
presented some diagnostic difficulty to one or more hospital 
physicians* All had been referred for radioactive iodine studies 
and the final diagnosis was made only after prolonged observation 
including the response to treatment. I am, however, confident 
of the final conclusions. At their first visit the presence
FIGURE 2
The clinical diagnostic index applied to cases in 
the doubtful group*
FIGURE 5
Distribution curves of clinical diagnostic indices 
in cases of the doubtful group*
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or absence of the symptoms and signs listed in Table I were 
recorded using the criteria described in Appendix I. Clinical 
indices were calculated only when the final diagnosis was decided 
after full investigation and the results of therapy were known.
The clinical diagnostic index. Since the weighting 
factors allocated to the clinical features in the definite 
group had produced indices giving a wide separation between 
toxic and non-toxic cases, the same weightings were adopted 
in the analysis of the doubtful group.
The indices of the 118 subjects of this group are shown 
in Appendix III and their distribution in Table II and Figure 
2. Thirteen cases had indices lying between + 11 and + 19©
I have called this the equivocal range. One non-toxic subject 
had an index lying within the toxic range. A good division 
persisted, however, between cases finally shown to be non­
toxic and those shown to be toxic, 88 per cent of each lying 
within the non-toxic and the toxic ranges respectively. The 
distribution curves for this group are shown in Figure 3 •
Statistical analysis of the results allowed the probabilities 
corresponding to the observed percentages, given in Table II, to 
be calculated.
Clinical diagnostic index Doubtful non-toxic Doubtful toxic
+10 and less 0.8315 0.0035
+20 and over 0.0107 0.8051
For values of the index below + 11 there was reasonably
good agreement in the non-toxic group between the above 
probability multiplied by 100 and the observed percentage of 
Table II. As in the case of the definite group this was due 
to the fact that a "normal” distribution could be fitted to the 
doubtful non-toxic subjects. In the case of the doubtful 
toxic group, however, a ’’normal" distribution did not provide 
a good fit to the observed distribution and this may be partly 
or wholly due to the relatively small number (51) of patients 
in this group.
Observer varia.tion studies.
Nine patients, not included in the present series, whose 
thyroid function was difficult to assess clinically were 
chosen for this study. Nine observers carried out an independent 
assessment of these patients using the scoring sheet shown 
in Table I. This group consisted of the author, three consultant 
physicians, two research fellows, one senior house officer, 
one house physician and one final year medical student. The 
medical student was given special training in the criteria 
and careful instructions on the use of the scoring sheet. The 
observers were thus chosen to include a wide variation of 
experience both in general medicine and in thyroid disorders.
The results of these observer variation studies are shown in 
Table III. Analysis of variance of the indices in 63 observations 
carried out by observers 1 to 7 showed no significant difference 
(f * 1.62). Observers 8 (one research fellow) and 9 (the senior
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TABLE III
Results of Observer Variation Studies Using the Clinical 
Diagnostic Index.
Case A B C D E F G H I Mean
Observer values
1 +24 - 3 +14 +13 0 +10 +59 +55 +31 18 .7
2 +29 + 2 +15 +18 -1 + 7 +37 +25 +21 17«0
3 +51 + 1 + 5 +19 -4 + 1 +39 +34 +22 16.4
4 +20 + 1 + 4 +12 -8 + 5 +39 +26 +25 15.6
5 +21-7 + 7 +14 -6 +10 +55 +26 +50 14.2
6 +50 - 2 +17 +16 -2 0 +55 +32 +24 16.4
7 +29 -5+15 + 6 -5 - 5 +36 +24 +26 13.9
8 +25 - 7 + H  0 -2 - 1 +25 +25 +29 11.7
9 +22 -11 +11 - 1 -5 - 5 +30 +26 +25 10.0
Case J K L M N 0 P Q R Mean
Observer values
3 — 4 ,+22 + 2 +51 +25 +17 +22 +52 +17 18.2
10 - 1 + 1 6 - 5  +34 +22 +12 +22 +54 +15 16.5
house officer) both of whom were newcomers to the unit 
scored systematically lower.
A further nine patients were similarly assessed by 
myself and a newcomer to the department with a wide experience 
of thyroid disease gained at another centre. This physician 
was given only typewritten ins tructions on the use of the 
scoring sheet. The results are shown at the foot of Table III. 
There was no significant difference in analysis of variance 
of these scores (f » 2.06)o
SECTION 5
Comparison of the Clinical Diagnostic Index with 
Laboratory Tests.
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Radioactive Iodine Studies* Pull studies were carried
out in 91 of the cases presenting no clinical diagnostic
difficulty (definite group) and in 110 of the subjects in
which initial diagnostic difficulty had been found (doubtful
group)* These studies consisted of the estimation of the
gland uptake of radioactive iodine and the protein-bound
plasma radioactivity four and forty-eight hours respectively
after the administration of 25yuc* of ^^1* The techniques
used have been previously described by Ansell, Macgregor,
Miller and Wayne (1953)* The method of estimating J>rotein- 
PSlbound y I has, however, been simplified by the use of an 
ion exchange resin*
The results of measurements of the 4~hour uptake of 
radioactive iodine by the thyroid in 202 subjects are shown 
in Table IV and Appendices II and III* The upper limit of 
the normal range of the 4-hour uptake is taken as 45 per cent 
of the dose. In 87$ of the non-toxic subjects included in 
the definite group in which the diagnosis was never in doubt, 
the uptake was within the normal limits* It was greater 
than this value in 98$ of the toxic subjects of this group0 
In the doubtful group the diagnostic accuracy of the uptake 
was of the same order as that of the clinical index for the 
same group. Thus, 89$ of non-toxic subjects (88$ by the 
index) and 94$ of toxic subjects (88$ by the index) were 
correctly diagnosed by this test*
29.
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Estimations of the protein-bound, radioactivity of the 
plasma at 48 hours were made in 201 subjects (Table V and 
Appendices II and III). In non-toxic cases 95^ of the definite 
group and 94^ of the doubtful group had values less than 
0*4$ of the dose per litre of plasma, which is considered 
to be the lower limit of the range indicating hyperthyroidism. 
In toxic subjects the protein-bound 13 Was above this 
level in of the definite group and 8 9 of the group 
which had given diagnostic difficulty. Statistical analysis 
shewed no significant difference between the proportion of 
correct diagnoses achieved by the index and radioactive 
iodine studies.
Basal metabolic rate. This was estimated in 108 
subjects of the definite group and 80 subjects of the doubtful 
group. All basal metabolic rate estimations were carried 
out by one experienced technician using a Benedict-Roth 
apparatus. Patients were admitted to hospital and given 
200 mg. of butobarbitone twelve hours before each test.
The tests were carried out in duplicate on two successive 
days and the lowest of four estimations accepted, using 
the standardsof Robertson and Reid (1952). Further details 
of the method are given by Crooks, Murray and Wayne (1958)*
The results of the 188 basal metabolic rate estimations 
are shown in Table VI and Appendices II and III. In 98$ 
of the non-toxic subjects of the definite group, the basal
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metabolic rates were within the normal range of the Robertson 
and Reid standards. The basal metabolic rate was raised 
in 97$ of toxic subjects of this group* Basal metabolic 
rates within the normal range were found in 87$ of the 
cases presenting diagnostic difficulty and finally shown 
to be non-toxic, while only 73$ of the toxic subjects of 
this group had elevated values® Statistical analysis showed 
no difference between the proportion of correct diagnoses 
achieved by the index and estimations of the basal metabolic 
rate*
Sleeping pulse rate. Sleeping pulse rates were 
obtained in 110 subjects of the definite group and 80 
subjects of the doubtful group. Since no satisfactory 
ranges of abnormality and normality had been previously 
established sleeping pulse rates were also obtained in a 
further $6 patients (27 toxic, 29 non-toxic) in all of 
whom the diagnoses were unequivocal* These additional 
subjects have been added to the definite group in the 
analysis of results (Table VII), Sleeping pulse rates 
were obtained as follows.-
Nurses were instructed to count the radial pulse for 
one minute after they were satisfied that the patiait was 
asleep® The sleeping pulse rates of patients admitted to 
hospital for full investigation of their thyroid function 
were taken as the means of the three lowest figures recorded®
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During1 their stay in the ward they had received, on at least 
two occasions, 200 mg* of but©barbitone 12 hours preceding basal 
metabolic rate estimations* In the case of patients admitted 
solely for -the purpose of obtaining basal metabolic rate 
estimations on two successive mornings, the lower of two 
sleeping pulse rates was accepted*
The values obtained for the sleeping pulse rate in the 
246 subjects are shown in Table VII while the individual 
values for the patients of the definite and doubtful groups 
can be found in Appendices II and III* In the 108 non­
toxic cases it was found that 97$ of both the definite and 
doubtful groups had sleeping pulse rates of 80 or less©
Of the 138 toxic cases, however, only 64$ of the definite 
group and 29$ of the doubtful group had sleeping pulse rates 
higher than 80* If the upper limit of the nounal sleeping 
pulse rate is taken as 80 then the proportion of correct 
diagnoses given by this method in the doubtful group is 
significantly lower than that achieved by the clinical 
diagnostic index*
Serum cholesterol* The serum cholesterol was 
estimated by the method of Bloor (1916) in 119 subjects 
of the definite group and in 80 subjects of the doubtful 
group* Estimations were also carried out in an additional 
53 cases (25 non-toxic, 28 toxic) with a diagnosis which 
was unequivocal. These cases were added to the definite group 
in the results (Table VIII) to provide more satisfactory 
ranges of abnormality and normality©
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The results of the serum cholesterol estimations 
in the 252 subjects are shown in Table VIII and the 
individual levels for the patients of the definite and 
doubtful groups are shown in Appendices II and III©
Of 104 non-toxic cases 94^ of the definite group and 
IQOfa of the doubtful group had serum cholesterol values 
above 149 On the other hand, of I48 toxic cases
only 29$ of the definite group and 32$ of the doubtful 
group had values less than 150 mg#/60 When the normal 
range for the serum cholesterol is taken as 150 to 
250 mgtffo then the diagnostic value of the procedure is 
significantly poorer than the clinical diagnostic 
index in discriminating between toxic and non-toxic 
subjects©
SECTION 4
Application of the Clinical Diagnostic Index*
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TABLE IX -t fl
TABLE IX
Results of the Clinical Diagnostic Index in Different Hospitals
Agreement with
Hos-pital Number of Cases Final Diagnosis 
A 50 86#
B 74 84#
C 24 88#
3) 23 83#
Total 171 85#
An aid to diagnosis in routine clinical practice
In order to obtain information on the diagnostic 
accuracy of the method in the hands of independent 
observers, score sheets, with written instructions for 
their use, were sent to three other hospitals (Table: IX, 
Hospitals B, C, and D) in Scotland* At their routine 
clinics a total of 121 patients referred for assessment 
of thyroid function were selected at random and score 
sheets completed. The final diagnosis, usually based 
on a conventional clinical assessment, radioactive 
iodine studies and basal metabolic rate estimations was 
confirmed by therapeutic trial or observation. It can 
be seen from Table IX that the diagnostic accuracy 
obtained in this group of subjects was of the same 
order as that found in the doubtful group of the 
original series*
The practical application of the index was also 
assessed in a further series of 50 patients referred 
to the clinic by other physicians because diagnostic 
difficulty had been found. In the case of these 
subjects indices were obtained before any further 
clinical assessment was made or laboratory investigations 
carried out* The final diagnosis was reached after 
full investigations and follow up including therapeutic 
trials in some cases* The index gave the correct 
diagnosis in 43 (86#) of the 50 cases (Table IX, Hospital A),
40,
Of the remaining 7 cases, all of whose indices lay within 
the equivocal range, 3 were finally shown to be toxic 
and 4 non-toxic.
The total number of correct diagnoses, 149 of 171 
subjects (85#), in this additional investigation is 
comparable with the results obtained by the application 
of the method to the doubtful group of the original 
series* It is most important to note that of the 22 
cases which were not correctly placed in toxic or noii- 
toxic categories, the diagnosis was completely misleading 
in only 5 subjects (3#)> since 17 fell withih the equivocal 
range, thus indicating a suspension of judgement until 
further tests had been carried out*
The use of the index in selected cases to illustrate 
the technique of clinical diagnosis
A conventional clinical diagnosis involves the 
unconscious application of the principles underlying 
discriminant analysis (Rao, 1948; Zieve and Hill, 1955a) 
and examples of the use of the clinical diagnostic index 
from both the definite and doubtful groups of the 
original series are described below in order to 
illustrate some of the sources of diagnostic difficulty*
The toxic members of the definite group are of 
lesser interest and the correct diagnosis would have been
made with ease by conventional clinical methods* It is, 
however, worth while looking more closely at three 
groups of non-toxic subjects in each of which an inexperienced 
observer might have been confused by the presence of 
several symptoms usually associated with the thyrotoxic 
state. \
Post-menopausal subjects. It has been suggested by 
Wayne (1954) that post-menopausal women show many of 
the symptoms of thyrotoxicosis, for example, dyspnoea, 
tiredness, excessive sweating, and that because of this 
such cases may cause diagnostic difficulty* He 
considered, however, that an experienced physician would 
be unlikely to misinterpret this clinical picture because 
of his skill in history-taking. Yfhen the index was 
applied to such patients they gained, as was expected, 
high symptom scores but these were nullified by their 
negative sign scores because of the absence of physical 
signs of high diagnostic significance* This is well 
shown in the following post-menopausal subject:
Case No. 49*
Female, aged 51 years (last menstrual period 16 months 
previously)*
Symptoms
Dyspnoea on effort (+ l) Preference for cold (+ 5)
Palpitations (+ 2) Increased weight (~ 5)
Tiredness (+ 2)
Symptom score * + 7
Signs
Goitre absent (- 3) Hands cool (- 2)
Bruit absent (- 2) Hands dry (- l)
Hyperkinesis absent (- 2) Casual pulse rate / q \
84 per minute ' '
Sign score * -10 
Diagnostic index: - 3*
Radioactive iodine studies; 4-hour uptake 50#, 48-hour 
protein -bound radioactive iodine 0.12# per litre*
Basal metabolic rate: + 14#.
Sleeping pulse rates 60 per minute.
Serum cholesterol: 222 mg.#.
Final diagnosis a Non-toxic, confirmed by observation.
It can be seen that in spite of the negative score for 
weight increase the patient still scored + 7 on symptoms 
The negative values allocated to absent physical signs, 
however, more than compensated for this.
Normal young adult females with some features of 
thyrotoxicosis♦ These subjects were found among a 
group of nurses, fully employed, who made no spontaneous 
complaints. An example of this type of subject is shown 
below*
Case No. 85.
Female, aged 19 years.
Symptoms
Dyspnoea on effort (+ l) Increased appetite (+ 3)
Tiredness (+ 2) Increased weight (- 3)
Excessive sweating (+3)
Symptom score » + 6
Signs
Goitre absent (- 5) Fine finger tremor (+ l)
Bruit absent (- 2) Hands hot (+ 2)
( + 1)Exophthalmos (+ 2) Hands moist
Hyperkinesis absent (~ 2) Casual pulse rate /
86 per minute ' '
Sign score « - 1 
Diagnostic index: + 5®
The relatively high symptom score in this subject is 
not supplemented by a raised sign score and although she 
had several of the signs found in thyrotoxicosis, these 
were the least heavily weighted. She did express, for 
example, a preference for cold weather and admitted to 
nervousness, but these symptoms had been present for 
as long as she could remember and for this reason lost 
their diagnostic importance.
Anxiety states. This group of cases may cause diagnostic 
difficulty to the inexperienced clinician and accounts 
for a large proportion of the patients referred for 
radioactive iodine studies in whom the tests prove 
negative. This is especially the case if a goitre is 
also present. The absence of diagnostically important 
physical signs, however, compensates for the high 
symptom scores as in the following example:
Female, aged 55 years.
Symptoms
Dyspnoea on effort 
Palpitations 
Tiredness
Signs
Goitre absent 
Bruit absent 
Hyperkinesis absent
Diagnostic index: + 8
Radioactive iodine studies: 4~bour uptake 36^ , 48-hour
protein-bound radioactive iodine 0*0$ per litre <>
Basal metabolic rate: ■* 13^.
Sleeping pulse rate: 64 per minute.
Serum cholesterol: 112 mg.$.
Final diagnosis: Non-toxic, confirmed by observation*
Subjects presenting initial diagnostic difficulty
(the doubtful group), are of greater interest since they
include the type of case which affords difficulty even
to the experienced clinician* In order to find out why
this difficulty arose an analysis was made of this group
and the cases appeared to fall into the following 
categories s
(+1) Preference for cold (+ 5)
(+ 2) Excessive sweating (+ 3)
(+ 2) Nervousness (+ 2)
Symptom score * + 15
(- 3) Fine finger tremor (+i)
( - 2) Hands cool (- 2)
(- 2) Hands moist (+ l)
Casual pulse rate /
88 per minute ' '
Sign score « -.7
Toxic subjects with many symptoms, but few signs* It 
is probable that these cases presented diagnostic 
difficulty chiefly because the positive signs appeared 
to be too few to allow a definite diagnosis to be made0 
The following patie.nt complained of nearly all the more 
important symptoms of thyrotoxicosis, but few signs 
were present. The index, however, gave the correct 
diagnosis©
Case No. 258.
Female, aged 55 years.
Symptoms:
Dyspnoea on effort (+ l) Excessive sweating (+3)
(+ 2) Nervousness (+ 2)
(+ 2) Weight decrease (+3)
Palpitations
Tiredness
Preference for cold (+ 5)
Symptom score ■ + 18
Signs:
Goitre 
Bruit absent 
Lid retraction
(+ 3) Fine finger tremor
(- 2) Hands hot
(+2) Hands moist
Hyperkinesis absent (- 2) Casual pulse rate
70 per minute
( + 1)
(+ 2)
(+ 1)
(-3)
Sign score « + 2 
Diagnostic index: + 20.
Radioactive iodine studies: 4“hour uptake 69$, 48-"hour
protein-bound radioactive iodine 0.3$ Per litre.
Basal metabolic rate: + 14$*
46 o
Sleeping pulse rate; 64 per minute0 
Serum cholesterol; I67 rag®$.
Final diagnosisi Toxic, confirmed by response to 
methyl thiouracil therapy*
Toxic subjects with few or atypical symptoms and many
signs. Most physicians tend to regard positive physical
signs as more reliable than positive symptoms and this
group rarely gives rise to diagnostic difficulty unless
the patient has symptoms which are regarded as highly
unusual in a toxic patient. The following case, for
example, is an exception to the rule that thyrotoxic
patients are heat intolerant. The numerous positive
signs more than compensated for this atypical feature
and the index gave the correct diagnosis®
Case No* 267,
Male, aged 67 years 
Symptoms
Preference for heat (-5) Weight loss (+3)
Nervousness (+2)
Symptom score *■ 0
Signs
Bruit present
Goitre (+3) Hyperkinesis (+ 4)
(+ 2) Fine finger tremor (+ l)
Lid retraction
Exophthalmos
(+ 2) Hands moist
(+ 2) Hands hot (+ 2) 
(+ 1)
Lid lag (+ l) Casual pulse rate *
100 per minute ' '
Sign score ■ + 21
Diagnostic index; +21*
Radioactive iodine studies; 4-hour uptake 83<fo9 48-hour 
protein-bound radioactive iodine 4*25$ per litre.
Basal metabolic rate: + 76$.
Sleeping pulse rate: 70 per minute*
Serum cholesterol; 105 mg.$.
Final diagnosis; Toxic, confirmed by response to 
methyl thiouracil therapy.
Toxic subjects with highly significant features missing. 
In these case, despite a fairly complete clinical 
picture, there had been a reluctance to arrive at a 
definite clinical diagnosis because of the absence of 
one or more features classically found in thyrotoxicosis* 
In the following case there was no goitre*
Case No* 282*
Male, aged 63 years.
Symptoms
Dyspnoea on effort (+ l) Excessive sweating (+3)
Palpitations (+ 2) Weight decrease (+3)
Preference for cold (+ 5)
Symptom score * + 14
Signs
Goitre absent (- 3) ^jrperkinesis (+ 4)
Bruit absent (- 2) Fine finger tremor ( + 1)
Exophthalmos (+ 2) Hands hot (+ 2)
Lid retraction (+ 2) Hands dry ( - 1)
Lid lag ( + 1) Auricular fibrilla­
tion.
(+ 4)
Sign score * + 10 
Diagnostic index: + 24.
Radioactive iodine studies: 4-hour uptake 68$, 48-hour 
protein-bound radioactive iodine 1.1$ per litre.
Basal metabolic rate; + 11$.
Serum cholesterol; 200 mg.$.
Final diagnosis; Toxic, confirmed by response to methyl
thiouracil therapy.
It should be noted that this patient was a male and it 
is recognised that hyperthyroidism without a goitre may 
not infrequently occur in this sex. Indeed it is 
probable that the diagnostic accuracy of the index 
would be improved by omitting the negative score where 
a gland was not palpable in a male subject; this was 
not done since it would increase the complexity of the 
scoring system. The incidence of the disease in males 
is in any case low and they represent 18$ of this series 
and 21$ of a larger series reviewed by Skanse (1949)* 
Thyrocardiac subjects ("masked11 hyperthyroidism). Thyro­
toxicosis in patients with auricular fibrillation with 
or without cardiac failure who do not show the classical 
features of thyrotoxicosis are notoriously liable to 
have the true nature of their disease overlooked. Thus, 
Bortin, Silver, and Yohalem (1951) investigated 55 cases 
of auricular fibrillation in which the aetiology was 
not obvious and decided on the results of radioactive
49.
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iodine studies that 8 were examples of '•masked'* 
hyperthyroidism* In the present series of cases 
all of 13 patients with thyrotoxic auricular fibrillation 
were correctly placed hy the index although one patient, 
seen subsequently, fell within the equivocal range* The 
index should be used with caution in patients with 
congestive cardiac failure since they usually score 
points (+6 or + 7) for dyspnoea, palpitations and 
either tachycardia or auricular fibrillation even if 
they are not thyrotoxic* Radioactive iodine studies 
or estimations of protein-bound iodine are of great 
diagnostic help in such cases*
Subjects with several atypical features and with 
indices in the equivocal range* The findings in 13 
cases with diagnostic indices lying within the equivocal 
range and one non-toxic subject with an index in the 
toxic range are worth special consideration* Some details 
are given in Table X» Within this group the non-toxic 
cases would appear to lie at the lower limits and the 
toxic cases at the upper limits of the equivocal range*
Prom the distribution curves of the non-toxic and toxic 
subjects of the doubtful group, however, it can be 
calculated that if a case has a score which falls 
within the equivocal range then the possibilities of 
toxicity or non-toxicity are equal (Figure 3)* The 
reason why a toxic case may fall within this equivocal range
is almost always due to the absence of features of high 
diagnostic significance, as is illustrated by the 
following}
Case No, 252,
Female, aged 51 years.
Symptoms
Dyspnoea on effort ( + 1) Nervousness (+ 2)
Palpitations (+ 2) Weight increase (- 3)
Preference for cold (+ 5)
Symptom score *= + 7
Signs
Goitre (+ 3) Hands hot (+ 2)
Bruit absent (- 2) Hands dry (- I)
Byperkinesis 
Fine finger tremor
(+ 4) 
(+ 1)
Casual pulse rate 
105 per minute (+ 3)
Sign score « + 10
Diagnostic index; + 17.
Radioactive iodine studies; 4-hour uptake 5C$, 48-hour
protein-bound radioactive iodine 0,44$ per litre
Basal metabolic rate ; + 29$.
Sleeping pulse rate; 76 per minute.
Serum cholesterol; 149
Final diagnosis; Toxic, confirmed by response to
methyl thiouracil therapy* Conventional diagnostic 
methods would possibly have placed this patient correctly©
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Non-toxic subjects falling within the equivocal 
range were usually patients with severe anxiety states, 
They had high symptom scores associated with one or 
two heavily weighted signs as for example the presence 
of goitre or tachycardia,* Negative scores arising 
from the physical examination did not compensate 
for positive symptoms scores as is illustrated in the 
following cases 
Case No. 245.
Female, aged 49 years.
Symptoms
Dyspnoea on effort ( + 1) Excessive sweating (+ 3)
Tiredness (+ 2) Nervousness (+ 2)
Preference for cold (+ 5) Appetite decrease (- 3)
Symptom score * + 10
Signs
Goitre- (+ 5) Fine finger tremor (+ l)
Bruit absent (- 2) Hands hot (+2)
Lid lag ( + 1) Hands dry (- 1)
Hyperkinesis absent (-2) Casual pulse rate
90 per minute ( 0)
Sign score » +2 
Diagnostic indexs +12.
Radioactive iodine studies; 4“hour uptake 45^ > 48-hour 
protein-bound radioactive iodine Qt0jfo per litre.
Basal metabolic rate; + 9$*
Sleeping pulse rates 64 per minute.
Serum cholesterol a 270 mg<$.
Final diagnosis; Non-toxic, confirmed by failure to 
respond to methyl thiouracil therapy.
Only two cases of this group, Nos. 243 arid 253» were not 
correctly diagnosed by radioactive iodine tests* The 
basal metabolic rate estimations were diagnostically 
correct in all but one of this group (No. 251)©
Non-toxic subjects following thyroidectomy0 with indices 
in the toxic range* This group includes cases which 
are apt to be wrongly assessed both by the index and by 
conventional clinical methods. These patients who at 
some time in the past have suffered from thyrotoxicosis 
are well aware of the symptoms of the disorder. If, 
in addition, they have tachycardia, goitre or eye signs 
they tend to score heavily. Unfortunately, radioactive 
iodine studies often give misleading results in this 
group and the most reliable objective evidence is 
afforded by estimations of the basal metabolic rate or 
of protein-bound iodine. A therapeutic trial using 
an antithyroid drug is often the most effective way 
of arriving at a correct conclusion. The following 
case is an examples
Case No, 249.
Female, aged 54 years.
Symptoms
Dyspnoea on effort (+ l) Preference for cold
(+ 2) Appetite increased
(+2) Weight decrease 
Symptom score * + 16.
Palpitations
Tiredness
Signs
Goitre
Bruit present 
Exophthalmos 
Lid lag
(+ 5) Fine finger tremor
(+ 2) Hands hot
(+ 2) Hands dry
(+ l) Casual pulse rate
76 per minute
Hyperkinesis (+4)
Sign score * + 11 
Diagnostic index? +27*
Radioactive iodine studies: 4-hour uptake 42$* 48*
protein-bound radioactive iodine 0*17$ per litre© 
Basal metabolic rate; + 6$.
Sleeping pulse rate: J2 per minute.
Serum cholesterol: 195 ®g.$.
Final diagnosis: Non-toxic, confirmed by failure
respond to methyl thiouracil therapy*.
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(+ 5) 
(+ 5) 
(+ 3)
(+ x) 
(+ 2)
(-1) 
(- 3)
•hour
SECTION 5
The Clinical Diagnostic Index as a Measure of 
Severity*
%•
In toxic patients the index gives a quantitative 
measure of the severity of the disease as judged by 
the presence of symptoms and signs. It is of interest, 
therefore, to see the extent to which it correlates 
with laboratory findings .
When the values for basal metabolic rate estimations 
were plotted against the indices of 188 cases a signficant 
correlation (r * 0.35) was present in toxic subjects (Figure
4).
The values for the 4-hour uptake of radioactive 
iodine were plotted against the indices of 202 cases (Figure
5), and a significant correlation was found between them 
in the toxic subjects (r * O.36).
A similar degree of correlation (r « O.36) was 
found in toxic subjects between the index and the 
values for 48-hour protein-bound plasma radioactivity (Figure
6).
When the sleeping pulse rates (Figure 7) and serum 
cholesterol levels (Figure 8) were plotted aginst the 
diagnostic indices no significant correlation was found 
between them in either the toxic or non-toxic subjects©
FIGURE 4
The clinical diagnostic index used as a measure of
severity and correlated with basal metabolic rate. The
regression line of index on B.M.R. in toxic cases is shown#
FIGURE 5
The clinical diagnostic index used as a measure of severity 
and correlated with the 4-hour gland uptake of radioactive 
iodine. The regression line of index on 4-hour gland 
uptake of radioactive iodine in toxic cases is shown.
FIGURE 6
The clinical diagnostic index used as a measure of
severity and correlated with the 48-hour plasma protein-
bound radioactivity. The regression line of index on 48- 
hour plasma protein-bound radioactivity is shown.
FIGURE 7
The clinical diagnostic index used as a measure of severity
and correlated with the sleeping pulse rate. The horizontal
line indicates the upper limit of the normal range.
FIGURE 8
The clinical diagnostic index used as a measure of severity
and correlated with the serum cholesterol. The horizontal
lines indicate the diagnostic limits chosen#
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SECTION 6
Discussion*
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The process of making a clinical diagnosis is 
complicated* It involves the sifting and evaluating 
of multiple symptoms and signs and results in the 
selection of the clinical syndrome which accounts best 
for the findings# The clinician attaches greater 
or less significance to the clinical features according 
to his past experience* He combines the findings 
into a formula, often subconsciously by applying the 
concepts of multiple correlation in a non-quantitative 
manner and in this way arrives at a diagnosis (Zieve 
and Hill, 19550')* Th® clinical diagnostic index applies 
this principle at a conscious level. Previously this 
concept has been used mainly in the evaluation of 
laboratory investigations* For example, Zieve and Hill 
(1955b) after studying 11 liver function tests found that 
four could be combined to produce a ’’cirrhosis abnormality 
score** which discriminated well between normal and 
cirrhotic subjects» Qyama and Tatsuoka (1956) used 
a similar technique to assess the prognosis of patients 
with pulmonary tuberculosis# Using thirteen 
characteristics they constructed an equation from which 
a score could be calculated for each patient0 This 
score discriminated with 757° accuracy between those who 
eventually relapsed and those who remained well* In 
the field of thyroid disease, Schultz and Zieve (1956) 
have attempted with some success to predict a remission
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of thyrotoxicosis following a single dose of 
radioactive iodine, from a score obtainedby allocating 
weighted values at intervals after therapy to the clinical 
state, the thyroid uptake of ^^1, the basal metabolic 
rate and the serum cholesterol.
In order to apply the technique to clinical 
diagnosis it is first necessary to carry out a symptom 
analysis in patients suffering from a particular disease 
and also in control subjects. The diagnostic significance 
of each feature can then be determined. A symptom 
analysis of thyrotoxicosis carried out by Wayne (1954) 
provided this necessary information and was used in 
the provisional allocation of values indicating the 
diagnostic importance of the various symptoms and 
signs. In this analysis it was apparent that the 
features most helpful in reaching a diagnosis were 
increased appetite, weight loss, preference for cold 
weather, hot sweating hands, persistent tachycardia 
and hyperkinesis* It can be seen from Table I that 
these are the features which have been given the highest 
positive scores. Additional features such as a bruit 
over the gland and excessive sweating have also been 
weighted heavily since Williams (1950) has shown them 
also to be of high diagnostic significance© When 
clinical diagnosis is taught or practised, emphasis 
tends to be placed on the presence of certain symptoms
and signs, but in many instances the absence of these 
features may be of equal importance. For example, the 
absence of peripheral vasodilatation favours the 
diagnosis of non-toxicity to the same extent that its 
presence favours toxicity. In order, therefore, to 
make the greatest possible use of the clinical evidence 
equivalent negative values were allocated to some of 
the features which carried the highest positive scores0 
This is illustrated by the weightings given to a palpable 
gland and a bruit over the gland. Thus a goitre (+ 5) 
with a bruit (+2) scores + 5 > while a goitre (+ 5) 
without a bruit (-2) scores +1. The values placed 
on the presence or absence of hyperkinesis, + 4 and - 2 
respectively (originally + 5 ond - 5) examples of 
the modifications of the initial scores carried out to 
minimise the effect of observer variation since it was 
soon appreciated that hyperkinesis, although of 
considerable diagnostic significance may be difficult 
to recognise by those to whom the criteria have not 
been demonstrated* The justification, however, for the 
retention of its heavy weighting is the frequent 
presence of the sign in those atypical cases which show 
few other positive features. The decrease in the 
weighting of other highly significant diagnostic 
features was designed to make it impossible for a single 
observation of any one feature, however diagnostically
important to alter a patient's total score so markedly 
as to move it from the toxic to the non-toxic range* or 
vice versa*
The value of diagnostic procedures, clinical, 
chemical and physical, depends to a large extent on 
their reproducibility and the greater the human element 
in a method the higher is the probability of variation 
when the observations are repeated.
History-taking is prone to error as Cochrane, 
Chapman and Oldham (1951) have shown, and it is 
difficult to diminish the effects of observer variation 
since they arise in the mind of the patient as well 
as in the interpretation the physician places on the 
patient's statements. The use of a written 
questionnaire was avoided since Glaser and Whittow 
(1954) have shown its unreliability. Ninety per cent 
of their normal subjects questioned by this procedure 
recorded at least one symptom initially, but when the 
questionnaire was repeated there was a significantly 
smaller number of positive responses. Wayne (1954) 
also noted a high incidence of positive responses 
in a normal control group in reply to set questions* 
but suggested that appropriate supplementary questions 
would reduce this effect. In the present series the 
history was taken by conventional methods, leading 
questions were avoided^ and appropriate supplementary
questions were asked about each symptom.
Inconsistencies in the recording of physical 
signs have been demonstrated by Fletcher (1952) in a 
study in which eight observers, all members or fellows 
of a College of Physicians, independently elicited 
the physical signs found in the chest of each of twenty 
patients suffering from emphysema* With most signs 
only two-thirds agreement was obtained. He suggested, 
however, that agreement might be improved by laying 
down more rigid criteria for the presence or absence 
of physical signs. The improvement, in agreement between 
observers when the criteria for physical signs can be 
clearly defined has been demonstrated by Schilling,
Hughes and Dingwall-Fordyce (1955)> who compared the 
accuracy of two observers in making the diagnosis of 
byssinosis. It was for this reason that rigid definitions 
of physical signs were laid down in the present series0
The results of the observer variation studies 
(Table III) show that in the case of observers 1 to 7 
these precautions were successful. It is of interest 
that observer 7> the senior medical student, who had 
had careful and detailed instruction on history-taking 
and the criteria for physical signs, showed no statistically 
significant difference in mean total score from the 
more experienced observers* Observers 8 and 9> however, 
who had no special experience of thyroid disease and,
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having only recently joined, the unit,had received 
no special instruction, scored systematically lower*
It might he objected that the close agreement between 
the total scores of observers 1 to 7 reflects their 
common experience and training. It was to test this 
objection that observer 10,whose special experience 
of thyroid disease had been gained in another department, 
was asked to obtain the total scores in nine patients 
within one week of his arrival in this department* In 
his case there was no significant difference between 
his mean total score and that obtained by me. In the 
recording of individual symptoms and signs there was 
usually some disagreement between observers which in 
eight out of ten was insufficient to alter significantly 
their mean total scores* These observer variation 
studies suggest that no statistically significant 
difference will be obtained by observers using the 
diagnostic index provided they have some experience 
of thyroid disease. It is also clear that with the 
ranges of normality and abnormality used in this study 
inexperienced observers tend to score low and may fail 
to reach a definite diagnosis in a number of mildly 
toxic cases. Most of these, however, will fall into 
the equivocal range, thus indicating the need for 
further investigation.
It is customary in assessing the accuracy of tests
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of thyroid function to correlate them with the 
final diagnosis arrived at after prolonged 
observation. No attempt has been made to correlate 
the initial clinical diagnosis based on signs and 
symptoms alone with either the results of laboratory 
investigations or with the final diagnosis. It is 
generally accepted that tests involving the use of 
radioactive iodine are especially reliable although 
different observers favour different technique^ In 
the present study the uptake of the thyroid gland 
was measured four hours after a dose of radioactive 
iodine had been administered and the protein-bound 
plasma radioactivity forty-eight hours after the dose© 
These tests had a diagnostic accuracy in the present 
series of the same order as that described by Wayne (1954) 
and Macgregor and Wayne (1957)* These radioactive 
iodine tests were carried out on nearly all the members 
of the doubtful group and it was possible therefore 
to correlate the results with both the initial diagnosis 
given by the clinical index and with the final 
diagnosis© Comparison of the radioactive iodine 
tests and the clinical index is rendered a little 
difficult because the former assign patients to either 
toxic or non-toxic groups whereas the clinical index 
may place some patients in an equivocal group. There 
was, however, no statistically significant difference
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between the accuracy of the index and either of the 
radioactive iodine tests, even when the equivocal results 
given by the index were regarded as entirely incorrect 
(Tables IV and V)* Basal metabolic rate estimations 
were obtained in eighty patients of the doubtful 
group and Table VI shows that about one quarter of the 
toxic subjects of this group had basal metabolic rates 
within the normal range* Even if all the equivocal 
indices are counted as incorrect, the basal metabolic 
rate has no statistically significant advantage in 
diagnostic accuracy over the index.
The clinical diagnostic index is of greater 
diagnostic value than either the sleeping pulse rate 
(Table VIl) or the serum cholesterol level (Table VIII), 
particularly in cases presenting initial diagnostic 
difficulty# The study has incidentally shown that 
sleeping pulse rates of more than 80 per minute make 
the diagnosis of thyrotoxicosis highly probable* and this 
agrees with the findings of Addis (1922). This, however, 
only occurred in a minority (29$) of the doubtful group 
finally shown to be toxic. It would appear that the 
serum cholesterol, contrary to the opinion of Hurxthal 
and Hunt (1935) has also a very limited place in 
diagnosis# Like the sleeping pulse rate its value lies 
in the diagnosis of toxicity which is highly probable 
if the level is below 150 mg*$. This finding is similar 
to that of Man et al. (1940)0
It should be pointed out that irrespective of the 
diagnostic procedures used, the final decisions were 
based on the response to therapy and it follows that 
for the purpose of the present investigation thyrotoxicosis 
is defined as a condition in which antithyroid therapy 
produces a remission of symptoms and signs« This 
definition has the great advantage that it supplies the 
essential information which a physician requires©
The results obtained in the present series suggested 
that the clinical index should be of practical value 
and this opinion was confirmed by the results obtained 
by other centres using the method in their routine 
clinical practice© It is of special importance to note 
(Table IX) that of the 121 patients assessed by the 
index at other hospitals only 15 were not correctly 
placed in toxic or non-toxic categories and of these 
10 were placed in the equivocal group indicating the 
need for further investigation© In only five cases 
was the diagnosis completely incorrect© One of the 
centres also studied the results obtained by medical 
students who had not been specially trained in the 
use of the scoring sheets and confirmed the finding 
of the fallacies produced by inexperience© While 
the independent observers were satisfied that the 
method provided good discrimination between toxic
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non-toxic subjects, the opinion was expressed by 
one physician that his over-all clinical assessment 
would have produced a separation of the same order*
Further observations would have to be made to confirm 
or refute this view but the index may well prove to 
be of most value to experienced clinicians who see 
cases of thyroid disease relatively infrequently#
The difficulty of obtaining a precise expression 
of clinical severity in thyrotoxicosis has complicated 
previous attempts to correlate its degree with objective 
measures of thyroid function* Goodwin, Macgregor,
Miller and Wayne (1951), however, classified their cases 
on clinical impressions into four grades from mild and 
border-line to severe, and found a rough correlation 
between the 4-hour and 24-hour uptake of radioactive 
iodine and clinical severity. No such correlation 
was found in the case of the 48-hour protein-bound 
radioactive iodine. Fraser (1953) has stated that 
the correlation of the urinary excretion tests with 
clinical severity is poor. He suggested, however,
(Fraser, Hobson, Arnot.t, and Emery, 1953) that one 
reason for this finding might be that when the 
itiptt in&ex is Well above the normal range it increasingly 
underestimates the thyroid uptake of radioactive iodine*
The clinical index is a measure of severity in so far 
as it indicates the number of target tissue effects.
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The weightings alloted to individual features ensure 
moreover that emphasis is placed on those phenomena such 
as heat intolerance which are the more reliable indices 
of abnormality. It is thus possible to plot this 
measure of clinical severity against the results of 
radioactive iodine studies* It can be seen from 
Figures 5 and 6 that a significant correlation was 
found between the degree of severity as reflected 
by the indices and the values both for 4-hour uptake 
and 48-hour protein-bound radioactive iodine. It must 
be admitted, however, that if the weighting factors 
making up the clinical index had been modified so as 
to express the degree of abnormality of individual 
clinical features, for example, if different weightings 
had been given to different grades of tachycardia and 
loss of weight the correlation might have been better.
Both Means (1916) and Fraser (1953) agree that 
the basal metabolic rate is the best index of the 
severity of the disease. The clinical index correlates 
well with the basal metabolic rate (Figure 4)* Foote, 
Mackenzie and Mac lagan (1952) have shown that a 
significant correlation exists between the basal 
metabolic rate and the thigh-neck clearance of ^^1 in 
thyrotoxicosis. It is, therefore, not surprising to 
find that the coefficients of correlation which exist 
between the index and the radioactive iodine criteria
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used, are comparable with that between the index and 
basal metabolic rates.
No such correlation, however, exists between 
the sleeping pulse rates and the diagnostic indices 
in the present series. These results agree with those 
of Sturgis and Tompkins (1920) who foundthat the basal 
pulse rate could not be taken as an absolute index 
of the activity of a given case of Graves's Disease, 
although they did find a close parallelism between the 
basal pulse rate and basal metabolism in successive 
observations on the same individual.
Hurxthal (1933 h) considered that the serum 
cholesterol reflected clinical severity and even 
suggested that in some cases its value in this 
respect exceeded that of the basal metabolic rate*
He also considered that it bore a general reciprocal 
relationship to the basal metabolic rate but this 
finding was not confirmed by Man et al. (1940).
The results of the present serieq^o not show any 
correlation between clinical severity based on the 
diagnostic indices, and serum cholesterol levels*
The results in general confirm that the clinical 
index can be used as a measure of severity of the 
disease. They also raise the possibility of the 
existence of a continuous gradation of thyroid activity 
comparable to that found for blood-pressure levels by
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Pickering (1955)* It should he made clear, however, 
that when allocating numerical values to the features 
which contribute to the clinical index weightings 
were used which would separate sharply normality 
from abnormality and this would tend to obscure 
any continuous gradation of thyroid function which 
might lie between the obviously normal and abnormal.
This problem is worth further study although it 
would involve changing the emphasis placed on the 
weighting factors. Estimations of non-radioactive 
protein-bound iodine might be the best index 
of thyroid function with which to correlate such a 
new index.
Conclusion
A clinical diagnostic index has been devised
which has been found to be of value as a reliable and
simple aid to diagnosis in day to day practice. When
its application produces a score which falls into the
equivocal range this indicates a case which is difficult
to assess? on clinical grounds alone and will require
investigation by special tests. It has proved so
reliable in routine practice that it has been possible
to reduce the demands on the laboratory services. The
clinical index enables one to see why certain cases
of suspected thyrotoxicosis give rise to diagnostic
difficulty and the analysis and classification of the 
responsible features should be of help to those who
have found themselves puzzled by a discrepancy between 
their clinical impressions and laboratory findingso 
The index makes it possible to minimise the effects 
of observer variation and also makes it easier to 
discover the reasons why differences in diagnosis 
occur. Lastly, it should be stressed that this 
technique is of more general application and might 
with advantage be applied to other diseases. Moreover, 
the application of the method to diagnostic problems 
throws much light on the technique of diagnosis and 
emphasises the value of precise clinical observation 
in modem medicine.
STJMMABX
1© Analysis of the frequency of symptoms and signs 
in thyrotoxic patients and normal individuals allowed 
the allocation of a numerical value to each clinical 
feature which varied with its diagnostic significance* 
The aggregate score in an individual case was termed 
the clinical diagnostic index and was derived in 99 
unquestionably non-toxic and 83 unquestionably thyrotoxic 
subjects. The values attached to individual signs and 
symptoms were then modified to minimise the effects 
of observer variation and to produce the greatest 
possible separation between the two groups, so that 
all non-toxic subjects had indices of less than + 11 
and all toxic subjects greater than + 19*
2. The method was then applied to 118 cases which had 
presented initial diagnostic difficulty using the 
weighting factors for clinical features established 
by the study of the definitely non-toxic and toxic 
cases* The clinical diagnostic indices produced good 
separation between cases finally shown to be non-toxic 
and those shown to be toxic* Fifty-nine of 67 non-toxic 
cases (8&fo) had scores less than + 11, 7 (10*5^) lay 
within the range + 11 to + 19 which is called the 
equivocal range, and 1 (1*5f°) fell in the toxic range. 
Forty-five (Q&fo) of the 51 toxic cases had scores greater 
than + 19 and the remaining 6 cases all fell within the
75.
equivocal range.
3. Studies on observer variation showed no statistically 
significant difference between scores obtained independently 
by experienced observers.
4* The diagnostic accuracy of the method was not 
significantly different from that of radioactive iodine 
studies and basal metabolic rate estimations and was 
greater than that of sleeping pulse rates aid serum 
cholesterol values.
5* The method has been applied in four different centres 
to 171 patients and the diagnostic accuracy (85^) was 
comparable with that of the original series of cases.
6. Examination of individual features making up the 
index often explains the mechanism by which a clinical 
diagnosis has been reached and makes it clear why, in 
certain cases, diagnostic difficulty has been found.
7. The scores can be used as indices of severity in 
toxic subjects and significant correlations existed 
between them and the 4-hour uptake of radioactive iodine, 
the 48-hour plasma protein-bound radioactivity and the 
basal metabolic rate. The indices did not correlate 
with either sleeping pulse rates or serum cholesterol 
levels•
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PART II
THE MEDICAL TRMTMENT OP THYROTOXIC OSIS
At the present time the choice of medical treatment 
of thyrotoxicosis lies between one of the various 
antithyroid drugs and the use of radioactive iodineo 
In this part of the thesis it is proposed to describe 
work carried out to evaluate the effectiveness of 
various antithyroid drugs in current use and to describe 
the results of radioactive iodine therapy in a series 
of cases with particular reference to the technique of 
dose estimation and the effect of pre-treatment with 
antithyroid drugs*
SECTION 1 
Antithyroid Drugs —  Introduction
Antithyroid drugs may be defined as chemical agents 
which interfere with the synthesis, release, or peripheral 
action of the thyroid hormone. A large number of chemically 
unrelated compounds are covered by this definition, but 
it is intended to deal only with those which have a place 
in the practical medical treatment of thyrotoxicosis*
Such drugs can be divided into two categories.
(1) Drugs preventing the iodination of tyrosine.
(2) Drugs inhibiting the iodide trap of the thyroid. 
Group (1) Drugs preventing the iodination of tyrosine.
The antithyroid dings of particular importance in 
this group are the thiouracil and imadazole derivatives. 
Mechanism of action. While the exact mechanism of action 
of these drugs is controversial, there is general agreement 
that they interfere with the iodination of the thyroid 
hormone precursors without affecting the ability of the 
gland to concentrate the iodide ion. The three current 
hypotheses given to explain this action are.-
(i) They may inhibit the enzyme system which oxidizes 
ionic to elemental iodine.
(ii) They may compete with iodide as a substrate 
for this oxidative enzyme.
(iii) Elemental iodine may be reduced to the iodide 
ion depriving the thyroid cell of iodine necessary for 
synthesis of the thyroid hormone.
Whatever the exact mechanism of action the effect 
of the drugs is to reduce the level of circulating thyroid 
hormone# This is accompanied by thyroid hyperplasia 
possibly due to increased production of thyrotropic 
hormone by the pituitary.
Group (2) Drugs inhibiting the iodide trap of the thyroid.
The anions which possess a significant goitrogenic 
action are, in order of decreasing activity, perchlorate, 
thiocyanate, and nitrate# Thiocyanate and nitrate have 
no therapeutic importance as antithyroid drugs because 
of their toxicity# Potassium perchlorate has, however, 
been used successfully in the treatment of thyrotoxicosis 
and much of the work to be described in the following 
sections consists of an evaluation of the place of 
perchlorate in the treatment of the disease.
Mechanism of action. The goitrogenie action of these 
anions can be overcome by the administration of iodide 
and this suggests that they interfere with the uptake 
of inorganic iodide by the thyroid (Franklin et al# 1944; 
Wyngaarden et al# 1952). Furthermore, inorganic iodide 
already trapped by the thyroid is discharged by the 
administration of the anions# The exact mechanism by 
which the anions act is unknown, but presumably if the 
circulating blood iodide level is high enough the block 
can be overcome#
The indications for using anti thyroid drugs.
In recent years the indications for the use of these 
drugs in the treatment of thyrotoxicosis have become more 
clearly defined* Most authorities agree that young adults 
with small or moderately enlarged, diffuse goitres should 
be given a prolonged trial of antithyroid drugs. When 
the disease occurs during pregnancy or puberty this form 
of therapy allows more flexible control of thyroid 
function during a period when the metabolic demands 
on the thyroid are varying. Before partial thyroidectomy 
is carried out toxicity should be controlled by treatment 
with one of these drugs. In some thyrocardiac subjects 
where rapid control of toxicity is required a short course 
of an anti thyroid drug can be given beginning ten days 
after radioactive iodine therapy. Finally, in patients 
where the diagnosis of thyrotoxicosis remains in doubt 
after full investigation, the patient’s response to 
antithyroid drug therapy is of diagnostic value#
Historical
Thiourea, the parent compound of most of the antithy­
roid drugs of Group (l) which are used therapeutically, 
was shown to be goitrogenic by Griesbach et al* (1941) 
and Kennedy (1942)* The latter also showed that a 
derivative of thiourea was responsible for the goitrogenic 
properties of Brassica seeds. Astwood (1943) further
confirmed the antithyroid activity of thiourea and its 
derivatives and in 1944 published the first clinical 
report of thiourea and thiouracil in the treatment of 
hyperthyroidism. T&e toxic effects of these drugs soon 
diminished the initial enthusiasm for antithyroid drug 
therapy, but this was revived by the introduction of 
4-methyl thiouracil and 6-H-propyl thiouracil, which 
because of their greater potency were effective in 
smaller doses and had fewer side effects. Both drugs 
had extensive clinical trials and are still widely used# 
Stanley and Astwood (1949) then demonstrated that 1-methyl- 
2-mercaptoimidazole (methimazole, ’Mercazole1, *Tapazolef) 
had greater antithyroid activity than any other known 
compound, while Bartels and Sjogren reported a successful 
clinical trial of the drug in 1951* Methimazole is 
widely used in the United States, but in this country 
2-carbethoxythio- 1-methy 1-glyoxaline (carbimazole, 
’Neomercazole*) synthesized by Rimington and his associates 
(Lawson et al. 195l)> is the more popular of the imidazole 
derivatives•
The history of drugs inhibiting the iodide trap of 
the thyroid began with the demonstration by Marine et al 
(1932) that acetonitrile and related compounds could 
produce thyroid hyperplasia and that the effect was 
antagonised by iodine. In 1952 Wyngaarden et al# studied
the antithyroid activity of various anions and concluded 
that the perchlorate ion was the most potent inhibitor 
of the iodide-trapping mechanism of the thyroid. This 
was followed in 1954 Dy successful clinical trials of 
potassium perchlorate in thyrotoxicosis (Godley and Stan bury, 
1954? Morgans and Trotter, 1954)®
SECTION 2
A Method of Comparing Antithyroid Drugs
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The relative activity of antithyroid compounds can 
he assessed by a method described by Stanley and Astwood 
(1947) which depends upon their properly of inhibiting 
the uptake of radioactive iodine. Their observations 
were carried out on normal human subjects and were thus 
more directly applicable to the clinical use of these 
drugs than those methods of assay which depend upon 
the goitrogenic action of the drugs in animals such as 
the immature rat (Astwood, Bissell and Hughes, 1945) 
or chick (VanderLaan and Bissell, 1946)* It is, however, 
generally agreed that the order of antithyroid activity 
obtained by Stanley and Astwood is not necessarily 
applicable to cases of thyrotoxicosis. Moreover, it 
is valid only when applied to drugs which act at the 
same point on the chain of thyroid hormone synthesis 
and so cannot be used to compare the activity of a drug 
such as potassium perchlorate, which acts on the iodide 
trapping mechanism, with drugs such as the thiouracils 
and imidazoles which affect the conversion of iodide to 
organically bound iodine.
Ideally, drugs should be assayed on patients suffering 
from the disease for which they are to be used. The 
particular method by which their effect is produced then 
becomes unimportant. Ho satisfactory method of doing 
this in thyrotoxicosis has so far been described and
despite extensive clinical trials of various antithyroid 
compounds there is an absence of exact data by which the 
therapeutic efficiency of the various drugs can be compared 
I have approached this problem in a new way. In Part I 
of this thesis I have been able to allocate figures 
indicating the relative diagnostic value of the various 
symptoms and signs of thyrotoxicosis by an analysis 
of their relative frequency in patients with the disease 
and in normal individuals. This procedure allowed me to 
derive, as previously described, a total score which I 
have called the clinical diagnostic index and I have shown 
that it has about the same degree of diagnostic accuracy 
as estimations of the basal metabolic rate or the results 
of radioactive iodine studies. By removing from the 
list of the diagnostic features of thyrotoxicosis those 
which are unaffected by treatment I have constructed 
a therapeutic index which gives a quantitative measure 
of the response to therapy. This section of the thesis 
describes the method and provides evidence as to its 
validity by applying it to a comparison of two antithyroid 
drugs, methyl thiouracil and potassium perchlorate.
Material and Methods.
Series 1. This series comprised 40 subjects who were 
definitely thyrotoxic. All were admitted to hospital and
87.
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the diagnoses were confirmed by radioactive iodine studies,
131including the 4-hour uptake of ^ I and the 4S'-,i1our 
plasma protein-bound radioactivity# Basal metabolic rate 
and serum cholesterol estimations were also carried out* 
All subjects had diffusely enlarged thyroid glands and 
were considered suitable for anti thyroid drug therapy*
They were allocated alternately to two groups, one to 
be given methyl thiouracil and the other potassium 
perchlorate • Methyl thiouracil was given in the doses 
used routinely in the Thyroid Clinic of the University 
Department of Medicine at Glasgow, namely 200 mg* three 
times a day for two weeks, followed by 100 mg* three 
times a day; potassium perchlorate was given in a dose 
of 200 mg# three times a day*
Before treatment began the patients were discharged 
from hospital and instructed to attend weekly# At the 
first out-patient attendance they were examined by a 
standard routine# Each subject was weighed in her clothes 
and asked to wear the same clothing on subsequent visits*
She was then instructed to lie down on an examination 
couch and was left undisturbed for 10 minutes# The 
resting pulse rate was then counted for one minute.
The presence or absence of the symptoms and signs shown 
in Table I was then recorded# The taking of the history 
and the physical examination were carried out in the
same way for each patient, the criteria for the identification 
of symptoms and signs being those laid down in Appendix 1 
except for pulse rate where a resting pulse rate higher 
than 85 beats per minute was considered abnormal*
Throughout the investigation all observations, with few 
exceptions, were made by one observer (the author) and I 
have shown in Part I of this thesis that my observations 
in observer variation studies involving the clinical 
features shown in Table I, did not differ significantly 
from those of 7 other experienced observers*
Numerical values were allocated to each clinical 
feature (Table i) on the basis of their diagnostic 
significance except in the case of appetite increase 
and weight loss* As I have previously described the 
combination of these two symptoms was of great diagnostic 
importance and for the purpose of diagnosis each was rated 
+ 3 giving a value of + 6 if both were present. In the 
assessment of therapeutic response* however, the restoration 
of weight loss is of much greater significance than the 
return to normal appetite and for this reason the rating 
for the symptom of weight loss was increased to + A and 
that for appetit^e increase reduced to + 1. lly adding 
the values obtained at the first out-patient attendance 
a total score ?/hich I term the therapeutic index was 
derived for each patient*
At the first out-patient visit treatment was started
with either methyl thiouracil or potassium perchlorate 
and patients receiving the latter drug were instructed 
not to eat fish or iodised salt, and to avoid medicines 
containing iodine*
At each subsequent weekly visit the procedure 
for ascertaining body weight, resting pulse rate, and 
the presence or absence cf the clinical features of the 
disease, was repeated. V/hen a symptom or sign disappeared 
completely its value was deducted from the therapeutic 
index of the previous week* In the case of weight 
increase one point was deducted from the initial index 
for each 4 pounds of weight gained. In this way a 
fresh therapeutic index was calculated weekly for each 
patiento
The week of full control or "cure'’ was defined as 
that week in which the therapeutic index first reached 
a value of 5 or less. If, however, the index fell below 
that value in either of the two subsequent weeks the 
week of "cure" was that with the lowest index* If in 
either of these two weeks it exceeded 5 it had to fall 
again in the way described above before the week of "cure” 
was reached* Indices of 5 or under were chosen to indicate 
full control because, irrespective of the other clinical 
findings, the combination of two or more clinical 
features of high diagnostic significance, and consequently
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scoring highly would suggest the persistence of toxicity 
and result in a therapeutic index greater than 5* Moreover 
in patients who were considered to he satisfactorily 
controlled by antithyroid drugs therapeutic indices fluctuated 
within the range zero to 5 over long periods. For these 
reasons it was considered that an index remaining* in 
this range for 3 successive weeks indicated that full 
control had been achieved#
In order to confirm that "cures'* had been effected 
at the times of the lowest therapeutic indices, basal 
metabolic rate estimations were carried out at fortnightly 
intervals in all patients until the week of "cure" had 
been reached. This was done by admitting patients 
to hospital overnight and giving 200 mg# butobarbitone 
12 hours before the test which was performed on the 
following morning. The procedure is described in greater 
detail by Crooks, Murray and Wayne, 1958* Th® serum 
cholesterol was also estimated each second week•
Following "cure" the patients were maintained in 
the euthyroid state with doses of the drugs ranging 
from 50 to 15 0 mg# daily for methyl thiouracil 
and 200 to 400 mg# daily for potassium perchlorate#
After three months maintenance therapy the drugs were 
stopped#
Series 2# This study comprised 14 cases made up of 
two groups: 8 subjects of Series 1 who had been given
FIGURE 1
Times taken to effect "cure" by potassium perchlorate
(600 mg# daily) and methyl thiouracil in patients of Series 1#
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TABLE II
Distribution of Patients in Series 3 Receiving Methyl Thiouracil 
and Potassium Perchlorate (600 mg.Daily) Showing Time Taken t o 
Effect "Cure*.
Time to 
Effect ’’cure”
(weeks) Methyl Thiouracil Pot* Perchlorate (60Qmg. daily)
3 - 4 1 -
5 - 6 3 -
7 - 8 4 5
9 - 1 0 10 3
11 - 12 1 4
1 3 - 1 4 - 3
15 - 16 1 -
17 - 18 - 2
19 - 20 1
21 - 22 - 1
C\J1N"\CM - 1
Total 20 20
Mean time to 
"cure*. 9*1 weeks 13 ol
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methyl thiouaad.1 and who, "because they relapsed following 
the cessation of therapy, were re-treated with potassium 
perchlorate; and 6 subjects who had been treated with 
potassium perchlorate and were re-treated with methyl 
thiouracil after relapse. The same dosage schemes for 
each drug were used in re-treatment as in the initial 
treatment and the follow-up procedure was identical*
Results
Series Is Time of "Cure*.* The weekly therapeutic indices 
obtained in the patients of this series are detailed 
in Appendix IV" (potassium perchlcrate 600 mg* daily —  
cases 1 to 20; methyl thiouracil —  cases 21 to 4^)* The 
times taken to effect "cure11, i.e., to reach scores 
of 5 or less, are shown in Table II* The mean time to 
“cure" of the 20 patients on methyl thiouracil was 
weeks and the comparable figure for the 20 patients on 
potassium perchlorate was 13*1 weeks. These values 
are significantly different (p <C0*0l). Figure 1 
illustrates the times taken to "cure" for both drugs and 
it can be seen that in the group of patients receiving 
potassium perchlorate the longest time taken to effect 
•’cure” was 23 weeks compared with 16 weeks for methyl 
thiouracil. It also shows the larger number of cases 
receiving perchlorate who required long courses before 
McureM was achieved©
FIGURE 2
Changes in therapeutic indices and basal metabolic 
rates during treatment with methyl thiouracil and 
potassium perchlorate (600 mg. daily). A and B show 
linear changes of the therapeutic indices with time*
B and IT^how the delayed type of therapeutic response*
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Variations of [Therapeutic Index with Time; Typical 
examples of the changes in the index during therapy are 
shown in Figure 2ik (methyl thiouraeil) and Figure 2b 
(potassium perchlorate). The associated changes in the 
basal metabolic rate plotted on the same figures showed 
good agreement with the clinical method of assessment#
In the case of both patients illustrated in those figures 
linear regressions of the therapeutic indices on time 
showed a significant fall in the values of the index 
with time. This relationship was found to hold in 17 
of the 20 patients treated with methyl thiouraeil. The 
remaining 3 patients were slow to respond to the drug and 
the changes in the therapeutic index and basal metabolic 
rate in this type of response are shown in Figure 2C<#
The indices of all three patients, however, reached 
values of 5 or less in subsequent weeks. Of the 20 
patients treated with potassium perchlorate 16 showed 
significant falls in the regression coefficient of the 
therapeutic index with time. In one of the remaining 
4 patients the values of the index suggested that the 
reason for the non-significant fall was the absence 
of data on three occasions on which she defaulted# The 
remaining 3 patients did not respond to treatment until 
6 weeks or more had elapsed and an example of this type 
of response to perchlorate is shown in Figure 2 h#
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Effect of Initial Values of the Therapeutic Index: A
comparison between the initial values of the therapeutic 
indices and the times taken to effect "cure" showed that 
for the groups on either drug there was no significant 
correlation between these two variables» In other 
words* the time takento effect a "cure" was uninfluenced 
by the initial values of the therapeutic index which 
is, of course, a measure of the severity of the disease# 
Basal Metabolic Hate and Serum Cholesterolt All 
measurements of basal metabolic rate and serum cholesterol 
made in the patients of Series 1 are shown in Appendices 
Y and VI respectively#
The mean values of basal metabolic rates in both 
groups before and after therapy are shown in Table III. 
Since the values of the basal metabolic rates were 
obtained at fortnightly intervals it was sometimes 
necessary to estimate the value of the basal metabolic 
rate corresponding to the therapeutic index when it 
had reached the week of "cure"# These estimations 
were made by first finding the linear regression of 
the basal metabolic rate on time and then estimating 
it at any given time from this regression# At the 
beginning of treatment using methyl thiouraeil the 
mean value for the 20 patients was + 46*95; at the 
conclusion when the jatients had reached values of the
therapeutic index of 5 or less they had a mean value 
of - 7o8 with a standard deviation of 9*7* A normal 
group of individuals would be expected to have basal 
metabolic rates with a mean value of zero and standard 
deviation 7*5 approximately# Thus the 20 patients 
had attained the euthyroid state as measured by the 
basal metabolic rate since the mean value of - 7*8 
is not significantly different from zero# At the 
beginning of treatment using potassium perchlorate the 
mean of the initial reading of basal metabolic rates 
for the 20 patients concerned was + 55*7; &t the 
conclusion when the time of "cure" had been reached 
by the therapeutic indices, the mean value was - 2#2 
with a standard deviation of 12#2# Thus, once again 
the estimations of basal metabolic rate ccnfirmed that 
tha patients were euthyroid at the time of "cure"#
It was hoped that the estimation of serum cholesterol 
values at fortnightly intervals might yield confirmatory 
evidence of "cure"# They were, however, found to be 
of little help. The mean values before and after therapy 
are given in Table III#
Series 2 —  Re-treatment: The therapeutic indices obtained
at weekly intervals in the patients of this series sire 
shown in Appendix VII# The times taken to effect "cure" 
in 8 subjects who initially received methyl thiouraeil
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and were given potassium perchlorate, following recurrence 
of the disease, are shown in Table IV. A t-test shows 
that the difference of 4 weeks is not significantly 
different from zero (t = - 2*18, 0.05 p<j 0,10)• The 
smallness of the probability suggests that the difference 
is probably different from zero* It should be noted that 
the difference obtained, i*e* potassium perchlorate 
taking 4 weeks longer than methyl thiouracil for "cure’1 
to be obtained, is similar to the difference found in 
Series 1* In 6 subjects who had received potassium 
perchlorate and who were given methyl thiouracil following 
recurrence of the disease, the times to "cure" are also 
shown in Table IV* A t-test shows that in this group 
of subjects the difference of 4 weeks is significantly 
different from zero (t = - 2*93> P ^Co.05)* Again 
the slower rate of control by perchlorate is similar 
to that obtained between the two groups of 20 patients 
in Series 1*
\
From a comparison of the two cross-over tests it 
is apparent that the findings are the same irrespective 
of which drug has been given first. It is valid 
therefore to consider both cross-over tests together and 
to conclude that in this group of 14 subjects potassium 
perchlorate, in the doses used, took 4 weeks longer 
than methyl thiouracil to control the disease* This
102.
confirms the results of Series 1 and provides evidence 
that the method of assessment is reproducible.
Discussion
Gaddum (1940) states, "Experiments on man are the 
only kind of experiment which can give certain evidence 
of therapeutic action on man". The truth of this statement 
is borne out by the work of Stanley and Astwood (1947) 
who found a poor correlation between their assays of 
antithyroid drugs in normal human subjects and the 
results obtained in the rat (McGinty and Bywater, 1945J 
Bywater, McGinty and Jenesil, 1945; Astwood, Bissell 
and Hughes, 1945)* There are many difficulties, however, 
in the way of assaying drugs in humans including individual 
variation of response, the small numbers as compared with 
animal experiments, the effect of suggestion, and the 
special difficulty of transferring results obtained in 
normal subjects to patients with disease. The various 
methods of carrying out drug assays in humans are 
admirably described by Gaddum (1954) who classifies the 
methods as direct assays, assays depending on measured 
responses, and those depending upon quantal (all or none) 
responses.
The method used by Stanley and Astwood to compare 
the antithyroid activity of various drugs is an example 
of the direct method of assay since they found the
minimum doses which would produce a definite inhibition 
of radioactive iodine uptake by the thyroid. By grading 
the degree of inhibition with various doses of the drugs 
these workers also incorporated the principles of assay 
by measured response and in this respect followed the 
design of the classical work on the antihistamines carried 
out by Bain (1949 )• Although this type of experiment 
gives reliable information about the relative activities 
of drugs in normal human subjects it is much more 
difficult to obtain comparable information in disease, 
yet this is the information which the practising 
physician requires© For example there appears to be 
a greater variation in the response to anti thyroid 
drugs in patients with thyrotoxicosis than in normal 
subjects. This variation, which is generally accepted 
by clinicians, may be due to the varying amounts of 
stored hormone present in toxic glands before treatment, 
but irrespective of the reason it cannot be ignored when 
providing comparisons of antithyroid drugs intended to 
be of help in clinical practice.
The method of assay by measured response, like 
all methods in which responses to single doses of 
drugs ape observed, has another disadvantage in that 
it fails to allow for the varying rates of accumulation 
of the drugs in the tissues© This is a particular 
disadvantage when comparing drugs with similar pharmacological
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actions, such as the antithyroid drugs and can produce r
1 Hfallacies in the extrapolation of the results to 
clinical therapeutics.
The objection to applying the results of animal 
experiments to humans has been avoided in the present 
study by carrying out the assay procedure in patients 
with thyrotoxicosis and allowance has beai made for the 
varying rates of drug accumulation by choosing the 
time taken to achieve "cure” as the response. Since 
’’cure*1 is an all or none phenomenon the procedure 
used belongs to the group of assays by quantal responses.
The difficulty in such assays lies in determining the 
end-point, in this case “cure”. This decision is essentially 
a clinical one and is conventionally based on the 
individual interpretation of a number of observations®
Such decisions can be criticised because of their 
subjective and interpretive basis and their scientific 
value has been questioned by a number of workers (Cochrane, 
Chapman, and Oldham, 1951)* (Duetto the inherent variability 
in conventional clinical assessments of Hcuren conflicting 
results may be obtained by different workers in comparing 
the effectiveness of drugs when this end-point is used.
For example Bartels (1945) found that thiobarbital was 
12 times more active in thyrotoxicosis than thiouracil
whereas Astwood (l$4$) found it to be only twice as 
active* The therapeutic index by expressing the 
response to therapy on a quantitative basis eliminates 
the necessity for reaching an opinion as to the time 
of’bure11. Instead the end-point is reached when the 
indices become five or less* The advantages of expressing 
the therapeutic response of a disease on a quantitative 
basis have been pointed out by Schultze and Zieve, 1958*
It allows much simpler statistical treatment and in the 
present study has enabled the high frequency of linear 
therapeutic responses with time to be identified. It 
has also made it possible to demonstrate that there was 
no relationship between the initial severity of the 
disease and the rate of therapeutic response*
The finding that the mean values of the basal 
metabolic rates in the two groups of Series 1 were 
not significantly different from zero when the decision 
as to Mcuren was reached by this method supports its 
validity. The index was also applied in a cross-over 
test of the type widely used in the assay of insulin 
in rabbits. This has the great merit of using each 
individual as her own control. This procedure is 
of course only possible in those relatively rare 
instances in which it is legitimate to allow a patient 
to relapse before re-applying treatment. Fortunately,
this is accepted practice in the treatment of thyrotoxicosis 
with antithyroid drugs. The results obtained in the 
cross-over tests confirmed those found in Series 1 and 
provide further evidence of the validity and reproducibility 
of the method. They also suggest that the possible 
errors of alternate allocation of drugs to two groups 
(Gaddum, 1940) did not occur in Series 1. It was 
appreciated that observer variation effects might 
introduce fallacies in the type of assessment which 
has been described. Such variation has been minimised 
since the indices were derived by one observer, the 
author, who in addition has shown no statistically 
significant differences in observer variation studies 
carried out in a similar clinical assessment of 
thyrotoxic patients.
In the comparison of antithyroid drugs the 
question of dose is of great importance. The doses 
of methyl thiouracil and potassium perchlorate 
chosen were the standard ones in use at the lime of the 
study. It is appreciated that it is generally desirable 
to use more than one dose of different drugs when comparing 
their relative potency and the method of comparison 
by therapeutic indices has been applied to potassium 
perchlorate at a higher dosage level and also to carbimazole 
in the investigation to be described in the next section 
of the thesis.
SECTION 2 
Summary
1. A clinical method of comparing the therapeutic 
effectiveness of antithyroid drugs is described#
The method is based on the allocation of numerical 
values to the reversible features of thyrotoxicosis, 
and the sum of these values for an individual case 
is termed the therapeutic index#
2# Therapeutic indices were obtained weekly in two 
groups of 20 cases, one group receiving methyl 
thiouracil and the other potassium perchlorate#
The anti thyroid activity of both drugs was assessed 
by the time taken to produce "cure" which was defined 
as a therapeutic index of 5 or under# "Cure" was 
confirmed by basal metabolic rate estimations#
5# The time taken to effect ’‘cure1’ was uninfluenced 
by the initial severity of the disease and in 33 of 
40 patients the rate of therapeutic response bore 
a linear relationship to time.
4* A cross-over test carried out on 14 patients 
who relapsed after the first course of treatment 
confirmed the validity of the method#
SECTION 3
A Comparison of Antithyroid Drugs, with Particular 
Reference to the Therapeutic Applications of Potassium 
Perchlorate#
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The ideal antithyroid drug for the treatment of 
thyrotoxicosis should have a sufficiently potent anti­
thyroid action to control the clinical features of the 
disease within a reasonable time, should be non-toxic 
in therapeutic doses, and should be inexpensive. The 
two anti thyroid drugs most commonly used in this country, 
methyl thiouracil and carbimazole, fulfil the first 
requirement, carbimazole having a greater antithyroid 
action, weight for weight, than methyl thiouracil 
(Macgregor and Miller, 1953)* Neither of these drugs 
qualifies as an ideal therapeutic agent in respect of 
non-toxicity since, in therapeutic doses both have 
caused serious side effects including agranulocytosis 
with a fatal outcome in some cases. Burrell et al. (1958) 
believe that fewer toxic effects are produced by 
carbimazole than by methyl thiouracil. In the case of 
both drugs the risks of toxic effects are less than 
the dangers of the untreated disease and for this reason 
they are acceptable therapeutic agents.
Potassium perchlorate was first shown to be an 
effective antithyroid drug in the treatment of thyrotoxicosis 
by Godley and Staribury (1954) and later by Morgans and 
Trotter (l954)> Beichart (1955)> Buttaro and Brunori (l955)> 
and Kleinsorg and Kruskemper (1957). It has a relatively 
simple molecule which would not be expected to produce
the serious side effects of the thiouracils and imidazoles, 
particularly on the haemopoetic system. The initial 
clinical use of this drug appeared to fulfil this 
expectation, and provided its low toxicity is confirmed 
it would he a better antithyroid drug in this respect 
than either methyl thiouracil or carbimazole. Morgans 
and Trotter (1954)> however, had the impression that 
the average rate of response to perchlorate in the dose 
they used (400 nig* daily) was less than that produced 
by methyl thiouracil in a dose of 200 mg. daily and that 
even with larger doses of perchlorate occasional patients 
were not adequately controlled. Buttaro and Brunori (1955) 
who used doses of 600 mg. daily also considered that the 
drug had a slower action than the other antithyroid 
drugs. Although it is not always necessary or even 
desirable to treat thyrotoxicosis rapidly it is likely 
that in the doses used by these workers it was a less 
effective antithyroid drug than either methyl thiouracil 
or carbimazole. If, however, the dose of potassium 
perchlorate could be increased sufficiently to achieve 
control of the disease at a rate comparable with that 
produced by methyl thiouracil or carbimazole, without 
a coincident increase in toxicity, then it would be nearer 
the ideal anti thyroid drug than either of the other .two.
The investigation to be described has been carried
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out to explore this possibility. I have used data 
obtained during the work described on the method of 
comparing the effectiveness of antithyroid drugs and 
in addition I have studied a further two groups of 
thyrotoxic patients who were treated with carbimazole 
and potassium perchlorate (l, 000 mg. daily) respectively.
I also took the opportunity to study certain other 
items of therapeutic interest, e.g.- the influence 
cf variation in dietary iodide intake on the therapeutic 
action of perchlorate, the effect of potassium perchlorate 
and methyl thiouracil on the degree of exophthalmos, 
and the place of perchlorate in pre-operative preparation 
and in pregnancy complicated by thyrotoxicosis.
Material and Methods.
/
Series 1. This series comprised two groups of 20 thyrotoxic 
patients, one group being treated with methyl thiouracil 
and the other with potassium perchlorate (600 mg. daily) 
as described in the preceding section.
Series 5. This series consisted of 40 cases with 
unequivocal thyrotoxicosis. The basis of selection and 
the methods of confirming the diagnosis were as described 
previously for the subjects of Series 1. The patients 
were allocated alternately to two groups one to be given 
carbimazole and the other potassium perchlorate. Carbimazole 
was given in doses of 20 mg. three times a day for two
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weeks followed by 10 mg. three times a day. This dosage 
scheme was chosen because it was the accepted equivalent 
of the dosage scheme for methyl thiouracil used in Series 1#
In the case of potassium perchlorate the dose of 600 mg* 
daily used in Series 1 was increased to 1,000 mg* daily 
in five divided doses. The dietary iodide intake was not 
restricted in the patients of Series 3*
The method of comparing the effectiveness of the 
two drugs by changes in the therapeutic indices was 
identical to that previously described except that 
patients were seen at fortnightly Intervals during 
treatment. Serial basal metabolic rate and serum cholesterol 
estimations were not carried out but "cure1 was confirmed by 
estimation of the basal metabolic rate in each case*
Dietary intake and urinary excretion of iodide. In 8 
patients of Series 1, all of whom had been treated with 
potassium perchlorate and advised to restrict their 
iodide intake, diet histories were obtained during 
the period of maintenance therapy. The histories were 
obtained by a dietitian who had no knowledge of the times 
taken to effect '’cure'* in the patients. From this data 
it was possible to estimate the approximate dietary 
iodide intake in each case#
The 20 patients of Series 1 advised to restrict 
their iodide intake because they were receiving potassium
perchlorate and the 20 patients of the same series 
treated with methyl thiouracil without restriction of 
iodide intake were asked to bring a sample of urine 
with them at each weekly visit, the sample being collected 
at 2 p.m* on the day of the visit. A qualitative test 
for the urinary iodide content of these samples was 
carried out in the following way.-
To a pair of test tubes were added 0#2 ml* and 1 mlo 
of the urine sample; standard tubes were also prepared 
with, instead, water and 0.1 ml. of a solution of 
iodide (0.5 mg. I per litre). To each tube the following 
was added: 5 ml. water, 1 ml. arsenious acid solution 
(Q.OT5 N arsenious acid in 0*75 N H2SO4 and 0*5 per 
cent Na OH), and finally, in quick sequence along the 
tubes, 0.4 ml. eerie sulphate (0.1 N eerie ammonium 
sulphate in 3.5 N HgSG^). The result was read at half- 
an-hour. No fading of the yellow colour in either tube 
showed that no iodide was present and was recorded as (-); 
a relatively large amount of iodi.de produced couplete 
fading in both tubes and was recorded as (++); all other 
results were recorded as (+).
This procedure is similar to that described by 
Fraser et al. (1953) except that these workers used 
aliquots of 24 hour samples of urine and consequently 
expressed their results in ranges of mg. of iodide per
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FIGURE 3
Times taken to effect "care" by oarbimasole and
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TABLE V
Distribution of Patients in Series 5 Receiving Carbimazole . 
and Potassium .Perchlorate (1, OCX) mg. Daily) Showing Time Taken 
to Effect "Cure”.
Time to NUMBER (F PATIENTS
Effect ’‘cure”
(weeks) Carbimazole Pot. Perchlorate (lOOOmgv daily)
3 - 4 -
5 - 6 -
7 - 8 7
9 - 1 0 2
11 - 12 4
1 3 - 1 4 3
15 - 16 -
17 - 18 2
19 - 20 -
21 - 22 2
Total
Mean time to 
',ciire,t.
20
12,
20
9*4 weeks
Exophthalmometry. Twelve patients were chosen at
random for this study from each of the two groups of 
Series 1, the one group receiving methyl thiouracil 
and the other potassium perchlcrate. Weekly exophthalmometiy 
readings were obtained using a.Zeiss-Hertel exophthalmometer, 
without reference to the readings of the previous week, 
until the time of "cure" was reached. Thereafter readings 
were made at fortnightly intervals during the three-month 
period of maintenance therapy and for a further 6 weeks 
following the stopping of the drugs.
Results
Therapeutic indices. The weekly therapeutic indices 
obtained in the patients of Series 3 detailed in 
Appendix VIII (carbimazole —  cases 41 to 60; potassium 
perchlorate, 1,000 mg. daily —  cases 6l to 80). The 
times taken to effect ’’cure” are shown in Table V and 
their cumulative distributions for both drugs are 
illustrated in Figure 3* The mean time to "cure" of 
the 20 patients on carbimazole was 12.3 weeks and the 
comparable figure for the 20 patients on perchlorate 
(1,000 mg. daily) was 9*4 weeks.
Table VI compares the mean times to effect "cure11 
of methyl thiouracil, carbimazole, and potassium perchlorate 
in doses of 600 and 1,000 mg. daily. For the purpose . 
of statistical analysis the drugs have been represented
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TABLE VI
Mean Times to Effect, “.cure.11, for Methyl Thiouracil, Potassium 
Perchlorate, and Carbimagole.
Time to effect
Drug HcureM (weeks)
A Methyl Thiouracil 9*1
B Potassium Perchlorate 600 mg, daily 13*1
0 Carbimazole 12*3
I) Potassium Perchlorate 1,000 mg* daily 9*4
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by the letters A, By C, and D as shown in the Table.
An analysis of variance on the 80 patients studied shows 
that there are significant differences between the mean 
values for A, B, C, and D. In particular A is significantly 
different from B and C (p <^0.05); D is significantly 
different from B and C (p < 0.05 ); and there was no 
significant difference between A and 3). A further 
analysis of variance was carried out on the 60 patients 
remaining after the exclusion of those who had been 
given methyl -thiouracil. It was found that there was 
a significant difference between B and D (p <T 0.05); 
a significant difference between C and I) (p < 0.C5; and 
no significant difference between B and C.
These results can be summarised as follows. In 
the doses used, methyl thiouracil and potassium perchlorate 
(1,000 mg. daily) were equally effective as measured 
by the time taken to effect “cure”, while both were 
more effective than carbimazole or potassium perchlorate 
(600 mg. daily).
Dietary intake and urinary excretion of iodide. The 
approximate intake of dietary iodide in 8 patients of 
Series 1 receiving potassium perchlorate is shown in 
Table ¥11 together with the times taken to effect "cure”.
Prom these results it can be seen that the iodide intake 
of subjects 11 and 1, who reached the time of ’‘cure”
TABLE VII
TABLE VII
Daily Iodide Intake of 8 Patients Receiving Potassium Perchlorate 
Subject No. Time to effect “cure” Iodine Intake aag./daily
11 7 94
1 8 122
10 11 56
5 12 65
9 14 120
7 18 99
4 18 124
8 21 120
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in 7 and 8 weeks respectively did not differ significantly 
from that of subjects J, 4 and 8 who did not reach the 
time of "cure” until 18, 18 and 21 weeks respectively#
This study therefore did not demonstrate any relationship 
between dietary iodide intake and the time of "cure”.
Table V H I  and Appendix IX show the iodide content 
of JO urine samples obtained from 20 patients of Series 
1 receiving methyl thiouracil and of 100 urine samples 
from 20 patients of the same series receiving potassium 
perchlorate. Significant differences were found between 
the two groups. In particular only J • ifo of the urine 
samples of the methyl thiouracil treated patients had 
no measurable iodide compared with 31$ of the samples 
of perchlorate treated patients. Also 45*7$ of the 
samples of the methyl thiouracil treated group had 
large amounts of urinary iodide compared with only 15$ 
of the samples of the perchlorate treated group. It is 
probable that the advice given to the patients receiving 
perchlorate to restrict their iodide intake m s  responsible 
for this difference. When the iodide content of the urine 
samples of perchlorate treated patients reaching time of 
"cure" before 15 weeks were compared with those of patients 
on the same driig “cured" after that time (Table YIIl) no 
significant difference was found. This finding like that of the 
dietary iodide study suggests that variations in the iodide
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intake of the patients receiving' potassium perchlorate 
did not influence the time taken to effect ’’cure”.
Exoph thalmometry. All exophthalmometry measurements were 
expressed as the sum of the changes in the values for 
both eyes using the pre-treatment measurement as a base­
line. The times chosen for comparison were the time of 
11 cure", after three months maintenance therapy, and 6 
weeks after the drugs were stopped. The data obtained 
for the 24 patients studied are shown in Appendix X and 
the mean values for the 2 groups of 12 patients receiving 
methyl thiouracil and potassium perchlorate (600 mg. daily) 
respectively are shown in Table IX.
In the case of both methyl thiouracil and potassium 
perchlorate there were significant increases in the degree 
of exophthalmos at both the time of "cure" and at the 
end of maintenance therapy compared with the pre-treatment 
levels. Six weeks after the drugs had been stopped 
this increase remained in the case of methyl thiouracil 
although the degree of exophthalmos had significantly 
diminished from the uend of therapy" levels (mean difference 
= + 1.62, significantly different from zero, p ^ O.Ol).
In the case of potassium perchlorate the "after therapy" 
value was not significantly different from the pre-treatment 
level but was significantly less than the mean value at 
the end of therapy (mean difference = + 1.04, significantly 
different from zero, 0.02 > p <C 0.05).
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Further statistical analysis carried out to compare 
the effects. of the two drugs on the degree of exophthalmos 
showed no significant difference between them at any 
of the three times chosen for comparison.
In summary both drugs increased the degree of 
exophthalmos and this diminished after they had been 
stopped. Six weeks after the cessation of therapy the 
exophthalmos had returned to the pre-treatment level 
in the case of potassium perchlorate but remained 
significantly higher in. the methyl thiouracil group.
Toxic effects. Since the three antithyroid drugs studied 
have a low frequency of toxic effects the incidence of 
such reactions in the patients of the present investigation 
are meaningless because of the small numbers. I have, 
however, obtained data on the toxicity of these drugs 
from a supplementary study carried out on all patients 
treated by me with antithyroid drugs in the University 
Department of Medicine, Glasgow between 1954 and 1958*
The results are shown in Table X. It can be seen that 
SO patients have been included who were given doses 
of potassium perchlorate exceeding 1,000 mg. daily and 
the vast majority of these received 2,000 mg. daily.
The rate of control with the larger doses of perchlorate 
was not studied in detail but no obvious advantage was 
apparent although there may have been a slight increase.
In the case of methyl thiouracil andcarbimazole the doses 
used were the same as those in the main investigation.
It was found that there was no significant difference 
between the incidence of toxic effects for the three 
drugs when the two dosage schemes of potassium perchlorate 
were taken together. The toxic effects produced by 
potassium perchlorate, however, in doses of 1,000 mg. 
daily or under were significantly less frequent than 
with larger doses of perchlorate or with either methyl 
thiouracil or carbimazole.
Potassium perchlorate and Surgery. Seven patients 
chosen because they had small nodular glands were prepared 
by me for operation with potassium perchlorate alone and 
the surgeon who carried out the operation expressed 
the opinion that the glands were no more vascular than 
similar glands pre-treated with methyl thiouracil or 
carbimazole.
Potassium perchlorate and Pregnancy complicated by 
Thyrotoxicosis. Seven pregnant thyrotoxic subjects
have been treated by me with potassium perchlorate. Control
of the disease was good and the pregnancies were uneventful.
Of the 7 babies 6 showed no evidence of thyroid disturbance
while the seventh had a very small goitre which disappeared
6 weeks after birth.
Discussion
The results obtained in this investigation show that 
potassium perchlorate is an effective agent for controlling 
thyrotoxicosis and confirm the findings of Godley and 
Stanbury, (1954)* Morgansand Trotter, (1954)* and 
Kleins org and Krftskemper (1957)®
Hate of control. Godley and Stanbury, found that the 
rate at which patients responded to treatment with 
potassium perchlorate varied widely but expressed the 
opinion that in general it compared favourably with 
the response rates to antithyroid drugs of the thiourea 
series. The dose they used was, with a few exceptions,
600 mg. daily but the number of patients was small and 
no control groups were studied. Morgans and Trotter on 
the other hand treated a much larger number of patients 
with perchlorate in doses of 4-C'O mg. daily and came 
to the conclusion that the average rate of response was 
somewhat slower than was usually seen after treatment 
with methyl thiouracil 200 mg. daily. They also found 
that when patients on maintenance doses of methyl 
thiouracil were changed over to potassium perchlorate 
the average dose necessary for effective control was 
two to four times as great. The results obtained in 
Series 1 confirm their conclusion in the dose range
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of perchlorate which they used. Buttaro and Brunori (1955) used j 
the same dose of perchlorate as that used in Series 1 and j
I
also commented on "the slower action and less stable J
effects”, compared with other antithyroid drugs. J
These workers comment on the frequency of cases which
appear to be ”resistant” to the drug and this was also !
i
found in the patients of Series 1 treated with 600 mg. j
daily of perchlorate. Indeed one quarter of the cases j
did not reach the time of ”cure” until 17 to 24 weeks j
had elapsed. An example of this slow rate of response j
can be seen in Figure 2D and should be compared with |
f(
the more rapid rate of control illustrated in Figure 2B. j
I
This variability of response rate is not however peculiar J
to perchlorate; slow responses occurred just as frequently j
with carbimazole and less frequently with methyl |
thiouracil. A comparison of Figures 2A and 2C illustrate 
this phenomenon in the case of methyl thiouracil. The 
explanation of these findings probably lies partly in 
variations in the amount of stored hormone which has to 
be utilised before the euthyroid state is reached, and 
also in the doses of the drugs being used. In any event 
the results of the present investigation indicate that 
an absence of clinical response after 6 weeks treatment 
with any of the drugs studied does not necessarily mean
150.
that control will not he achieved ultimately.
That "resistance” to potassium perchlorate is in 
part a function of dosage and not a property of the drug 
is further suggested by the finding that when the dose 
was increased from 600 mg. daily to 1,000 mg. daily 
(Series 5) the rate of control became equal to that achieved 
by methyl thiouracil in the patients of Series 1 and more 
rapid than that of carbimazole (Series 5)* This is also 
suggested by the findings of Smellie (1957) who treated 
6 young children with relatively large doses of potassium 
perchlorate and found that the rate of response was no 
slower than that produced by propyl thiouracil. It is 
of interest that since the present investigation was 
completed Morgans and Trotter, 1957 in & letter to the 
Lancet confessed that their initial dosage scheme for 
perchlorate was too small and that they were now using 
larger therapeutic doses. Kleinsorg and Kriiskemper 
(1957) also concluded that the speed of action of the 
drug is dependent upon the doses used from the r esults 
they obtained in a study of 47 patients given varying 
doses of perchlorate ranging from 800 mg. to 2,000 mg. 
daily. They also believe that in full doses it has 
a speed of action comparable with imidazole derivatives 
and point out that those who say that perchlorate has 
a slow action have all used snail doses.
Macgregor and Miller (1953) using the technique of 
Stanley and Astwood (1947) found that the antithyroid 
effect of carbimazole m s  $0 times greater than that 
of methyl thiouracil. They emphaased, however, that 
considerable caution should, be exercised in the transfer 
of potency trials of this type to clinical therapeutics* 
Both they and other observers have expressed the opinion 
that, weight for weight, carbimazole is 10 times more
active clinically than methyl thiouracil although there
X ■:€
is no adequate data to support this view. The results 
of the present investigation suggest that this estimate 
is over-generous and carbimazole is only 7 to 8 times 
more active, weight for weight than methyl thiouracil* 
Toxic effects* The results I have obtained demonstrate 
that the dose of potassium perchlorate can be increased 
sufficiently to make it comparable with the other 
antithyroid drugs in respect of rate of control. Since 
it is probable that this parameter of antithyroid activity 
is a function of both dose and the amount of stored thyroid 
hormone for each of the antithyroid drugs the choice of 
such a drug for clinical use will depend upon the 
incidence of toxic effects produced*
The findings in the present investigation that 
carbimazole is no different from methyl thiouracil in 
respect of toxicity is contrary to the conclusions of
Burrell et al. 1956 and Green and Morgan, 1956* The 
vast majority of the patients studied by these workers 
received doses of 20 to 30 nig. daily of carbimazole and 
their claim concerning the low toxicity of the drug may 
well be due to the low dosage schemes used. As in the 
case of the rate of control of thyrotoxicosis the incidence 
of the toxic effects of antithyroid drugs is likely to 
be a function of dose. This concept invalidates 
the numerous attempts made to evaluate the toxicity of 
the various antithyroid drugs by comparing series of 
patients in which different dosage schemes have been 
used. That this concept holds for potassium perchlorate 
is shown by the finding of the significant increase 
in the incidence of toxic effects when the dose was 
increased above 1,000 mg. daily.
The type of toxic effects produced by methyl 
thiouracil and carbimazole shown in Table X have all 
been previously reported by other workers. In the case 
of agranulocytosis the two cases produced by carbimazole 
can be added to the 10 already reported from the Ikiited 
States and Great Britain and this complication of 
treatment with this drug would not appear to be as rare 
as suggested by Burrell et al. 1956. Since potassium 
perchlorate has only been used as a therapeutic agenfcfor a
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relatively short time much less is known about its toxic 
effects. Godley and Stanbury (1954) reported one case 
of dyspepsia and one case in whom a duodenal ulcer 
perforated, in a series of 24 patients treated with 
perchlorate. Morgans and Trotter (1954) treated 106 
cases with this drug and the only side effects observed 
were gastro-intestinal symptoms in two patients one of 
whom had a diaphragmatic hernia and the other a peptic
(1957)
ulcer* Kleinsorg and Krflskemper/on the other hand found 
no gastro-intestinal upsets in their 47 patients. In 
the present study 3 °f "tbe 4 patients who complained 
of nausea continued taking the drug together with alkalis 
and the symptoms disappeared within one week in each 
case. The fourth patient refused to continue treatment 
and defaulted. The skin rashes which developed 
when a dose of 2,000 mg. daily was used were maculo-papular 
in nature and confined to the extremities except for 
one patient in whom the rash was generalised. In three 
of the 5 patients it was not necessary to stop 
treatment. Skin rashes produced by perchlorate have been 
previously reported by Kleinsorg and KrUskemper (1957) 
in 2 of 47 cases treated but in neither was it necessary 
to discontinue the drug. It is of Interest that these 
workers were using large doses of the drug. They also 
reported a skin rash in one other case but this may
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have been due to a barbiturate which had been given at 
the same time. "When this patient was given perchlorate 
with prednisone, following operation, the skin rash 
did not return. Morgans and Trotter (1957)> in a letter 
to the Lancet describing briefly their further experience 
with perchlorate using doses of 1,600 mg. daily also 
encountered, for the first time in their experience, 
skin rashes which occurred in two patients.
Although no exanthems were produced in the present 
series with doses of perchlorate of 1,000 mg. daily or 
less Buttaro and Brunori (1955) reported a skin rash 
in one patient of 25 treated with doses of 600 mg. 
daily.
It is concluded, therefore, from the results of 
the present study and those of other workers that the 
skin rashes produced by perchlorate are relatively minor 
in nature and are more liable to be produced by doses 
larger than those which can effectively control thyrotoxicosis.
The case of agranulocytosis produced by perchlorate 
is of great importance since this complication has not 
been previously described. The patient, a young female, 
was an unequivocal case of thyrotoxicosis and was treated 
with perchlorate in doses of 500 mg. three times daily.
During the third week of treatment she developed a sore 
throat and pyrexia with generalised muscle pain. Blood
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examination revealed a polymorphonuclear leucocyte 
count of 750 per cmm. hut the other blood findings 
were normal and the bone marrow histology showed no 
evidence of a maturation defect of the white cell series. 
After cessation of the drug, however, there was a rapid 
increase of the leucocyte count to normal levels. The 
patient had not been receiving any other drugs and the 
evidence points to perchlorate as the causative agent.
The fact that the rate of response to doses of 
1, 000 mg. daily of potassium perchlorate is comparable 
to that of the accepted therapeutic doses of the 
other antithyroid drugs and that this dosage scheme is 
associated with negligible side effects suggests that the 
use of larger doses of this drug should be avoided.
The effect of iodide intake on perchlorate therapy. Table 
VIII shows that the measures adopted to reduce the 
dietary iodide intake of the patients of Series 1 were 
successful. No correlation was found, however, 
between the degree of iodide deprivation, as measured 
by both the diet histories and urinary iodide values, and 
the time taken to effect "cure". Furthermore a 
significant increase in the rate of response to perchlorate 
was obtained by using a larger dose in the patients of 
Series 3 who continued to have their normal diet.
Perchlorate acts on the iodide-concentrating mechanism 
of the thyroid and would become ineffective if the blood- 
iodide levels were high enough to raise the concentration 
within the thyroid to the level normally attained by 
the gland’s iodide-concentrating mechanism* Such a 
situation is unlikely to occur during therapy and the 
results obtained in this study suggest that the normal 
variations in dietary iodide intake do not influence the 
therapeutic response to the drug*
Changes in the degree of exophthalmos produced by potassium 
perchlorate and methyl thiouracil* Dobyns and Haines
(1945) reviewed 11 cases in which patients with exophthalmic
goitre were treated with thiouracil and followed carefully
with exophthalmometric measurements. Seven of the 11
patients showed an increase in the prominence of the
eyes ranging from 0.5 to 4*75 ana* Ch the other hand
Beierwaltes (1948) studied 28 patients with thyrotoxicosis
and without malignant exophthalmos who were treated
with either thiouracil or propyl thiouracil* Weekly
exophthalmometry readings for an average period of 4
months did not show a significant average increase in
exophthalmos. He suggested that the difference in his
findings from those of Dobyns and Haines might have been
due to the inclusion by the latter of some cases of
malignant exophthalmos. The present work confirms the
findings of Dobyns and Haines and since I did not include
any cases of malignant exophthalmos the explanation put
forward by Beierwaltes does not apply. Beierwaltes does 
not give any details of the dosage schemes he used nor 
of the rates of therapeutic response and it is possible 
that his failure to observe changes in the degree of 
exophthalmos might be explained by the difference between 
these two variables i.e. dose and rate of response, in 
his series and those of both the present series and 
that of Dobyns and Haines. Important confirmatory 
evidence of a true increase in the prominence of the 
eyes produced by antithyroid drugs is shown by the results 
I obtained after treatment had been stopped when a 
significant decrease in the "end of therapy" readings was 
found. The results also showed that the increase in 
exophthalmos during treatment with perchlorate was not 
as great as that with methyl thiouracil although the 
differences were not statistically significant. A 
significant difference was found, however, in the 
"after therapy" values for the two drugs, the perchlorate 
group reverting to the pre-treatment level while the 
methyl thiouracil group remained significantly above it.
The dose of perchlorate given in this study was 600 mg. 
daily and the rate of response was slower than that 
produced by methyl thiouracil. This may account for the 
difference found in the effect of the two drugs on the 
degree of exophthalmos. The implication of this finding
is that the smaller dose of perchlorate should be given 
to patients with severe eye signs.
Potassium perchlorate and Surgery. Godley and Stanbury, 
1954» treated 13 patients pre-operatively with potassium 
perchlorate and stated that it was the concensus of 
the operating surgeons that a few of the glands were more 
vascular than those of patients prepared with propyl 
thiouracil and iodine. Of two patients who received 
iodide in addition to perchlorate during the week before 
operation one escaped from control. For this reason 
Morgans and Trotter, 1954> did not use perchlorate 
for pre-operative preparation. On the other hand,
Kleinsorg and Krtf.skemper (1957) carried out partial 
thyroidectomy in a small proportion of their cases 
and found that hyperaemia at operation was not great 
enough to give technical difficulties. The results 
I have obtained by the pre-operative use of perchlorate 
confirm their findings in respect of the absence of 
technical difficulties. Until satisfactory techniques 
for measuring the vascularity of the glands are evolved, 
however, for use in such studies no definite conclusions 
can be reached but for the present it would he reasonable 
to reserve the pre-operative use of perchlorate for patients
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with small nodular glands.
Potassium perchlorate and Pregnancy complicated by 
Thyrotoxicosis. Goitre and hypothyroidism have been
reported in the babies of mothers receiving antithyroid 
drugs of the thiouracil group during pregnancy (Eaton,
1945; Ball and Morrison, 1948) hut this is an uncommon 
event. Astwood (1951) pointed out that if the dose 
of the antithyroid drug has been adjusted to ensure 
a normal output of hormone by the maternal thyroid it 
is unlikely that the function of the foetal thyroid 
would be significantly depressed. He reported 22 
completed pregnancies in 19 patients, the 22 living 
children showing no evidence of thyroid disturbances.
The use of potassium perchlorate in pregnant thyrotoxic 
patients has not yet been reported. As can be seen 
from the results 7 such patients have been satisfactorily 
treated with this drug and these findings suggest 
that potassium perchlorate is a satisfactory drug for 
use in pregnancy, complicated by thyrotoxicosis.
Conclusion
The studies described above in which I have 
compared potassium perchlorate, methyl thiouracil, 
and carbimazole in the treatment of thyrotoxicosis 
have led me to the conclusion that perchlorate is the 
antithyroid drug of choice in the medical treatment of
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the disease. This conclusion is based on three points•-
(a) fhen perchlorate is administered in doses of 1,000 mg. 
daily the rate of therapeutic response is comparable 
with that produced by methyl thiouracil and exceeds
that of carbimazole, the antithyroid drugs in current 
use in this country.
(b) At this dosage level the incidence of toxic effects 
is significantly less than with either methyl thiouracil 
or carbimazole in comparable therapeutic doses.
(c) Potassium perchlorate is the cheapest of the anti­
thyroid drugs. Sufficient tablets to treat a patient 
at a dosage of 1,000 mg. daily for one month cost 5d.
This is from a tenth to a three hundredth of the cost
of equivalent doses of other antithyroid dings in common 
use.
SBCTIC8ST 3 
Summary
1. The times taken to "cure" thyrotoxicosis have 
been compared in four groups of 20 patients treated 
with methyl thiouracil, potassium perchlorate (600 mg* 
daily), carbimazole, and potassium perchlorate (1,000 mg 
daily)* The mean time taken to effect "cure1’ for 
potassium perchlorate —  1,000 mg* daily —  (9*4 weeks) 
was not significantly different from that of methyl 
thiouracil (9*1 weeks) and shorter than that for 
either carbimazole (12*3 weeks) or for potassium 
perchlorate —  600 mg* daily —  (13*1 weeks).
2. The incidence of toxic effects with potassium 
perchlorate in doses of 1, 000 mg. daily or under was 
less than with methyl thiouracil, carbimazole, or 
larger doses of perchlorate*
3* Variations in dietary iodide did not influence 
the times taken to effect "cure" by potassium perchlorate 
4* The mean degree of exophthalmos increased during 
treatment in two groups of 12 patients given methyl 
thiouracil and potassium perchlorate (600 mg. daily).
The exophthalmos diminished when the dnags were 
stopped, returning to the pre-treatment level in the 
cane of perchlorate and remaining significantly above 
it in the case of methyl -thiouracil.
5. Experience in 7 cases prepared with potassium 
perchlorate for partial thyroidectomy suggested that 
this drug is a satisfactory antithyroid drug for pre­
operative preparation in patients with small, nodular 
goitres»
6. Seven pregnant thyrotoxic patients have been 
successfully treated with potassium perchlorate. Six 
of the babies showed no evidence of disturbed thyroid 
function and the seventh had a small goitre which 
disappeared six weeks after birth.
7* It is concluded that potassium perchlorate is the 
drug of choice in the medical treatment of thyrotoxicosis.
PART II (ctd.).
SECTION 4
Radioactive Iodine Therapy in the Treatment 
of Thyrotoxicosis —  Introduction.
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Radioactive iodine has been used in the treatment
of thyrotoxicosis for two reasons* The first is the natural
avidity of the thyroid for iodine in either its stable
or radioactive forms* The second is that radioactive
iodine decays within the thyroid by the emmission of high
energy beta rays which penetrate only a few millimetres
into the tissue and destroy it in the same way as X-rays
produce tissue destruction* The radioactive isotope of
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iodine which is most suited for therapeutic use is I
because of its physical characteristics* It produces its
irradiation effects primarily by the emission of beta
particles and emits one half of its energy every eight
130
days i.e., it has a half-life of eight days. I
which was the first radioisotope of iodine to be used 
therapeutically, has a half-life of only 12 hours.
Historical
Radioactive iodine treatment of thyrotoxicosis
was introduced in the United States of America where,
in 1941, a thyrotoxic patient was first given one milli-
curie of By 1942 this dose had been increased
130by Hertz to 16 millicuries of " ±  and Hertz and Roberts 
(1946) described the results obtained in the first 29 patients 
treated between 1941 and- 1945* These workers administered 
stable iodine following radioactive iodine treatment to 
prevent uncontrolled hyperthyroidism if the latter was
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not effective* They found, however, that the thyroid 
function of the majority of the patients remained normal 
after the stable iodine was stopped* In this report 
they concluded that such treatment "is highly effective 
as a cure of the disease in about 80 per cent of cases”•
Since these patients had received stable iodine in 
addition to radioactive iodine it was difficult to discrimi­
nate between the effect- of the radiation and that of the 
ordinary iodine but Chapman and Evans (1946) showed that 
radioactive iodine alone was effective in the treatment
of thyrotoxicosis* They also reported that overtreatment
131produced myxoedema. In the same year I became generally
available in the United States and this isotope began to
be used in many centres. Indeed 5 years later 130 centres 
131
were using I in the treatment of the disease
(United States Atomic Energy Commission, 1951)* $he 
131effectiveness of ' I therapy was rapidly confirmed by 
Soley and Miller (1948), and Werner et al. (1949), 
and in the first British report by Blomfield et al.(1951). 
Since then an extensive literature has grown on the 
subject and because of the early American experience 
the most complete reviews are to be found in the reports 
of American workers (Clark et al. 1952? Chapman and 
Maloof, 1955? and Werner et al. 1957)®
The history of radioactive iodine therapy is one
of growing enthusiasm and there is no evidence in the 
17 years of its use that the initial optimism was 
unjustified#
The advantages and disadvantages of radioactive iodine 
therapy. This form of treatment has many advantages
among which may be listed simplicity of administration -
a drink of tasteless water through a straw — , its
potential for treatment on an out-patient basis, its
safety, and the ease with which re-treatment can be
carried out if necessary. It has, however, certain
disadvantages 5 its slowness in controlling the
clinical features of the disease, the difficulties of
dose estimation, its absolute contraindication in
pregnancy, and the theoretical possibility of the
treatment being carcinogenic* There is universal
agreement that it is an effective way of treating
thyrotoxicosis and it is only the doubts which remain
concerning its possible carcinogenic effects which have
prevented its use in the vast majority of cases of
the disease. During the 17 years in which radioactive
iodine therapy has been used, however, there has been
no reported case of resulting thyroid cancer and this is
also true of X-ray therapy for thyrotoxicosis which,
though a disappointing form of treatment, has been
widely used in the past. On the other hand carcinoma
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of the thyroid has been produced in rats by ^lj (Goldberg 
and Chaikoff, 1951> 1952) and with ^^1 and methyl 
thiouracil together (honiach, 1953)* 1** & further three
years this type of treatment will have been in use for 
twenty years and provided that there is no increase 
in the incidence of thyroid carcinoma above that to be 
expected in the population at large, radioactive iodine 
may become even more extensively used than it is at 
present.
Indications for the use of radioactive iodine. The 
above considerations imply the selection of suitable 
cases for treatment with -^3Ip based on the principle 
that it should be reserved for those with an expectation 
of life less than that of the latent period for the 
development of carcinoma ,d.e. about twenty years.
Applying this principle Blomfield et al. (1955) advised 
the restriction of treatment to the following groups 
of cases.-
(a) patients over 45 years of age;
(b) those in whom associated disease reduces life 
expectancy to less than 20 years;
(c) those who are refractory or hypersensitive to 
antithyroid drugs and in whom thyroidectomy is 
either contraindicated or refused;
(d) recurrence after thyroidectomy, since antithyroid 
drug therapy is unlikely to lead to sustained 
remission and a second operation is much more likely 
to be followed by some post-operative complication;
(e) cases of heart disease associated with
thyrotoxicosis since expectation of life is 
low and operative mortality high*
Most authorities agree with the above method of 
selection and it is on this basis that patients have 
been selected for radioactive iodine therapy in the 
investigations to be described in this section of 
the thesis*
SECTION 5
A Comparison of Various Methods of Dose 
Prescription in Radioactive Iodine Therapy*
The aim of radioactive iodine therapy in thyrotoxicosis
is to produce the euthyroid state with as few treatments
as possible. It is self-evident that in attempts to
achieve this there will be an inverse relationship
between the number of treatments necessary in any
group of patients and the incidence of hypothyroidism
due to overdosage. A few centres have evaded this
difficulty by using multiple small doses (Y/erner et al.
1948; Williams et al. 1949 > Gordon and Albright, 1950;
McCullagh, 1951) but the inconvenience of this
procedure to both patient and physician has not made
it generally acceptable. Whereas the majority of
workers aim at a high cure rate with one treatment there
is considerable disagreement as to how this is to be
achieved. Some centres for example select a dose which
1^1is thought to be effective in terms of  ^ I concentration 
in the thyroid gland (Chapman and Maloof, 1955? Fraser 
et al. 1954) while others select their dose on the 
basis of the number of rads of radiation delivered to 
the gland (Blomfield et al. 1951> 1955? Freedberg et al« 
1952). Macgregor (1957) the other hand has criticised 
these methods because they are based on a number of 
assumptions which are not necessarily valid. He 
therefore adopted a simplified form of dose estimation 
by adjusting the dose in millicuries to that which
would produce a rapid clinical cure while avoiding,
as far as possible, myxoedema. He admitted that in
his method of dose estimation he was applying the
experience he had gained while employing a precise and
quantitative technique (Blomfield et al* 1955)
many years* The present investigation was carried
out to ascertain if a physician (the author) who at
the outset had no specialised experience in this field
could prescribe doses of radioactive iodine by a method
similar to that of Macgregor, although devised
independently, and achieve results comparable to
those of the latter and of Blomfield et al* (1955)*
Before this investigation began a group of
patients suitable for this form of treatment were
treated by me with methyl thiouracil and became euthyroid
before radioactive iodine therapy became available*
Since there is much controversy and little published
data on the effect of pre-treatment with antithyroid
drugs on the response to radioactive iodine therapy
I decided to answer this question by treating this
131group of patients with I at random intervals during 
a period when newly diagnosed cases were being treatedo 
In this way I have been able to compare the number of 
cures by one dose of ^lj patients pre-treated 
with methyl thiouracil and in those who have had no 
previous treatment.
Material and Methods.
One hundred and fifty patients in whom the 
diagnosis of thyrotoxicosis had been confirmed by 
the clinical diagnostic index described in Part I 
of the thesis, and by radioactive iodine studies, 
were considered to be suitable for radioactive iodine 
therapy by the criteria laid down by Blomfield et al. 
(1955)* Tlie cases fell into the following categories. 
Group 1 (28 cases).
The patients of this group had received treatment 
with methyl thiouracil for three months to one year 
before radioactive iodine therapy was given and were 
either euthyroid or only minimally thyrotoxic at this 
time. The drug was stopped 1 week before ^ ^ 1  treatment. 
All cases of this group were treated with ^31i between 
January, 1954 an<i July, 1956. Originally there were 
30 cases in this group but one patient died pf a 
myocardial infarction 2 months after the second dose 
of radioactive iodine and 1 patient defaulted 2 months 
after treatment; both were excluded from the study.
Group 2 (43 cases).
The patients of this group were treated in the 
same period as those of Group 1 but had had no previous 
treatment with anti thyroid drugs. One patient who 
became euthyroid with one dose of -^Ij at 5 months, 
died a month later of broncho-pneumonia and has not
been included in the group*
Group 5 (21 cases)*
This group had been previously treated with 
methyl thiouracil for periods similar to that of 
Group 1* The drug was also stopped one week before 
radioactive iodine therapy which was given between 
July, 1956 and August, 1957*
Group 4 (56 cases)*
This group received radioactive iodine therapy 
during the same period as Group 3 but had had no 
previous treatment with antithyroid drugs* One 
patient in this group defaulted one month after the 
first treatment and has not been included in the study*
A H  cases, with the exception of a few at the
beginning of the investigation, were given tracer 
131doses of J I during the week before treatment and
131the 48-hour gland uptake of I estimated* In the 
case of these patients who had been receiving methyl 
thiouracil the drug was stopped 48 hours before the 
tracer dose was administered*
In the first year of the investigation all 
patients were admitted to hospital both for the 
initial therapeutic dose of and for subsequent
doses if necessary* After the first year, because of
the growing pressure on hospital beds, a large 
proportion of the cases were trdated on an out-patient 
basis.
Method of dose estimation. The basic principle of 
dose estimation used was that small doses were 
prescribed for patients with small glands and large 
doses for patients with large glands. It was decided 
from a review of the results of other workers that 
patients with impalpable glands would be given doses 
of 4 *“ 5 millicuries (me.), with minimal but definite 
diffuse enlargement of the gland —  6 - J me., and for 
patients with larger glands increasing doses up to 
25 me. Many other factors besides gland size 
influenced the dose prescribed; for example post- 
thyroidectomised patients were given 5 ~ 6 me., unless 
the gland remnant was exceptionally large; larger 
doses were given to patients with nodular glands, with 
cardiac failure, with uncontrolled diabetes mellitus, 
or whenever the need for a rapid remission of symptoms 
outweighed the disadvantages of the possible production 
of myxoedema.
This method of dose prescription was used for 
the patients of Groups 1, 2 and 4. By July, 1956, 
however, it had became clear that only a small number 
of the patients of Group 1 were being cured with one
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dose and from that time pre-treatment with methyl 
thiouracil was considered to be an indication for 
increasing by a factor of 2^ fo the dose of radioactive 
iodine decided upon by the criteria already described.
The doses of radioactive iodine given to the patients 
of Group 3 thus included this factor.
When each patient was being examined with a 
view to dose prescription the size of the gland 
was estimated in grammes, although the inaccuracies 
of this estimate were appreciated. This was done in 
order to obtain, after each patient had been treated, 
the dose which would have been given if the formula 
for dose prescription recommended by Blomfield et al.
(1955) bad been used. This formula is.-
j./ 805 x 48-hour^ uptake of gland
Bose in radsWrnco = — 4  — 6— T"7-----  ----' mass of gland (grammes
These workers1 aimed to give 7,000 rads for diffusely 
enlarged glands, 5>000 - 7>000 rads for small post­
operative recurrences, and 8, 000 rads or more .for 
large and multinodular glands.
Follow-up procedure. All patients were seen at monthly 
intervals at the Thyroid Clinic until they had either 
become euthyroid or required further treatment. The 
assessment of the euthyroid state was initially made 
on clinical grounds but was confirmed by basal metabolic 
rate estimation* The necessity for re-treatment was
One rad = 100 ergs per gramme of tissue.
considered at 3 “ 4 months after the initial dose.
Bose prescription in the case of re-treatment was based 
on the same principles as those for initial treatment. 
Boubtful cases were left for a further two months and 
if by that time the presence of toxicity was still in 
doubt they were re-admitted to hospital for further detailed 
study before a final decision was made. After patients 
became euthyroid they were seen at intervals of 2 - 6 
months as the circumstances warranted©. Cases suspected 
of hypothyroidism on clinical grounds were further 
investigated by estimations of serum cholesterol 
and basal metabolic rate and also by electrocardiography.
If the hypothyroidism was mild replacement therapy was 
not given because of the well-recognised occurence 
of transitory hypothyroidism. If the hypothyroidism 
persisted for 3 - 4 months or became more marked then 
1-thyroxine sodium was prescribed.
The minimum period of follow-up was one year 
and the maximum Tfh years. Cure was considered to have 
taken place if the patient was euthyroid at 12 % 18 months. 
Hyxoedema was considered to have been a consequence of 
radioactive iodine therapy only if treatment with 
thyroxine was necessary.
Biological half-life of the therapeutic dose of ^^1.
The biological half-life of ^lj was measured in
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13 patients of Group 1 and 16 patients of Group 2.
This measurement was obtained as follows•-
An uncollimated scintillation counter with 1 inch
of lead filtration was used in conjunction with an Ecko
autoscsLer. On the second day after the therapeutic 
131dose of  ^I had been administered the counter was 
set up 12 inches above the isthmus of the thyroid gland 
and the radioactivity counted for 100 seconds* The neck 
was then shielded with 2 inches of lead and a background 
count made in order to obtain the net radioactivity 
from the gland in counts per 100 seconds. This 
procedure was repeated at intervals until the gland 
radioactivity had fallen "by one half. After these values 
had been corrected for physical decay they were plotted 
against time using semi-logarithmic paper and the 
biological half-life recorded as the time taken for 
the radioactivity to fall to half of its original value.
Results
Present series. In all, 150 cases have been reviewed and- 
of these 119 were female and 31 male, giving a female*male 
ratio of 4*1* The complete data in these cases is 
shown in Appendices XI, XII, XIII and XIV.
Table XI shows the distribution of the cases by 
gland types. The gland types were classified by palpation 
except in patients with post-operative recurrences. The
TABLE XII
TABUE XII
Clinical Results of Radioactive Iodine Therapy 
Follow-up, One Year).
Series Present Macgregor (1957) Blomfield et al (1955)
Ho. of 
Cases 150
Euthyroid
with one dose 85(57$)
Myxoedema io( r/o)
150
89(5#) 
15 ( # )
140
87(6#)
17(1#)
1 6 1 .
largest group had either diffuse enlargement of the 
gland or an impalpable gland (60$), while there were 
45 cases with nodular glands (30$), and 15 cases who 
had had previous partial thyroidectomy (lC$). Table XI 
also shows that by 12 - 18 months 134 cases (89*5f°) 
were euthyroid, of which 85 (57$ of the total number 
treated) were successfully treated with one dose. Two 
or more doses were necessary to produce a cure in 49 
cases (32*5$)• Of these 49 cases 13 required 3 doses, 
and 10 required 4 doses. The treatment was considered 
to have failed in 6 cases (3»5$)» 4 doses having been 
given to 3 °f these cases, 5 doses to 2, and 6 doses to 
1. Of these 6 failures 2 had diffusely enlarged glands, 
one being very large, 3 had nodular glands which were 
not unusually large, and 1 had a post-operative recurrence.
Ten cases (7$) developed myxoedema following treat­
ment, 5 after one dose and five after 2 doses. All these 
cases returned to the euthyroid state following thyroid 
admini s trat i on•
The mean number of doses used in the series was 
1.86 doses.
Comparison of one dose cure rates in the present series, 
with those of Macgregor (1957) and Blomfield et al. (1955).
This comparison is shown in Table XII. The one dose
FIGURE 4 
1*1Therapeutic doses of J I, prescribed in the present series, 
plotted against doses calculated from the formula of 
Blomfield et al. (1955)* The oblique line has been drawn 
at 45° to the ordinates#
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cure rate of the present series, 57^>w&s not 
significantly different from the 5 Macgregor (1957) 
who used a similar method of dose estimation, or from 
the 62fo cured with one dose hy Blomfield et al. (1955)•
The last group of workers aimed at delivering 6,000 
to 8,000 rads to the gland and prescribed their doses 
by an elaborate method. Figure 4 is a scattergram in 
which the doses used in the present sdries have been 
plotted against the doses which would have been used 
if the method recommended by Blomfield et al* had been 
applied. It can be seen that in the lower dose range 
I have tended to give larger doses while in the higher 
dose range smaller doses have been given. This 
difference is not reflected in the one dose cure rates 
of the two series. The incidence of myxoedema produced 
by overdosage is not significantly different in the three 
series which have been compared in Table XII0
A separate analysis was made of the results obtained 
in the four groups of patients making up the present 
series*
Group 1*
The data for this group consisting of 28 patients 
pre-treated with methyl thiouracil is given in Appendix 
XI. Table XIII summarises the clinical results of 
radioactive iodine treatment. It can be seen that 19 
cases have diffuse or impalpable glands (68fo),
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6 have nodular glands (21/6), and 3 cases had post-operative 
recurrences (ll$6)* Of the 28 patients in the group 
only 8 (28.6^) became euthyroid with one dose although 
cure was achieved by 18 months in 24 (86c/o), Two 
patients developed myxoedema and there were two failures* 
The mean number of doses given to this group was 2*35 
doses*
Group 2*
This group of 45 patients had not been given 
methyl thiouracil before radioactive iodine therapy 
and the latter was given during the same period of 
time as that of Group 1* The data for this group is ) 
shown in Appendix XII* Table XIV summarises the results 
and shows that 11 of the cases (25fo) had nodular glands 
and 6 (13/0 had post-operative recurrences* The 
incidence of nodular and post-operative glands is 
therefore similar to that of group 1* The one dose 
cure rate, however, was 75*5/^  and the increase over 
the comparable figure for Group 1 (28.6/6) was 
statistically significant* Two cases of this 
group developed myxoedema and there were three 
failures* The mean number of doses given was 1*5 doseso 
Group 3*
This group of 21 patients, like those of Group 1, 
had received methyl thiouracil preceding radioactive 
iodine therapy* Because the unsatisfactory response
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to treatment in many of the patients of Group 1 
was already known the patients of Group 3 had 
their prescribed d.ose of radioactive iodine increased 
by -255k The data for this group is shown in Appendix 
XIII and the results are summarised in Table XV.
The incidence of nodular glands was 33°/° and 10 cases 
(47*5f°) became euthyroid with one dose. Two cases 
became myxoedematous and there were no failureso 
The mean number of doses given was 1.9 doseso 
Group 4.
This group comprised 56 untreated patients given 
radioactive iodine therapy during the same period 
as Group 3* The data; is) shown in Appendix X U  and
Art*.
the results summarised in Table XVI. The incidence 
of nodular glands was 37 * 5 and 6 patients (10.5^) 
had post-operative recurrences. Thirty-three patients 
(59f°) became euthyroid with one dose and this one 
dose cure rate while higher was not significantly 
different from that of Group 3 (47 <>5/0 • Four patients 
of this group became myxoedematous and there was 1 
failure. The mean number of doses given was 1.6 doses. 
Biological half-life of the therapeutic doses of ^^1. 
The biological half-lives of 131t in the 29 patients 
studied are shown in Table XVII. The mean biological 
half-life in the l3 patients who had been pre-treated 
with methyl thiouracil was 11.0 days and this was
168.
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TABLE XVII
........ .......... -.................   151
Biological Half-lives of Therapeutic Boses o f l
Cases pre-treated with Cases with no pre-treatment
Methyl Thiouracil ..    —  -----
 (aays)___________________________ (for8)__________
9*4 17.8
13.2 17.0
13.0 20.0
8.0 4.7
5.0 7.0
8.5 14.4
14.0 7.4
9.0 4.0
11.3 12.4
20.0 4.0
6.0 7.0
23 oO 
15.2 
12.4
Mean * 11.0 Mean - 12.0
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not significantly different from the comparable 
value of 12.0 days in the case of the 16 patients 
who fofld received no pre-treatment with an antithyroid 
drug.
Discussion
The major difficulty in the use of radioactive 
iodine in the treatment of thyrotoxicosis is the 
determination of the dose. Most workers attempt 
to produce cure with one treatment. The prescription 
of the dose necessary to do this has been determined 
by many workers using principles which have been based 
on the assumptions that the gland volume and the 
biological properties of radioactive iodine can be 
accurately measured.
The inaccuracies which occur in estimations of 
gland size by palpation are generally admitted, even 
by those who incorporate this measurement in 
their dosage calculations, and estimations of gland 
size by this method have been shown to be inaccurate 
by as much as 4 (Soley et al. 1949)* Attempts 
have been made to increase the accuracy of this 
estimate by comparing the clinical estimate with the 
true weight in glands removed at operation or autopsy. 
Another method advocated is the use of gland models 
at the time of palpation. These measures, while
increasing accuracy, still allow potentially large errors 
(Loevinger, 195$). The use of a collimated counter after 
the administration of a tracer dose of radioactive 
iodine can he used to measure gland volume (Allen et al. 
195?> Bauer et al. 1952; Blomfield et al. 1955; 
and Bauer and Blahd, 1957)* This technique does not 
wholly eliminate subjective bias and Kelly (1954) found 
large errors associated with techniques of this type. 
Franco and Quina (1956) have attempted to visualise 
the thyroid gland radiologically following oxygen 
insufflation of the neck and claim that the error
of gland size estimate does not exceed 10^ >. This
/
method, however, is time-consuming- and potentially 
hazardous•
The three biological properties of radioactive 
iodine which influence dose estimation are the uptake 
of the radioisotope by the gland, its distribution in 
the gland, and the time it remains in the gland. The 
uptake of the therapeutic dose of radioactive iodine by 
the gland can be predicted with fair accuracy from the 
behaviour of a tracer dose (Keating et al. 1949; 
Freedberg, 1952). On the other hand the distribution 
of radioactive iodine in the gland is unpredictable 
(Fitzgerald and Foote, 1949; Kelsey et al, 1949), 
particularly in nodular glands (Le Blond et al. 1946)0 
The third biological property of radioactive iodine
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which influences dose estimation, the length of stay of 
a therapeutic dose in the gland, is also difficult to 
predict from the behaviour of a tracer dose as shown by 
Skanse, 1948; Miller and Sheline, 1951; Freedberg et al. 
1952; and Blomfield et al. 1953)*
The remaining factor which influences dose 
estimation is the sensitivity of the thyroid tissue to 
irradiation. As yet little is known of the variability 
of this factor owing to the difficulty of estimating the 
radiation dose which the gland actually receives.
There is, however, evidence to suggest that considerable 
variation in gland radiosensitivity does occur (lyant 
and Pochin, 1955)•
Owing to these uncertainties the amount of 
radioactive iodine necessary to give a critical radiation 
dosage cannot be determined with any degree of accuracy®
It was for this reason that Macgregor (1957) adopted 
'•by previous accepted standards a completely heretical 
technique". By his simple clinical scheme of dose 
prescription he achieved results comparable with those 
obtained by Blomfield et al. 1955 whose method involved 
precise and quantitative calculations® The results 
obtained in the present series confirm Macgregor's 
conclusions that complicated schemes of dose prescription 
have no therapeutic advantages. Indeed the results
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obtained in the three series compared in Table XII 
are almost identical. Furthermore Bauer and Blahd (1957) 
using a similar method of dose prescription to that of 
Blomfield et al. obtained a one dose cure rate of 5^*6^ 
which is not significantly different from that of the 
present series.
3h the early stages of the therapeutic applications 
of radioactive iodine it was obligatory to attempt to 
use precise methods of dose prescription until the effects 
of treatment were fully evaluated. The results of 
the present series and those of Macgregor (1957) 
suggest that this is no longer necessary and that 
radioactive iodine therapy can be administered by 
simple clinical techniques. Furthermore the suggestion 
by Macgregor that other physicians could achieve the 
same results as he did even if they had not previously 
had the advantage of experience with more meticulous 
methods, has been fully confirmed.
The adoption of a clinical method of dose 
prescription increases the responsibility of 
physicians prescribing such treatment to evaluate 
the various factors which influence their decision.
For example, it can be seen from Figure 4 that doses 
prescribed in the present investigation tended to be 
larger in. the lower dosage range than those which would 
have been prescribed if the method recommended by
Blomfield et al* (1955) bad been used* On the other 
hand in the higher dosage range smaller doses were 
given using the clinical method. These findings 
emphasise one difference in the two types of dose 
prescription since a physician using the clinical 
method tends to be emotionally influenced by the dangers 
of myxoedema when large doses have to be given. Because 
very large doses are seldom necessary and because the 
percentage difference is less than with lower doses, 
the overall results are not appreciably affectedo
Another factor which might influence dose prescrip­
tion is previous treatment with an antithyroid drug.
The results obtained in cases pre-treated with 
methyl thiouracil (Group l) showed a significantly 
lower one dose cure rate than cases who had received 
no pre-treatment (Group 2). It can be seen from Tables 
XIII and XIV that this finding cannot be accounted for 
by variations in gland types between the two groups. 
Furthermore there was no significant difference 
between the average gland sizes of the two groups.
It was considered possible that the biological half- 
life of the therapy dose might be shortened in the 
methyl thiouracil treated gland and in this way produce 
a decrease in the amount of irradiation. Ho significant 
difference was found, however, between the biological 
half-lives of therapeutic doses of ^Ij ^  patients
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who had received the drug compared with those of
patients who had been given no pre-treatment (Table XVIl).
This finding is similar to that of Hamilton and Werner
(1952). In addition consistency of dose prescription
was ensured in the patients of Groups 1 and 2 by the
fact that they were treated by the same physician
(the author) during the same interval of time. It is
possible that methyl thiouracil treatment might
produce a more patchy distribution of the therapeutic 
131
dose of I but there is no evidence available on
this point, and indeed Fraser (1954) bas used the
131drug to produce a more even distribution of x I 
within the gland. The other possibility which could 
account for the findings is that the methyl thiouracil 
treated gland is radio-resistant. This conclusion 
is supported by Werner (1955) who cites jRynearson*
Williams et al. (1949) on the other hand studied a 
group of patients who had received radioactive iodine 
therapy following a course of propyl thiouracil and 
had the impression that these patients required smaller 
doses than untreated cases. His findings, however, 
were not subjected to statistical analysis.
The biological effects of irradiation are still 
improperly understood as are the factors which modify 
them. There is, however, evidence that thiourea
compounds can protect biological systems against the
effects of irradiation. For instance Dale (1947) and hale
et al. (1949) demonstrated this protective effect of
thiourea on certain enzymes and limperos and Mosher
(1950) showed the same phenomenon with nucleo-proteins
in vitro and in vivo. The radio-protective action of
thiourea compounds has also been shown in the case of
bacteria (Forssberg, 1950), animal cells (Patt, 1952),
and intact animals (Mole et al. 1950). Direct
evidence of the modification of the irradiation effect 
131
of I on thyroid cells, was obtained by Hugh, 1953 
in work on the Japanese Fire Salamander. He found that 
thiouracil gave protection to thyroid cells for periods 
up to 7 months after the administration of the drug.
One possible explanation of the protection given by 
thiourea compounds against irradiation may lie in their 
capacity as reducing agents since there is some evidence 
to suggest that diminished availability of intracellular 
oxygen is protective (Hollaerder and Stapleton, 1953)*
It is of interest that other compounds containing sulphur 
or sulphydryl groups have a radio-protective action 
(Patt et al. 1952; Gray, 1954; Bacq, 1954; Hugh and 
Wang, 1953)*
It was because of the poor therapeutic results 
obtained in the patients of Group 1 that I decided to
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151give larger doses of ' I to patients who had
previously received methyl thiouracil. This attempt
to increase the one dose cure rate in such patients may
he responsible for the fact that the results in Group 3
are not significantly different from those obtained in
the patients of Group 4 who had received no pre-treatmente
Possibly due to the small number of patients, however,
no statistically significant difference could be shown
between the one dose cure rates of Groups 1 and 3
although the respective percentages were 28 «6 and 47»5*
It is possible therefore that patients pre-treated
with methyl thiouracil require more than a 25°/c increase 
1*1of the dose of  ^I to completely overcome the effects
of the antithyroid drug therapy. The necessity for
151increasing the dose of I because of the effects
of antitbyroid drug therapy has been tentatively suggested
by Hamilton and Werner (1952)o They gave two groups
of patients a two-weeks course of propyl thiouracil and
l-methyl-2-mercaptoididazole respectively, starting
151the drugs one week after J I therapy. When they
compared the results with those obtained in a group who
had had no antithyroid drugs they noted a tendency to
151increased resistance to the radiation effect of I in 
the cases given antithyroid drugs with a diminution 
in the one dose cure rate. Their results
however, were only of horder-line statistical significance.
The present investigation has clearly demonstrated 
that radioactive iodine therapy can be carried out 
successfully on a clinical basis and provided simple 
rules are observed this can be achieved with the 
maximum economy of both the patient’s and physician’s 
time* It is clear too that more extensive use of 
radioactive iodine in the treatment of thyrotoxicosis 
should not be limited because of the lack of 
experience of physicians in prescribing effective 
doses. The more general use of radioactive iodine 
therapy would further increase the responsibility of 
those centres with special facilities to evaluate fully 
the factors which influence dose prescription.
SECTION 5 
Summary
1. One hundred and fifty cases of thyrotoxicosis have 
been treated with radioactive iodine using a simple 
clinical method of dose prescription. Twelve to 18 months 
after treatment had been started 134 (89«5$) of the 
cases were euthyroid, 10 cases (7$) had developed 
myxoedema, and 6 cases (3*5‘$) remained toxic.
2. Eighty-five cases (57$) were cured with one dose and 
this result was not significantly different from that 
obtained by Macgregor (1957)» who used a similar method 
of dose prescription, or from that of Blomfield et al. 
(1955) who used a more complicated technique.
3* In 28 cases who had been receiving methyl thiouracil 
before radioactive iodine therapy the one dose cure 
rate of 28, 6 f o  was significantly less than the value 
of 75*5$ obtained in 45 patients who had received no 
pre-treatment.
4. Twenty-one cases who had been receiving methyl 
thiouracil had their doses of radioactive iodine increased 
by 25$ and the one dose cure rate obtained (47*5$) 
was not significantly different from that of 56 patients 
who had received no pre-treatment (59$)*
5* Evidence is produced to show that the effect of 
methyl thiouracil on radioactive iodine therapy in 
the present study is not due to differences in gland 
type or size, or changes in the biological half-life
of the therapeutic dose* It is suggested that 
pre-treatment with the drug protects thyroid cells 
against the effects of irradiation and that this factor 
should he allowed for in the dose prescription of 
radioactive iodine*
6* Because radioactive iodine therapy can be carried 
out on a clinical basis its more extensive use 
should become possible#
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PART III
METABOLIC STUDIES IN THTROTOXICOSIS
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Increased thyroid activity influences the energy 
requirements of the hody and has consequent secondary 
effects upon the metabolically active cell mass and the total 
body fat* The change in body composition produced by 
thyrotoxicosis is in the main due to a loss of both lean 
tissue and fat and a disturbance in the percentage 
contributions which each of these components makes to the 
total body weight. It is clear therefore that any metabolic 
studies in thyrotoxicosis using body weight as a reference 
standard will be difficult to interpret.
In recent years it has become possible to measure the 
metabolically active tissue mass or lean body mass by a 
number of techniques including the estimation of total 
body water. The derivation of lean body mass from total 
body water has as its basis the finding by Pace and Rathbun 
that there is a constant relationship between the two in 
guinea pigs and rats (Pace and Rathbun, 19455 Rathbun and 
Pace, 1945). These workers showed that in animals 
approximately three fourths of the total body water is 
associated with the metabolically active cell mass and 
there is no reason to doubt that the same relationship 
exists in man (Morales et al. 1945)* 'Ehis view is 
supported by the few published reports of direct analysis 
ofcadavers (Widdowson et al. 1951> Forbes and Lewis, 1956).
Total body water can be measured in living human subjects
by using deuterium, tritium, or antipyrine dilution and 
from this measurement it is possible to derive fat-free 
weight or lean body mass.
By the elimination of the metabolically inert depot 
fat lean body mass should theoretically be a better reference 
standard than body weight for fundamental physiological 
values. This has been shown to be true by Mller and Blyth 
(1952-1955) in the case of oxygen consumption and by 
Muldowney (1957) for total red cell mass. These workers 
emphasised the fallacies which can be introduced by variation 
in the amount of depot fat in their subjects and recommended 
that this factor be taken into consideration in any metabolic 
studies. For this reason lean body mass has been chosen as
the reference standard for the metabolic studies in
thyrotoxicosis to be described in this part of the thesis.
It was decided to investigate the effects of the disease 
on the total red cell mass, and on the total exchangeable 
sodium, potassium, and chloride. In the case of total red 
cell mass a range of normal values based on lean body mass 
has been provided by Muldowney (1957)» but normal ranges were
not available for the exchangeable electrolytes. The
investigation of the electrolytes in thyrotoxicosis had 
therefore to be preceded by a study of the relationship of 
total exchangeable sodium, potassium, and chloride with 
lean body mass in normal subjects. A range of normal values
for the exchangeable electrolytes based on lean body mass 
was thus provided. The section dealing with the exchangeable 
electrolytes in thyrotoxicosis contains an account of this 
necessary preliminary study.
SECTION 1
The Total Red Cell Hass In Thyrotoxicosiso
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It has previously been shown by Muldowney (1957) that 
the relationship between total red cell mass and lean body 
mass is so close that if the latter is known then the former 
may be predicted with 9 5 confidence limits of - 75 
He also showed that the relationship held for both sexes 
over a wide range of age and body weight and suggested 
that the correlation was based on the regulation of oxygen- 
carrying power or red cell mass by the oxygen requirements 
of the metabolically active lean body mass. He deduced 
that depot fat makes insignificant demands upon oxygen-carrying 
power and this view is supported by the fact that depot fat 
has a very low rate of oxygen utilisation (Krebs and Johnson,
1948). If the suggestion is valid that the relationship 
of lean body mass to red cell mass depends on basal oxygen 
consumption then in thyrotoxicosis where basal oxygen 
consumption is increased the total red cell mass might 
be expected to show a parallel increase. This relationship 
has been studied in the present investigation. Because cases 
of myxoedema have a diminished basal oxygen consumption and 
so might be expected to have a lower red cell mass than 
normal the opportunity was also taken to study the relationship 
in this condition. The observations to be described below 
confirm that the total red cell mass in thyrotoxicosis is 
increased relative to lean body mass and evidence will be 
presented that this increase is related to the changes in 
basal oxygen consumption of the tissues.
Methods. Seven thyrotoxic and 8 myxoedematous subjects 
were studied. In addition three thyrotoxic and three 
myxoedematous subjects were studied after treatment. The 
assessment of thyroid function in each case was made clinically 
and confirmed by special investigations, including estimations 
of basal metabolic rate and serum cholesterol, together with 
radioactive iodine criteria and response to therapy*
Antipyrine estimations were carried out by the method 
of Brodie et al. (1949)* Antipyrine (2 g.) was administered 
slowly by intravenous injection from a calibrated syringe 
and blood samples were taken at 3> 4i 6 hours.
Plasma water concentration of antipyrine was derived by 
multiplying the plasma concentration by 100/93 "to correct 
for plasma proteins, which were assumed to average 7$ of 
plasma volume. All estimations were carried out at room 
temperature, the extremes being 18 and 22°C. Lean body 
mss was derived from the total body water (antipyrine space) 
by means of the equation of Pace and Rathbun (1945)*-
100
Lean body mass * Total body water X —==■
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Blood volume measurements were performed by means of 
the Evans blue (cellulose extraction) method (Bedwell et al« 
1955)* Extraction of Evans blue with this method has been 
constantly 96 - 100$ with the majority of results falling 
in the range of 97 - 98$* Accordingly each estimation has
been corrected for an extraction rate of Ten ml«
of 0.1$ Evans blue were given intravenously to each subject 
from a calibrated syringe and samples were taken 15 and 30 
minutes later.
Turbidity due to protein in the eluate of Evans blue was 
avoided by washing with teepol-saline until the filtrate was 
clear of turbidity on testing with ICffo sa^icyl-sulphonic acid. 
(Muldowney, 1957).
Haematocrit figures were obtained with Wintrobe tubes 
spun at 3*000 r.p.m. for 55 minutes. A correction for 
-trapped plasma was made according to the figures of Chaplin 
and Mollison (1952). The true venous haematocrit was then 
corrected by the factor 0.91 to calculate total body haematocrit 
(Chaplin et al* 1955). All subjects studied had mean cell 
haemoglobin concentrations within the normal range. Red cell 
mass was calculated from the Evans blue plasma volume as follows*
_ , . „  „ Plasma volume X Total body haematocrit
Red Cell Mass ^ “ 0— T^teTbo^ haemlto'o'ri^-----
Thiocyanate space estimations were carried out by the 
method of Bowler (1944). Sodium thiocyanate 1*2 g* was 
injected intravenously from a calibrated syringe at the same 
time as the antipyrine injection, and the 2J- hour plasma 
sample was used for both thiocyanate and antipyrine estimations, 
Wedgewood et al. (1953-1954) have shown that the urinary 
excretion of thiocyanate during the first two hours after 
injection is less than Vfo and accordingly no correction has
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been made for this factor. The plasma concentration of 
thiocyanate was multiplied by the factor 100/93 to correct 
for plasma proteins, before calculating thiocyanate space*
Fat-free body weight (including minerals) was derived from 
the equation as suggested by Keys and Brozek (1953) as follows*- 
Fat-free weights A + (0*563)(A - E)
Where A » antipyrine space and E = 0.7 (thiocyanate space).
This value for fat-free body weight was compared with the 
value for lean body mass derived from the Pace-Rathbun equation.
In one additional case of myxoedema, red cell mass studies 
were carried out before and during the administration of 2,4- 
dinitrophenol (D.R.P*) which increases oxygen consumption 
without influencing thyroid function. The dose of D.N.P* 
was adjusted to maintain serum levels between 45 50 mg* per
litre and these levels were maintained for ten days* the 
average daily dose being 200 mg. Somnolent metabolic rate 
estimations on this subject were carried out as described 
by Fraser and Nordin (1955) since difficulty was experienced 
in obtaining satisfactory basal metabolic rate determinations*
Results
The complete data are given in Table I, in which values 
for lean body mass were derived from the Pace-Rathbun 
equation. Comparison of the values for lean body mass 
derived from the Pace-Rathbun and Keys-Brozek formula in 
fourteen of the fifteen subjects showed that the latter provided 
a systematically higher estimate, the mean difference, however,
FIGURE 1
Red cell mass and lean body mass in thyrotoxicosis. 
The parsdlel lines represent the 95i° confidence 
limits in 36 normal subjects.
FIGURE 2
Red cell mass and lean body mass in myxoedema. The 
parallel lines represent the 95f^  confidence limits 
in 36 normal subjects*
FIGURE 3
Red cell mass and basal oxygen consumption.
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being only 1,3$.
The parallel lines in Figures 1 and 2 represent the 95$ 
confidence limits relating lean body mass to red cell mass 
established by Muldowney (1957) in a series of normal 
subjects. The red cell mass of all subjects studied in 
the present series fell outside these limits, the thyrotoxic 
cases falling above (Figure l) and the myxoedematous cases 
below the normal range (Figure 2), Thus, in terms of Kg« 
lean body mass, the thyrotoxic subjects had a larger red 
cell mass and the myxoedematous subjects a smaller red cell 
mass than normal.
It can also be seen from Figures 1 and 2 and from Table I 
that 3 thyrotoxic and 3 myxoedematous cases studied after 
treatment showed a reversion towards the normal range of 
red cell mass.
Figure 3 shows that the correlation between red cell 
mass and basal oxygen consumption in the thyrotoxic and 
myxoedematous cases is highly significant (r ** 0,88),
In the case of the myxoedematous subject to whom dinitrophenol 
was given the total red cell mass before therapy was 998 ml, 
compared with a normal mean of 1725 ml, (based on a lean body 
mass estimate of 47 ®8 Kg*)® Fifteen days after commencement 
of D.N,P,, when the somnolent metabolic rate had risen from 
the pre-treatment level of - 38$ to + 5$> the red cell mass 
had risen slightly to 1048 ml. After a further 6 days,
the red cell mass had risen to 1183 > representing an
increase from - 42.2$ to ■» 31*2$ of the normal mean.
Discussion
The results show that in thyrotoxicosis there is an 
increase in the red cell mass relative to lean body mass. 
Furthermore the red cell mass - lean body mass relationship 
returned towards normal in the 3 thyrotoxic subjects studied 
after treatment. The mean cell haemoglobin concentrations 
did not vary following treatment and therefore the red cell 
mass changes reflect the changes in total circulating haemo­
globin. The time taken to reach the euthyroid state varied 
from 6 to 12 weeks, but the picture after treatment was 
complicated by considerable increases in lean body mass.
This was most marked in the case of subject No. 10 where 
lean body mass increased by 14 Kg. In this subject,
although an absolute rise of 375 re^ cell mass
occurred, the red cell mass per Kg. of lean body mass fell 
from + 15.4$ to + 5*8$ of the normal mean.
Gibson and Harris (1939) have shown that the blood 
volume tends to be increased in thyrotoxicosis but since 
they used total body weight as a standard of reference 
their results were not statistically significant. They were, 
however, able to show a decrease in the blood volume after 
treatment. The increase in total red cell mass found in 
thyrotoxicosis in the present series implies increased bone 
marrow activity and Axelrod and Berman (1951) have described
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erythroid hyperplasia at the expense of fat in patients with 
the disease. Functioning cellular marrow may extend even 
into the long bones in the adult. The results also suggest 
that the moderate increase of faecal urobilin found in 
thyrotoxicosis (Werner, 1955) is probably due to an elevated 
total circulating haemoglobin undergoing breakdown at a 
normal rate rather than to an excessive rate of red cell 
destruction*
The relationship between lean body mass and red cell 
mass in the myxoedematous patients is in accord with that 
found in thyrotoxicosis. Thus, when thyroid activity was 
low the total red cell mass related to lean body mass was 
less than normal and returned towards normal with treatment. 
Gibson and Harris (1959) who studied blood volume in myxoedema 
showed a tendency to low values in this disease, but as in 
the case of thyrotoxicosis their results were not statistically 
significant presumably because of their use of body weight 
as a reference standard. They demonstrated, however, an increase 
in blood volume with treatment.
The validity of applying the Pace-Rathbun formula to 
derive lean body mass in thyrotoxicosis and myxoedema may 
be questioned on the grounds that in these conditions there 
may be a disturbance of the lean body mass - total body water 
relationship. Accordingly, the formula of Keys and Brozek (1955) 
for fat free weight incorporating a correction for changes
in extra-cellular fluid was also applied and these values 
compared with these obtained from the Pace-Rathbun equation. 
The estimate of lean body mass provided by the Keys and 
Brozek formula was systematically higher, the mean difference 
being 1.3$* This pattern corresponds exactly with that 
obtained in a group of normal subjects by Muldowney (1957)*
It is concluded, therefore, that the Pace-Rathbun formula 
for lean body mass in thyrotoxicosis and myxoedema 
requires no correction involving measurement of extra­
cellular fluid.
The close relationship previously shown between red 
cell mass and lean body mass in normal subjects was 
regarded by Muldowney (1957) as a possible result of the 
correlation of each of these entities with basal oxygen 
consumption. He suggested that oxygen-carrying power, 
or red cell mass, may be regulated directly by basal 
oxygen demands. The results show that increase or decrease 
in basal oxygen consumption is accompanied by parallel 
changes in red cell mass. It is apparent, therefore, 
that the correlation between lean body mass and red cell 
mass in normal subjects no longer holds when basal oxygen 
requirements are abnormal. On the other hand, the relationship 
between red cell mass and basal oxygen consumption remains 
and this lends strong support to the view that this is the 
primary relationship on which the red cell mass - lean body 
mass correlation in normal subjects depends.
It may be argued, however, that the regulation of 
red cell mass is not achieved directly by changes in basal 
oxygen consumption, but by a coincident action of the 
thyroid hormone on the bone marrow. This has been discussed 
by Romford (1938) who suggested that the former explanation 
was the case but produced no evidence in support of this.
It was, therefore, desirable to study the effect on red 
cell mass of an increase in basal oxygen consumption in 
the absence of any increase in circulating thyroid 
hormone. This was done by the administration of dinitrophenol 
to a myxoedematous subject, since this drug has been shown 
to stimulate oxygen consumption without affecting thyroid 
function (Castor and Beierwaltes, 1956). The absence of 
an effect on thyroid function was confirmed by the fact 
that the abnormally (low uptake of ^^I by the gland before 
and during treatment was unchanged. In this case the 
red cell mass significantly increased in association with 
a rise in basal oxygen consumption and in the absence of 
increased production of thyroid hormone. This is further 
evidence that the bone marrow responds primarily to changes 
in basal oxygen demands.
The changes in red cell mass in thyrotoxicosis and 
myxoedema must be re-examined in the light of this concept. 
Thus, thyrotoxicosis is accompanied by a polycythaemia 
which may be regarded as a hypertrophy - of oxygen-carrying 
tissue in response to increased metabolic demands© This
polycythaemia disappears with the decrease in basal oxygen 
consumption produced by antithyroid therapy. Conversely, 
the diminished oxygen requirements in myxoedema result 
in a shrinkage of red cell mass, thus producing an anaemia 
which may be regarded as physiological. This anaemia 
responds to thyroxine therapy and the response may be 
accounted for by the associated rise in basal oxygen 
consumption©
SECTION
Summary*
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1* The relationship between total red cell mass and lean 
bodj mass has been studied in 7 thyrotoxic and 8 myxoedematous 
subjects.
2. There is a significant increase in total red cell mass 
in thyrotoxicosis and a significant decrease in myxoedema, 
and in both conditions treatment produced a return of 
the red cell mass - lean body mass relationship towards 
normal.
3* Red cell mass is closely related to basal oxygen 
consumption in both conditions.
4* Evidence is put forward that red cell mass is regulated 
by changes in basal oxygen consumption and not by a direct 
action of thyroid hormone on the bone marrow.
5. Thyrotoxicosis is thus accompanied by a polycythaemia 
which represents a physiological hypertrophy of red cell 
mass in response to increased oxygen demands, and myxoedema 
by an anaemia which represents a physiological re-adjustment 
in oxygen-carrying power.
SECTION 2
Total Exchangeable Sodium, Potassium and Chloride 
in Thyrotoxicosis.
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Physiologists have long appreciated that comparisons 
of the electrolyte content of various tissues are invalidated 
by variations in the proportion of lipid since the latter 
is poor in electrolytes (Hastings and Eichelberger, 1937)*
For this reason they expressed their measurements of 
electrolytes on the basis of fat-free weight rather than 
tissue weight. Thyrotoxicosis results in a variable 
loss of lean tissue and fat (Moore et al. 1952) and a 
study of the changes in the exchangeable electrolytes 
produced by the disease should take this factor into 
account. This cannot be satisfactorily achieved if body 
weight is used as the standard of reference. Notwithstanding 
the findings of physiologists clinical workers have 
continued to use body weight as a standard of reference 
for exchangeable electrolytes in both normal subjects 
(ikkos et al. 1955; Corsa et al. 1950) and in thyrotoxicosis 
(Munro et al. 1958)* Even the normal variation in the 
proportions of lean tissue and fat found in health may 
produce certain fallacies of interpretation. For example,
Aikawa (1952) found that the exchangeable potassium (Kg) 
in females had a lower value per Kg. body weight than 
in males (Corsa et al* 1950)o This finding, as will be 
demonstrated in the investigations to be described, is 
due to the greater fat content of females and the 
difference disappears when lean body mass in used as the 
reference standard.
Because of the varying fat component of normal 
subjects it was felt that the established mean values 
for exchangeable sodium (Na0) (Miller and Wilson, 1953)* 
exchangeable chloride (Cle) (ikkos et al. 1955)» and Ke 
(Aikawa, 19525 Corsa et al. 1950) would not be helpful 
in a study of the changes in these electrolytes produced 
by thyrotoxicosis. For this reason it was decided to 
substitute fat-free weight or lean body mass for body 
weight as the reference standard for the exchangeable 
electrolytes in a group of normal subjects as a preliminary 
to investigating the relationships between the three 
electrolytes and lean, body mass in thyrotoxic subjects.
In thyrotoxicosis there is an associated disturbance of 
bone metabolism (Aub et al. 1929)* Since there is a 
special relationship between Na0 and Cle in bone the 
opportunity was also taken to study this relationship both 
in normal and in thyrotoxic subjectse 
Subjects studiedo
Na. measurements were made in 21 normal males and ©
17 normal females. Ke was also measured in 21 males 
and 17 females, and Cle in 22 males and 19 females. In 
24 of the normal subjects studied all three electrolytes 
were measured —  Nae and Ke being measured simultaneously. 
The subjects covered a wide range of age and body weight 
as shown in Tables II and III.
All three electrolytes were measured in 20 subjects 
(19 females, 1 male) with unequivocal evidence of 
thyrotoxicosis —  Nae and Ke being measured simultaneously. 
The diagnosis in each case was confirmed by measurement 
of the 4-hour uptake of the 48-hour plasma protein-
bound radioactivity. In all cases the basal metabolic rate 
was above the upper limit of the normal range (Robertson 
and Reid, 1952).
Methods.
Nae was measured by the method of Miller and Wilson
(1953)* giving 30/hc. of Na^4 orally andaLlowing an
equilibration period of 24 hours. K0 measurements were
performed by the method of Corsa and his colleagues (1950)
4 spot urine specimens being collected between 22 and 26
hours after injection of 150/uc. of (K Cl irradiated
/
as Kg C0^) using a calibrated syringe. Simultaneous
measurements of Na^ and K_ were made by the method of
Munro et al. (1958). In this procedure 100yuc. of ^ K  
"24
and 50y»uc« of Na were given intravenously from a 
calibrated syringe, and an equilibration period of 22 
hours was allowed, after which a plasma sample was obtained 
followed by two spot urine specimens 1 and 2 hours later. 
Each spot urine was divided into two portions and potassium 
separated from sodium by precipitation of the former 
with sodium tetraphenylboron. Potassium and sodium 
concentrations in plasma and processed urine were estimated
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by flame photometry. The measurements of Cle were carried 
out by the method of Bradley et al. (1956). Twentyyuc® 
of ®^Br (Na Br irradiated as NH^ Br) were administered 
orally and an equilibration period of 22 - 26 hours was 
allowed. ®^Br was not given until at least 3 days after 
the administration of ^ % a  and ^K. This procedure
Op
ensured that Br plasma counts required no correction 
for residual ^%a. Plasma chloride concentration was 
estimated by the method of Van Slyke (1923)*
To derive total exchangeable electrolyte the following 
equation was used.-
Total exchangeable electrolyte (mEq.) ** Electrolyte space (litres)
X plasma electrolyte
(mEq./litre)•
In the case of sodium, the electrolyte space and plasma 
concentration did not require correction by the Donnan Factor 
since this is cancelled by the correction for plasma 
proteins. In deriving the chloride space, however, it 
is necessary to correct for the Donnan equilibrium and for 
plasma proteins since they are additive for anions and 
a factor of 0.91 was therefore used. In the normal subjects 
where had been measured by the method of Corsa et al.
(1950) it was necessary to find a correction factor in 
order to make them comparable with the values given by 
the simultaneous Nag and technique. This correction 
was obtained by the following in vitro experiment.
A suitable quantity of 42K was g^ed to 1 litre of 
urine which was divided into 2 portions* Six aliquots 
of 1 portion were counted in an M.6 Geiger counter and 
the stable potassium concentration measured by flame 
photometry, this being the method of Corsa et al. (1950).
Six aliquots of the remaining portion were processed as 
in the method of Munro et al. (1958)* Consistent specific 
activities were obtained by each method, but the mean value 
given by the method of Corsa et al. was 6$ higher than
that given by the simultaneous method of obtaining Ha. and K .
6 6
The data for Ke obtained by the former method was therefore 
corrected by this factor.
The radiation dose for a person of "JO Kg. weight 
did not exceed 0.07 rad due to 50yuc<> of Ua^, 0.07 rad 
due to lQG^iCo of K^, and 0.05 rad due to 20yuc<> of ^Br, 
i.e. the radiation dose due to the combined technique lies 
considerably below the weekly tolerance dose of 0*3 rad.
Lean body mass was estimated from the Pace-Rathbun 
formula (Pace and Rathbun, 1945) ♦-*
Lean body mass *■ Total body water x
Total body water was measured by the antipyrine dilution 
technique of Soberman et al. (1949) the plasma concentration 
of antipyrine being corrected for plasma proteins. Antipyrine 
estimations were carried out by the method of Brodie et al. 
(L94$}. In a few normal subjects values of lean body mass
206.
i  l I l  l J I I I  1 I 1 I 1 I * ' * . ♦ * • ’ *
i— ! ;— i r— i .'i r-- I i \ —, !
. \ J ■ / ".-i ; !.'j r~: 1 i / ■*. i.'.'• ' ■'
l • h i . -? •/ I I I 1 I I I : < i : : - w  ^
i.", I • i . I j  h  ' J- ! :• i ’ > ;
iO
< I f ;-i I i J : -i J J [ - J :o . .) ; • >
O
• -• v Oru h-1
1 i i i i I I I !h , h i .
h ,  hi; -■ i
TABLE II
i.'.> i'j fii h ;  t~A ■ ‘a  a'-; i : . • :jO i V / h ;  ' j
r V-, *-'-1 . / .1
-r hi --J rv --j \o
..— 3 ,Vv - o  ;
C i / ' - ' i co h/ 05 io Oh/io i-'-i :.j -..tt - ~ '••
t'u C. c ■ /.:■ 1 i ,'if;c:v/h to ... :: /h, h  ■ i . o h '
co-- - ”■ —  j ■.v,-:. - . -Ci.'--:2 v - ' i  --J --j - .
£*-»■ i- !'™i h ~  i ”i  ! ! ' i  ! T h i  • —l ■— i . “ i ■' 'i  . ~  l ~ i  • ~ i •"  '■ ■ "> ' ■ ■' • • ' 'I ■ ‘  • i . . '— i .
0) <Do O
cd cdft ft
CO CO
cd rH
ft O
<DCr< 
rH P£J 
O S
CD O'*
<D o
cd ct1 
6
>5 ! •
3 $w
£
cd
CD
-P
is
•&
a
-P CO
W 0 o
o
ft
0)
to
cd
o
CM VO VO t—  KN C'— VO rH O  'sf ON O  rH
O N  MO Q N  UN ®  VQ CD O  ’vj" t*- CM E—  CM O  
H H O O O h O w W  ff\fCNWrHo o <* • ©
rH rH rH rH i—I i—! i—I i—1 i—I i—I i—I I I I I I ( t 1 I I t | 1 I 1
Q O O O O O O O O O O O O O
N- GO O  f - O  l A i n O  CD O N H  CO ON VO 
ON C—  CO CM O  00 O N H  CO UN C—  CM C—  rH 
H H r l W W H H C M H C M H C ' l H C ' J
O O O O O O O O Q O O O O O  rH M-M)wOHo\(mOC0OC0C0M- 
IN- rH CC UN ON CM VO O  VO CM rH UN CM t—  
KN KN Cm KN KN KN CM K\ KN KN K M A  fA KN
I I I 1 I I I
o o o o o o o
rH CM tH KN ON UN GO
C—  O  O  (J\H M" I ON
rH CM KN rH CM CM rH
I I I
o
KN
rH'st- I I I
o o o o 
si- Ml" O  co
rH CM UN O  
KN KN "sj" KN
o o o o o o o o o o o o o o o o o o o o o
C rH '0 CM tH -^ TVO CO ON 00 ^  CO CD IT— CM C— ON ON rH KN C—
O  KN O  ON C C rH C—  00 'si" O  ON KN UN O  ON UN KN I I I I
KN CMCMKNCMCMCMKNCMKNCMKNKNCMKNCMCMKNCMKNCM
I vo
KN
t i l l
£-— C*— O  VO LT\ VO CO O  O  UN t1— O  O  rH O  O  CM UN UN NO E"- 00 CM K- O  CM VO UN UN
H  rH KN rH CO 00 ON NO KN rH O  C— CM rH MO C'— C— O  CM ^  ''si" 00 VO rH CM 00 CM ON t—
LT\ UN UN VO UN ^  VO V£) UN UN VO UN VO VO UN *vf VO UNlN-'^f’vtuNC— UNUNC— UNUN
on vo inKrt^vrKvo i n O  w  unvo cd ©  o  kn o  un kn cm O  O  un cm cm OO » O O O O O * O « O * O » f t O O « » 0 O O O O * O O O »
UN KN UN C—  CM UN f—  KN O  ON KN ON CO rH rH CM rH O  C“- GO UN H  CD CM UN UN C—  IN- rH 
VO'VO UN ON t VO UN CO O  VO VO C—  UN t"- GQ ON VO CO UN H  UNVO VO 00 VO VO CD C— VO
vu u \ uj ua n a i—  uA^rriAwuAUAc.vi CM on un cm un cd un cd c—  cm un cd KN cu lt>
C—  VO VO t" 00 t—  C—  CD VO C—  C—  t IN— 00 ON C— UN CO VO IN— VO VO IN- ON VO C—  CO IN-VO
*■4 <b4 o—i vbJ 4^ «n*J •mi «mj mi rmi mJ rw4 m4 -1 imi ami ami * mJ mJ amJ * f^Hl fmj
VO UN 00 UNKNC UN ’^ -KN'^'^-UNONCM
- ~ vo In- co  c—  co vo t n - c—  r go
rH rH rH rH rH rH i—I rH rH rH rH H i—IrH tH
CO KN ON VO C— CM £—  UN UN rH 'vf' 00 H  00 
rH KN CM KN CM CM CM KN CM CM CM rH CM CM
ONONCMIACOIACDN- CM ON 00 CD UN
  vo t— vo vo ~  ~ ^ -
H  rH rH rH rH rH rH i—I
^-ctrHN— VOUNCMCMCMCMKNLfNKNKN 
CM IN- KN VO "vt" VO CM CM CM CM CM CM KN
rH CM KN M' UNVO N- CD ON O  H  CM KN •'M' UN VO t—  CO O N O  H  CM KN ^ U N V O  N— GO ON 
H r H r H r H r H r H r H r H r H i H C M C M C M C M C M C M C M C M C M C M
207,
■'V ! J ; • /"'it ' y  I '
.--■j . '■ - ■■-■7 -
] I I 1 I I I 1 I t  I I I I * I I 1 * V  * * ? *
i — ■. • i- r • i  J
:;r- -!5 ( - o'/w i o: 'u i j i i i i i
t ~ .  I - - ,  I---; f t  i ' l  ■' ! * i
to
■ to
I r-».'C. i  I lo :.‘j .o  l J
. 0 : ’  •••:'> l I I I I .1 j
I I 1 J 1 I J 1 3 I I !■ 0 i
!-^ .C' -
* 4 *
’ to /o; - -■ i -i . "c
TABLE III
O O 0/ 7 * * # •/ H c 
r\i r\: 0 ,0  o
.0 t- . ;! i X: 0
■ O  0.0-T,- :,0 ft ■ j • • •*/":•! ru : -> . v r"
.• - SO •: ■ -> ,-v; O 'oo - o /"u . “ j - ■ c - /■'•.1 .
'“"I V'1; i"; 1", [ -\ ;
o  co rj. O'; : : • to • , ,o „,0; Of O ; f- . : • .I- -, r-i 1—: ; 1 ~i 1-'. r~i : - ; ;
ocd
PMCQ
g
<Uo
$PMCQ
rHO
<Da<
o
<3)0*
Q) • 
cd cr1 
tsi W
03
03
A
o
m
03
►n
-p
•&
o
PQ
a>
<D
03
cdo
St
O  ON CTn KN UN '>3' KN CD OJ VO 
vi) KN UN ■'3_ On CO CM C—  C— VO 
CM CM i—i H  W  O  (VI O  ON rH » » « » * * * » • *  
rH rH rH rH rH rH rH rH O  rH
o o o o o o o o o o
00 KN KN 00 rH rH C—  "^J" UN VO 
UN UN C—  VO CM ON CM UN VO "3* 
H H H H O l H C M H H O J
O O O O O O O O O O  
UN CD KN CO KN CM t—  ON KN
ON CO UN UN C—  CV) ^  KN UN
' CM CM CM KN CM KN CM CM KN
O  O  ON VO rH VO O  C— •'nT C—  O  ON ON O  KN VO ON
[VO KN M" KN ITM> UN O  O  KN CM ^  CM CM UN KN O
CM CM CM CM KN CM KN CM CM KN CM CM CM CM CM CM CM
I 1 I I I I t I I t I I I I 1 I I t
I I I I 1 1 I
O O 
KN 00 
CO ON 
rH rH
O O O O O O o
UN 00 'si' KN CM KN C~
CM VO 'M' C~- I C—  CO KN
i—I rH CM (—I rH rH rH
I I I I I I I I
O O o
CM VO
UN CM CM 
CM CM rH
O
KN
O O O
rH VO O
I ON rH 1 t— 
rH CM rH
O O O O q O O O O O O  
O C Nt'C— O N C n O k N V O O N
I I 1 I I I I I 1 I I
O  UN CM O  O  O  O  UN O  UN On UN O  t— VO C— VO UN O  ON KN KN UN CM C'~ O  00 rH
CD r~) UNVO UNCO UN 'vi' CM CM rH MD ON O  KN IN- CD CD CM UN KN UN rH UNVO IN- UN CM
'^ '■vf-'H-’sj-VO UN UN KN VO 'H''H-'H-'H-'^'H-KN,c^ 'UN';d'KN ^ V O  ^  KN
t - O i r \ ^ O H i r \ v r M ' O W C M V U N M ' O n f ~ V C l f M A O w W  O-VO O  O
KN UN O  'M’O  ON UN ON VO C'— CM CM ON VO UN 00 CM KN O  VO Q  tN-O KN UN "H"
GO VO GO GO KN CO ON ^  UN O  VO t—  C— UN UN VO "cf 00 ON C^ - ^  VO O  UN UN VO UN UN 
rH rH rH
O  ON ^  rH CO ^  UN C— UN rH KN CM M O  00UNQ0 IN-CO UN CMM0 KN GO rH M  O  KN
UN UNVO VO UNVO UNVO UNVO ^  UN VO VO VO VO UNUNUNUNUNt— f— UNUNC~-VO
H H H r l H H r l H H r l r l r l H H H H H H H H r l r t H H r l r l H H
VO rH UN rH ON CO C— i—1 VO C~~ O  rH CD vj- CM i—(CM UN C—  00 rH UN 00 O  H  CM C VO
UN KN UN rH VO rH CM CM UN KN C—- UN KN CM CM CM UN UN KN 00 UN rH UN UN UN KNVO
If—i CM KN ^  UN VO C—  CD ON O  rH CM KN "Vf UN VO t—  CO ON O  H  CM KN 'M' UN VO C~C0 
K V K N K N K N K N K N K N K N K N M - M - M - M - M ’ M - M ’ M - M ' M ' l A i n U N U N i n U N l f M r M f N
208.
i i i
i i
i - . *
;i V
r;':
r Y‘
--•j
r
I - r  1 I -:- !
l-’r I :
TABLE IV
:-i
I
I ! I -i-
! O ! 0
Hi K j
o
>M
9Eh
to
-P
o
03
• r j
*§m
o
}25
II
03•H
03
£«s
4
cdo•H
-P
03
•H
-P
cd-p
to
10•H
03
030)
&
03
P3 a) . P Ch  -h
O r-H
£O
"S
&w
03
•P JH 
•H Cd 6 03•H £
03 O  O
eJ -p  a> $3 a>•h o
O m 
O  p ,
-pp
03o
U
03
Ph
u n
ON
Oa1
03
-PiH O
rH 03
<** •rs
2
CO
02
03
rH
<H
O sl
03
&! iH03
-2s 03p 03
rH
<D
§ 39 «
03 
03 43
w  cn
03
-p
5
o?H
■p
o
03
rHw
X
rH^r0•"tf-c—1X
CMO«
UN
UNC—
CMI
{>3
CO•*q-
«
CM
LfNIX
CM
O-d-
6 i
UN C— 
CM I>3
CO'^ r
IX
ccT
UN
o
VO
rHII
COi—Io
V^3
c~~C~-
•
CM
UNIX
mcT
rH
v o
II
COrH0
KN11*3
-UN
ON0
KNC—1X
CO
v o•O
rH
n
CM
ON
iHI
1*3
VO
ON0 
CM 
UN1X
co0 
rH 
KN
I
CM
ONt—11>3
O rH VO rH O
CM CM -3- CM KN CM
+  1 +  1 +  I +  1 +  » +  1
O O o o Q o
^r VO UN ON O ON
C~- UN CM c— vo KN
rH
+  i + 1 + 1 + 1 - f  I +  1
CM CM UN KN UN
vo 00 "vT 00 UN 00o o o e o •
O O o o O O
00 ao CD CO i—1 rH
KN KN KN KN -3- 'vt~
t— I— C— £— ON ON
rH rH rH rH rH tH
rH rH i—1 rH CM CM
CM CM CM CM CM CM
e o •
SS S a4 • • • • •
feS pq pq fee pqo o « • • sPQ P2 pq HI PQ r-q
03 03 03 <x
cd cd 03 03 rH rH
!S5 1*25 W W O O
■P
r£
*H
CD
fie
-H*TJ
o
PQ
p q
L.
B
.M
. 
= 
Le
an
 
bo
dy
 
m
as
s
were derived from measurements of red cell mass employing 
the correlation established by Muldowney (1957)* The 
error in the derivation of lean body mass from red cell 
mass was estimated by taking half the difference between 
successive measurements of red cell mass and combining 
it with the 95*f> confidence limit of the correlation between 
red cell mass and lean body mass expressed as a percentage 
of the mean value of lean body mass. This error should 
not exceed £ 5$*
Results
Exchangeable electrolytes in normal subjects. The complete
data obtained in the normal subjects are shown in Tables
II and III, and the statistical analysis is given in Table
IV. The reproducibility of the measurements of exchangeable
electrolytes was tested by carrying out two successive
estimations in a number of subjects. The standard deviations
were - 2.8fo for Na (8 subjects), - 3*5*f> K (5 subjects)e e
and t j^ jfo for Cl (5 subjects).
6
The relationship between Na and body weight is shown©
in Figure 4* The coefficient of correlation was 0.62 and
the 95i<> confidence limits £ 2 7 It was found that the
majority of the points representing males lay above the
regression line while the converse was true of the females.
When Na was correlated with lean body mass, however, in 
e
the same subjects (Figure 5)» both the correlation coefficient 
(r « 0.82) and the 9 5 confidence limits (£ 20^) were improved.
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FIGURE 4
The correlation of total exchangeable sodium with 
total body weight in normal subjects showing the 
regression line and its 95i° confidence limits o
FIGURE 5
The correlation of total exchangeable sodium 
with lean body mass in normal subjects showing 
the regression line and its 95i° confidence limits*
FIGURE 6
The correlation of total exchangeable potassium 
with total body weight in normal subjects showing 
the regression line and its 95^ confidence limits*
FIGURE 7
The correlation of total exchangeable potassium with 
lean body mass in normal subjects showing the 
regression line and its 95f° confidence limits* The 
interrupted line is the regression line derived from 
the date, of Ikkos et al* (1956)*
FIGURE 8
The correlation of total exchangeable chloride with total 
body weight in normal subjects showing the regression 
line and its 95^ confidence limits*
FIGURE 9
The correlation of total exchangeable chloride with
lean body mass in normal subjects shoving-the regression 
line and its 95^ confidence limits*
^  j
+ FEMALE• MALE
4 0 0 0  -]
| 3 0 0 0 -
-H- +2000-
Z  IO O O -
TOTAL BODY W E IG H T—  Kg.
L——  --   ,-------------  ___
j.'TPTTTJTP c;• - . 1 J.U UiUU > •
• MALE + FEMALE
4 0 0 0  - i
| 3 0 0 0 -
2000-
IOOO-
■!
IO 2 0  30 4 0  5 0  60  7 0  60  9 0  IOO IIO 120 130O
LEAN BODY MASS —  Kg.
EX
CH
AN
G
EA
BL
E 
P
O
TA
S
S
IU
M
 
 
m
Eq
.
5 0 0 0 M A LE
FEM ALE
4 0 0 0  -
3 0 0 0  -
•+
2000 -
1000
3 SO 6 0  7 0  8 0  90 |0<
total body weight k9.
HO 120 130 140
FIGURE 7
5 0 0 0  -i M A LE
FEM ALE
4 0 0 0  -
3 0 0 0  -
2000 -
IOOO -
IO 2 0  3 0  4 0  5 0  6 0  7 0  8 0  90 IOO 110 120 130 140
LEAN BODY MASS—  Kg.
EX
CH
AN
G
EA
BL
E 
CH
LO
RI
DE
 
—
m
Eq
. 
EX
CH
AN
G
EA
BL
E 
CH
LO
RI
DE
 
— 
m
Eq
.
FIGURE 8.
M A LE5 0 0 0  -i
+  FEM ALE
4 0 0 0  -
3 0 0 0  -
2000 -
IOOO -
TOTAL BODY W E IG H T  Kq.
FIGURE 9.
5 0 0 0  -i M A LE
+  FEM ALE
4 0 0 0  -
3 0 0 0  -
2000 -
IOOO -
IO 2 0  3 0  4 0  5 0  60  7 0  8 0  90 IOO IIO  120 130 140
LEAN BODY MASS ___ Kg.
The points for both males and females were also more 
uniformly distributed about the regression line. When K
e
was correlated with body weight a very wide range of
normal values was found (Figure 6). Once again most of
the males lay above the regression line and the females
below. When lean body mass, on the other hand, was used
as the reference standard, the normal range narrowed
and the male and female values were distributed on either
side of the regression line (Figure 7)* The effect of
using lean body mass instead of body weight as a reference
standard for Cl was similar to that observed in the case e
of Nag and Kq (Figures 8 and 9)*
In 14 males and 10 females the correlation between 
Na^ and Cle was highly significant (r * 0.88) and the 
95$ confidence limits (t 17$) were narrower than those 
for Nag when either body weight or lean body mass was 
used as a reference standard. Because of the primarily 
extracellular location of both these ions, this finding 
was not unexpected. Of greater interest, however, was 
the observation that in this group of subjects the Na 
could not be wholly acoounted for by that present in 
the extracellular fluid, as represented by the chloride 
space, since the mean ratio of the sodium space to the 
chloride space, 1.179> was significantly greater than 
unity (p <0.01, standard deviation of the mean * 0.024)*
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Exchangeable electrolytes in thyrotoxicosis. The complete
data obtained in the thyrotoxic subjects are shown in Table Ve
It was found that all but two of the values for Na (Figure 10)
and all but 4 of those for Cl (Figure 11) lay above
e
the regression line for the normal groups
In the case of K , however, there was a more even e’ 9
distribution of values about the regression line (Figure 12).
The observed values of the exchangeable electrolytes were 
reduced to a common value of lean body mass in both thyrotoxic 
and normal subjects by using the regression line for each 
group. In the case of Nag the difference between the 
mean values of the thyrotoxic and normal subjects was 
found to be statistically significant (p <s 0.05). No 
statistically significant difference was found for K
6
(f * 5.87, p <0.05) and Cle (f * 3*92, p <0.05).
The ratio of sodium space to chloride space was
calculated in these subjects and found to be 1*135•
This value is just within 2 S*D. of the mean value obtained
in the normal group.
In 10 of the 20 subjects the measurements of exchangeable
electrolytes and lean body mass were repeated as soon as
the patients had become euthyroid. The changes in Na
and Cle showed no consistent pattern but in all but one
case K rose0 e
FIGURE 10
Total exchangeable sodium plotted against lean body 
mass in thyrotoxic subjects also showing the 
regression line and its 95$ confidence limits for 
normal subjects*
FIGURE 11
Total exchangeable chloride plotted against lean body 
mass in thyrotoxic subjects also showing the regression 
line and its 95$ confidence limits for normal subjects*
FIGURE 12
Total exchangeable potassium plotted against lean body 
mass in thyrotoxic subjects also showing the regression 
line and its 95$ confidence limits for normal subjects*
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Discussion
Exchangeable sodium. Miller and Wilson (1953), Forbes
and Perley (1951), and Edelman et al. (1954) found no statistically
significant difference in Na per Kg. body weight between
6
males and females. The present series of normal subjects,
however, shows a striking sex difference (Figure 4) which
is accounted for by the inclusion of many obese females*
Forbes and Lewis (1956) have shown by direct analysis that
the sodium content of adipose tissue is low compared
with that of the fat-free tissue. Hastings and Eichelberger
(i95T) also found that it was necessary to analyse fat-
free muscle before consistent results could be obtained
for the sodium content of different muscle samples. It
might be expected, therefore, that Nag per Kg. body weight
would decrease as the proportion of depot fat increased®
This effect is well illustrated by 2 of the normal subjects®
One was a grossly obese female, with an Na of 27 mEq®/Kg*
body weight, this figure being lower than any of the
published values for females. The other, a male subject,
had an Na of 41 mEq./Kg. body weight. When expressed
per Kg. lean body mass, the difference between those values
was considerably reduced the values becoming 54 mEq./Kg*
and 50 mEq./Kg* respectively. The findings, therefore,
in conjunction with the evidence of direct tissue analysis,
show that it is more accurate to predict Na from lean
©
body mass than from body weight®
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Munro et al.(1958) could not demonstrate any increase
of Na^ in thyrotoxicosis before treatment because, in
their own words, "the range of normal values is wide and
in any condition in which weight has been altered it is
of little value to compare the values as mEq. per Kg. of
body weight with the range in health” • By using lean body
mass as a reference standard it has been possible to overcome
this difficulty and the results of the present investigation
show that there is in fact an increase in Na relative
e
to lean body mass in this disease. This increase is
probably due to the increase in plasma volume found in
thyrotoxicosis by Gibson and Harris (1939)* The increase
in Nag found in the present series is unlikely to be
due to an associated increase in the Na of bone fore
reasons which will be discussed below. The fact that
serum concentrations of sodium are normal in thyrotoxicosis
(Werner, 1955) does not of course preclude an increase
in total body content of the electrolyte0
Munro et al. (1958) also carried out serial measurements
of Na in thyrotoxic patients undergoing treatment and 
e
found that the alterations did not follow any clear 
pattern. In the present investigation this finding was 
confirmed in 10 thyrotoxic patients in whom Na and lean 
body mass me astir ements were repeated as soon as they had
"become euthyroid. This finding might be explained on 
the basis that treated thyrotoxic subjects do not return 
to metabolic normality when they reach the stage described 
by the clinician as the euthyroid state but remain in 
a condition of metabolic instability.
Excess exchangeable sodium of bone. The results show that 
the ratio of sodium space to chloride space in normal 
subjects is significantly greater than unity. This finding 
must be interpreted in the light of the available evidence 
on the distribution of sodium and chloride in body fluids 
and tissues (Figure 13). The sodium content of bone may 
be regarded as being divided into two parts, that contained 
in the extracellular fluid of bone, and that incorporated 
into the bone crystal itself (Robinson, 1952). The bone 
chloride, on the other hand, is confined to the extracellular 
fluid, where it is present along with sodium in the same 
ratio as in serum. Both ions in this compartment of 
bone are exchangeable. Bauer (1954) has shown by direct 
radioisotopic studies of rat bones that part of the sodium 
incorporated into the bone crystal is also rapidly exchangeable 
and that it is in excess of the exchangeable chloride 
in bone. This excess of exchangeable sodium in bone is 
likely to lie at the surface of the bone crystal, where 
it would be in close contact with the extracellular fluid*
This finding that the ratio of sodium space to chloride 
space is significantly greater than unity therefore means
FIGURE 15
The distribution of sodium and chloride in bone and 
extracellular fluid#
FIGURE 13.
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that there is a pool of exchangeable sodium in excess 
of exchangeable chloride which is large enough to be 
detected by isotope dilution techniques. It seems probable 
from Bauer*s work that the greater part of this excess 
is localised in bone although it is possible that a 
contribution is made by other tissue such as muscle 
(Harrison et al. 1936). Harrison (1937) has shown that 
the molar ratio of calcium to sodium in bone is the same 
in normal, rachitic and osteoporotic rats. It follows 
that disturbances in calcium metabolism might be associated 
with changes in the sodium of bone which might be demonstrable 
by an alteration in the ratio of sodium to chloride spaces.
Thyrotoxicosis is often associated with negative calcium
bhlance and decalcification of bone (Aub et al. 1929). A
close correlation has also been found between blood levels
of protein-bound iodine and the ratio of calciunuto creatinine
in the urine (Crooks, Farrell, Macgregor and Fordin,
unpublished data). The finding therefore that there is
no significant change in the Fa of bone, as reflectede
by the ratio of sodium space to chloride space suggests 
that either the relationship between calcium and sodium 
found by Harrison, does not hold in thyrotoxicosis or the 
ratio of sodium space to chloride space is not sensitive 
enough to detect small changes in the Fag of bone. The 
fact that there is no significant different© in the ratio
of sodium space to chloride space between thyrotoxic and
normal subjects also suggests that the increased Na ine
thyrotoxicosis is unlikely to be accounted for by an 
increase in bone sodium.
Exchangeable potassium. The correlation obtained between 
K and lean body mass is supported by experiments of 
other workers both in human subjects and in animals. Thus, 
Ikkos, Ljunggfcen, and Luft (1956) in Sweden as part of 
an investigation into the relation between extracellular 
and intracellular water in acromegaly, measured total 
body water and Kg in a control group of 55 normal subjects. 
From their data antipyrine space measurements were derived 
and, after correcting for the water content of plasma, 
lean body mass was estimated by means of the Pace-Rathbun 
formula. When this was done a-regression line of Kg on 
lean body mass was obtained which has been included in 
Figure 7» the coefficient of the correlation being 0*92. 
This regression line lies within the 95$ confidence limits 
of the present series, although a slight systematic 
difference is apparent. Carcass analysis in rats also 
provides direct evidence of a close correlation between 
total body potassium and lean body mass, (Cheek and West, 
1955), The results obtained in the present series also 
provide a range of normal values much narrower than that 
given by body weight the 95$ confidence limits being 
reduced from -53$ of the mean to t 25$ of the mean as
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well as eliminating the apparent sex difference due to the
greater fat content of female subjects. They also allow
a proper evaluation of the changes in K found in thyrotoxicosis,
6
a disease in which,as previously pointed out, there are 
considerable changes in the proportions of lean tissue and 
fat*
The results obtained in the patients with thyrotoxicosis 
suggest that the diminution in potassium content in this 
disease shown by Dsnowski and Elkinton (1951) and Munro 
et al. (1958) can be wholly accounted for by a corresponding 
loss of lean tissue. In other words the change in body 
potassium is related directly to the diminution in cell 
mass. It is noteworthy that the mean value of the lean 
body mass in the thyrotoxic subjects of the present series 
was approximately 39 Kg* compared with a corresponding 
figure of 53 Kg. in the normal group. This finding accords 
well with the recognised negative nitrogen balance found 
in the condition.
Of 10 subjects in whom the measurements of Kg were 
repeated after treatment, the values increased in 9 a*nd 
were associated with coincident increases in body weight0 
A similar finding was made by Munro et al. (1958) i** 14 
of 16 patients. This is confirmatory evidence of the 
close relationship between the changes in K and lean 
body mass found in the disease in view of the accepted
positive nitrogen balance and increase in lean tissue 
produced by treatment.
Exchangeable chloride. Weir (1940) has demonstrated that
Cl^ is directly related to the lean carcass in dogs. This
evidence suggests, therefore, that chloride is not present
in depot fat, Forbes and Lewis (1956), however, have
analysed two human cadavers and found an appreciable
chloride content in adipose tissue. This appears
to conflict with the results in the present normal
series and with the data from animal studies quoted
above. The discrepancy is, however, one of definition
since the term depot fat, as used in the present study
refers only to the lipid content of adipose tissue. Keys
and Brozek (1955) estimate that lipids form 62$, water
31$ and cell solids 7$ of adipose tissue. These relative
proportions of water and cell solids are similar to those
obtained in muscle, and the non-lipid portion of adipose
tissue is therefore included in the estimate of lean body
mass derived from total body water. One would expect
therefore that adipose tissue as a whole should contain
a percentage of chloride in proportion to its non-lipid
content. It is clear from the results obtained in the
normal subjects of the present series that the relationship
between Cl and lean body mass is closer than that 
e
between Cl and body weight and indeed the 95$ confidence 
e
limits of the former, - 14$ of the mean is narrower than
those of Na or K • e e
Although ispection of Figure 11 suggests that there
is an increase in Cl in thyrotoxicosis, which might bee
expected because of the increase in plasma volume 
found in the condition, the changes were not statistically 
significant. This may be due to the small number of 
cases studied. When measurements of Cle were repeated 
after treatment in 10 of the 20 subjects the same absence 
of any clear pattern was found as in the case of
SECTION
Summary
1* The correlations of total exchangeable sodium (N&e)>
potassium (K ) and chloride (Cl ) with lean body mass is 0 0
better than with body weight* In normal subjects it is
the same for both males and females*
2. The ratio between sodium space and chloride space
in normal subjects is significantly greater than unity
and it is suggested that this is due to the excess
of Na over Cl in bone* e e
3* In thyrotoxicosis Nae increases relative to lean body
mass whereas K remains unchanged. The relationship 0
between sodium space and chloride space is undisturbed*
APPERPIX I
Clinical Diagnostic Index —  Recommendations for Use*
APEENDIX I
Clinical Diagnostic Index Recommendations for Use* 
Symptoms
Questions requiring only positive or negative replies 
should be avoided and special care should be taken to ensure 
that the initial question about each symptom is not a 
leading one. Supplementary questions should always be 
asked and before a symptom is recorded as present these 
supplementary questions should confirm or clarify the 
initial answer. For example, in the case of te|^perature 
preference the patient should be asked first: "What type 
of weather do you prefer?” rather than ”Do you prefer cold 
weather?**. A suitable supplementary question would be 
••Do you feel comfortable or uncomfortable in a warm room?” *
Only symptoms of recent onset or recently increased 
severity should be recorded with one exception. If 
preference for heat is present, irrespective of its duration, 
it should be regarded as significant since it is highly 
unusual in thyrotoxic patients. Where there is any doubt 
about the presence of a symptom it should not be recorded* 
The criteria for individual symptoms are as follows:
Dyspnoea on effort0 The age of the patient should be 
taken into account. The symptom is only significant when 
it is of recent onset*
Palpitations are significant if they occur at rest or 
during moderate exercise. The age of the patient is 
relatively unimportant*
Tiredness refers to a feeling of unusual exhaustion after 
familiar physical effort and not to symptoms of psychogenic 
origin such as tiredness on first waking in the morning* 
Temperature preference is of high diagnostic significance 
and the type of preference should be reached only after 
supplementary questions have been asked. Suitable ones 
elicit the presence of discomfort in a warm environment, 
the habit of sitting away from the fire and diminished use 
of hot water bottles*
Excessive sweating refers to both thermal and emotional 
sweating and the adjective ’’excessive1’ should be omitted 
from the initial question,,
Nervousness. Questions should be asked about irritability, 
easy loss of temper, jumpiness and tenseness* The symptom 
is recorded only if these manifestations have shown a recent 
increase*
Appetite increase or decrease* The question "How is your 
appetite?" should be an enquiry as to whether it is regarded 
as less than normal, normal or excessive.
Weight increase or decrease should be definite, recent, 
progressive, and confirmed both by slackness or tightness 
of clothing, and by the opinion of friends or relatives*
If the patient has kept records of weight an increase or 
decrease of 7 lbs. or more during a period of up to one 
year should be considered significant*
Signs
The following* criteria must be fulfilled before a 
physical sign is recorded as present.
Palpable thyroid. The gland should be significantly 
enlarged and visible as well as palpable, except in the 
male, where any palpable thyroid tissue is considered 
abnormal.
Bruit over thyroid. The bruit should be high-pitched and 
systolic or to-and-fro, and to distinguish it from a 
venous hum it should be uninfluenced by rotation of the 
head or pressure on the neck veins.
Exophthalmos. Sclera should be seen between the lower 
lid and the iris of one or both eyes with the patient 
looking directly ahead.
Lid retraction* Sclera should be seen between the upper 
lid and the iris of one or both eyes with the patient 
looking directly ahead.
Lid lag. An area of sclera should increase or appear 
when the patient*s eyes are fixed on the examiner*s finger 
moving from above downwards. It should be noted that 
this criterion is more strict than that usually employed. 
Hyperkinetic movements. The movements of removing and 
replacing clothing have to be unusually rapid and jerky, 
conveying an impression of over-reaction, wasted energy and 
clumsiness. It is the combination of rapidity and inaccuracy 
of movement which is significant.
Fine finger tremor. With the patient’s eyes closed, the 
outstretched separated fingers should show a fine tremor.
Coarse tremor is ignored, but if doubt exists, the sign 
is recorded as present.
Warm, moist hands. The palms are compared with the hands 
of the examiner, taking into account the temperature of 
the environment and his normal vasomotor tone. They 
should be warmer than those of the examiner and a 
sensation of dampness should remain on his hands after 
withdrawal.
Casual pulse rate. This is counted for one minute at the 
end of the examination.
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